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Abstract
Circadian rhythms are biological oscillations with a period length of roughly 24 hours. They
confer an adaptive advantage as they enable the prediction of the regular environmental changes
caused by the rotation of the Earth, and so they are highly conserved. Circadian coordination of
biology is an important feature not only across kingdoms, but also at multiple levels of biological
scale, from behaviour to physiology and cell biology. On the cellular level it is thought that
mammalian circadian rhythms are driven by a delayed feedback loop, involving the transcription
and translation of a core set of ‘clock proteins’. This cellular timekeeping system is remarkably
precise and robust to perturbations.
In the first chapter of this thesis I explored the mechanism of action of picrotoxin, a drug
that shortens circadian period through unknown means. I uncovered features that are not readily
explained by the canonical transcriptional-translational-feedback loop (TTFL) model of circadian
rhythm generation. In the second part of this thesis I used mass spectrometry-based proteomics to
characterise the cellular circadian proteome, and I uncovered the reciprocal, rhythmic regulation
of protein and ion concentrations in cultured cells. Strikingly, by using a genetic knock-out
of the CRYPTOCHROME (CRY) proteins I found that the generation of these rhythms was
not dependent upon the TTFL, strongly supporting an alternative model of circadian rhythm
generation – the post-translational oscillator (PTO) model. In the next chapter I explored the
circadian regulation of the PERIOD 2 (PER2) protein in CRY-deficient cells, suggesting that a
key determinant of PER2 behaviour in the absence of the TTFL may be cellular protein and ion
concentrations. In the final chapter I investigated the functional consequences of CRY knock-out.
I found that CRY-deficient cells and animals have disrupted proteostasis and metabolism, and
found that impaired proteostasis attenuates circadian rhythmicity at the cellular and organism
levels.
Altogether, the work presented in this thesis provides evidence for a PTO model of circadian
rhythm generation. I have uncovered circadian regulation of the cellular proteome even in the
absence of the canonical TTFL. I propose that rather than driving circadian rhythms, the TTFL
confers robustness to cellular timekeeping and facilitates proteostasis.

Table of contents
List of figures xvii
List of tables xxi
Nomenclature xxiii
1 General introduction 1
1.1 Circadian rhythms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.2 Circadian timekeeping at multiple levels of biological scale . . . . . . 3
1.1.3 Rhythmic gene expression is coordinated by transcription/translation
feedback . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.1.4 Problems with the TTFL model . . . . . . . . . . . . . . . . . . . . . 6
1.1.5 An alternative model: the post-translational oscillator (PTO) . . . . . . 9
1.1.6 Implications for the evolution of circadian rhythms . . . . . . . . . . . 11
1.2 Quantitative proteomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.2.1 An introduction to proteomics . . . . . . . . . . . . . . . . . . . . . . 11
1.2.2 Quantification methods . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.2.3 Post-translational modifications . . . . . . . . . . . . . . . . . . . . . 13
1.3 Protein homeostasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.3.1 Introduction to protein homeostasis . . . . . . . . . . . . . . . . . . . 13
xii Table of contents
1.3.2 The proteostasis network . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.3.3 The integrated stress response (ISR) . . . . . . . . . . . . . . . . . . . 15
1.4 Overview of the thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2 Materials and Methods 21
2.1 Mammalian cell culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2 General statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.3 Longitudinal bioluminescent reporter experiments . . . . . . . . . . . . . . . . 22
2.4 Luciferase assays after picrotoxin treatment . . . . . . . . . . . . . . . . . . . 23
2.5 Biochemical characterisation of picrotoxin activity . . . . . . . . . . . . . . . 23
2.6 Proteomics and phosphoproteomics . . . . . . . . . . . . . . . . . . . . . . . 23
2.6.1 Sample preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.6.2 Enzymatic Digestion . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.6.3 TMT (Tandem mass tag) peptide labelling . . . . . . . . . . . . . . . . 24
2.6.4 Basic pH Reverse-Phase HPLC fractionation . . . . . . . . . . . . . . 25
2.6.5 Enrichment of phosphopeptides . . . . . . . . . . . . . . . . . . . . . 25
2.6.6 LC MS/MS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.6.7 Spectral processing and peptide and protein identification . . . . . . . . 26
2.6.8 Bioinformatics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.7 Cell volume measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.8 Western blotting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.9 Timecourse experiments: general structure . . . . . . . . . . . . . . . . . . . . 28
2.10 Measurement of cellular protein content . . . . . . . . . . . . . . . . . . . . . 29
2.11 Measurement of the effective diffusion coefficient of quantum dots . . . . . . . 30
2.12 Measurement of intracellular ion content . . . . . . . . . . . . . . . . . . . . . 31
Table of contents xiii
2.13 Luciferase folding assays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.14 Proteasome activity assays . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.15 Measurement of translation rate . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.16 Metabolic profiling of cells in culture . . . . . . . . . . . . . . . . . . . . . . 33
2.17 Mouse behaviour experiments . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.17.1 General structure for mouse behavioural recordings . . . . . . . . . . . 34
2.17.2 Mouse behaviour experiments with ixazomib treatment . . . . . . . . . 35
2.18 Details of antibodies and drugs . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3 Pharmacological manipulation of a state variable by picrotoxin 37
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.1.1 Pharmacological screens to interrogate the clock mechanism . . . . . . 37
3.1.2 Aims of this chapter . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.2 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.2.1 Picrotoxin treatment is a strong synchroniser . . . . . . . . . . . . . . 38
3.2.2 Picrotoxin increases PER2::LUC half-life . . . . . . . . . . . . . . . . 39
3.2.3 Picrotoxin has some irreversible effects . . . . . . . . . . . . . . . . . 39
3.2.4 Removal of Picrotoxin is a strong synchroniser . . . . . . . . . . . . . 43
3.2.5 Picrotoxin biochemical characterisation . . . . . . . . . . . . . . . . . 43
3.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.3.1 Summary of findings . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.3.2 Future strategies to find the target of picrotoxin . . . . . . . . . . . . . 47
4 Circadian proteomics and phosphoproteomics 49
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.1.1 Current understanding – circadian proteomics . . . . . . . . . . . . . . 49
xiv Table of contents
4.1.2 Aims for this chapter . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.2 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.2.1 Experimental design . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.2.2 Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
4.2.3 Validation with clock proteins . . . . . . . . . . . . . . . . . . . . . . 54
4.2.4 Coverage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
4.2.5 Rhythms in cellular ion content . . . . . . . . . . . . . . . . . . . . . 55
4.2.6 Rhythms in cytosolic protein concentration . . . . . . . . . . . . . . . 57
4.2.7 Regulation of protein:ion ratio . . . . . . . . . . . . . . . . . . . . . . 62
4.2.8 Insights into the clock mechanism . . . . . . . . . . . . . . . . . . . . 64
4.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.3.1 Summary of findings . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.3.2 Evidence for a post-translational oscillator . . . . . . . . . . . . . . . . 66
4.3.3 Novel roles of the TTFL . . . . . . . . . . . . . . . . . . . . . . . . . 68
5 PER2 links the post-translational oscillator with transcriptional feedback repres-
sion 71
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
5.1.1 Cellular mechanisms of circadian rhythm generation . . . . . . . . . . 71
5.1.2 Circadian rhythms in CRY1−/−; CRY2−/− fibroblasts . . . . . . . . . 72
5.1.3 Aims of this chapter . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
5.2 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
5.2.1 Variability in PER2::LUC rhythms between multiple cell lines . . . . . 73
5.2.2 PER2 has large regions of disorder . . . . . . . . . . . . . . . . . . . . 74
5.2.3 Increased contact inhibition . . . . . . . . . . . . . . . . . . . . . . . 74
5.2.4 Reduced metabolic activity . . . . . . . . . . . . . . . . . . . . . . . . 77
Table of contents xv
5.2.5 Increased protein folding . . . . . . . . . . . . . . . . . . . . . . . . . 79
5.2.6 Decreased synthesis of amino acids . . . . . . . . . . . . . . . . . . . 82
5.2.7 Manipulations that did not promote rhythmicity . . . . . . . . . . . . . 82
5.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.3.1 Summary of findings . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.3.2 Disorder amongst TTFL components . . . . . . . . . . . . . . . . . . 86
5.3.3 Evidence for the PTO model . . . . . . . . . . . . . . . . . . . . . . . 87
6 Cryptochromes regulate cellular proteostasis 91
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
6.1.1 Non-timekeeping roles of cryptochromes . . . . . . . . . . . . . . . . 91
6.1.2 Aims of this chapter . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
6.2 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
6.2.1 CKO cells show defects in protein homeostasis . . . . . . . . . . . . . 92
6.2.2 CKO cells have reduced proteasomal degradation compared to WT . . 92
6.2.3 CKO cells do not have altered basal translation rate . . . . . . . . . . . 94
6.2.4 Development of a method to measure cytosolic protein folding activity 96
6.2.5 CKO cells are more sensitive to stress . . . . . . . . . . . . . . . . . . 99
6.2.6 Cryptochromes limit the rhythmic regulation of intrinsically disordered
proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
6.2.7 CKO cells show a metabolic defect . . . . . . . . . . . . . . . . . . . 105
6.2.8 CRY-deficient mice have physiological defects . . . . . . . . . . . . . 108
6.2.9 Pharmacological inhibition of rhythmicity in WT cells . . . . . . . . . 110
6.2.10 Pharmacological inhibition of rhythmicity in WT animals . . . . . . . 110
6.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
6.3.1 Summary of findings . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
xvi Table of contents
6.3.2 Proteostasis and TTFL function . . . . . . . . . . . . . . . . . . . . . 114
7 Perspectives and future work 117
References 123
Appendix A Appendix Tables and Figures 157
List of figures
1.1 Features of Oscillations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 The mammalian transcriptional-translational feedback loop (TTFL). . . . . . . 5
1.3 Two models for cellular circadian rhythm generation. . . . . . . . . . . . . . . 7
1.4 The proteostasis network. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.5 The integrated stress response. . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.1 Picrotoxin shortens period length and resets circadian phase. . . . . . . . . . . 40
3.2 Picrotoxin increases the stability of PER2::LUC. . . . . . . . . . . . . . . . . 41
3.3 The irreversible effects of picrotoxin. . . . . . . . . . . . . . . . . . . . . . . . 42
3.4 Picrotoxin removal is a strong zeitgeber. . . . . . . . . . . . . . . . . . . . . . 44
3.5 Assaying the biochemical properties of picrotoxin. . . . . . . . . . . . . . . . 46
4.1 Proteomics and phosphoproteomics experimental workflow. . . . . . . . . . . 51
4.2 Definitions of rhythmicity – statistical and functional. . . . . . . . . . . . . . . 53
4.3 Benchmarking using CRY1. . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
4.4 Global features of the circadian proteome and phosphoproteome. . . . . . . . . 56
4.5 Circadian regulation of cellular ion content. . . . . . . . . . . . . . . . . . . . 59
4.6 Phase clustering of rhythmic proteins and phosphopeptides. . . . . . . . . . . . 60
4.7 Cytosolic protein concentration is rhythmic in antiphase to ions. . . . . . . . . 63
4.8 Protein:ion ratio is dysregulated in the absence of CRY. . . . . . . . . . . . . . 66
xviii List of figures
4.9 Kinase binding predictions from phosphopeptide sequences. . . . . . . . . . . 67
4.10 Model for the generation of 24-hour rhythms in cytosolic protein concentration
and ion content. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
5.1 Characterisation of PER2::LUC rhythmicity in CKO cells. . . . . . . . . . . . 75
5.2 The structure of PER2::LUC is around 40% disordered. . . . . . . . . . . . . . 76
5.3 Robustness is increased by length of time in culture and passage number. . . . . 78
5.4 Low glucose concentration increases robustness in CKO cells. . . . . . . . . . 80
5.5 Robustness is increased by 4-phenylbutyrate treatment. . . . . . . . . . . . . . 81
5.6 Increased amino acid concentration may increase robustness. . . . . . . . . . . 83
5.7 Supplementation with non-essential amino acids increases robustness. . . . . . 84
5.8 Model of PER2::LUC as a temporal signalling factor. . . . . . . . . . . . . . . 89
6.1 CKO cells have more protein in total than WT. . . . . . . . . . . . . . . . . . . 93
6.2 CKO cells are more sensitive to serum-induced changes in protein synthesis. . . 93
6.3 CKO cells have reduced proteasome activity. . . . . . . . . . . . . . . . . . . 95
6.4 CKO cells do not have a different translation rate compared with WT. . . . . . 97
6.5 Development of a luciferase refolding assay. . . . . . . . . . . . . . . . . . . . 98
6.6 Comparison of chaperone abundance in WT and CKO cells. . . . . . . . . . . 100
6.7 CKO cells have a higher expression of phosphorylated eIF2α compared to WT. 102
6.8 The loss of CRY results in increased phosphorylation of eIF2α in response to
tunicamycin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
6.9 Disorder in the rhythmic proteome and phosphoproteome in WT and CKO cells. 107
6.10 CKO cells have a higher rate of glycolysis compared to WT cells. . . . . . . . 107
6.11 CKO mice have health defects. . . . . . . . . . . . . . . . . . . . . . . . . . . 109
6.12 WT cells phenocopy CKO cells upon CRY inhibition or proteasome inhibition. 111
List of figures xix
6.13 WT mice show decreased circadian organisation of activity when treated with
proteasome inhibitor ixazomib. . . . . . . . . . . . . . . . . . . . . . . . . . . 113
7.1 An expanded post-translational oscillator model. . . . . . . . . . . . . . . . . 118
A.1 Circadian features of PER2::LUC rhythms in CKO cells. . . . . . . . . . . . . 170
A.2 Post-translational modification of PER2 in CKO cells. . . . . . . . . . . . . . . 171
A.3 Examples of WT and CKO mouse behavioural recordings. . . . . . . . . . . . 172

List of tables
2.1 P value representation with asterisks. . . . . . . . . . . . . . . . . . . . . . . . 21
2.2 Antibodies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.3 Drugs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
6.1 Histopathology of CRY-deficient mice. . . . . . . . . . . . . . . . . . . . . . . 108
A.1 Proteomics data: Proteins rhythmic in both WT and CKO cells . . . . . . . . . 158





cAMP Cyclic adenosine monophosphate
CCG Clock-controlled gene
CK1 Casein kinase 1
CKO CRY1/CRY2 double knockout
Cry Cryptochrome gene
CRY CRYPTOCHROME protein
DBP D-box binding protein
DMSO Dimethylsulfoxide
DNA Deoxyribonucleic acid
eIF2α Eukaryotic initiation factor 2 alpha
FRQ FREQUENCY protein
GSK3 Glycogen synthase kinase 3
ICP-MS Inductively coupled plasma mass spectrometry
IDP Intrinsically disordered protein
IDR Intrinsically disordered region
IMAC Immobilised metal ion affinity chromatography
ISR Integrated stress response
iTRAQ Isobaric tag for relative and absolute quantitation
KCC1 Potassium-chloride cotransporter 1
xxiv Nomenclature
LC-MS/MS Liquid chromatography with tandem mass spectrometry
MOAC Metal oxide affinity chromatography
NEM N-ethylmaleimide
NKCC1 Sodium-potassium-chloride cotransporter 1
OSR1 Oxidative stress-responsive kinase 1
PER2::LUC PER2::LUCIFERASE fusion protein
Per Period gene
PER PERIOD protein





ROR RAR-related orphan receptor
SCN Suprachiasmatic nucleus of the hypothalamus
SILAC Stable isotope labelling with amino acids in cell culture
TMT Tandem mass tag
TRX Thioredoxin
TTFL Transcriptional-translational feedback loop





The circadian field is extremely broad, from the study of bird migration [1] to the structural in-
vestigations of proteins in cyanobacteria [2]. Therefore there is a unique richness to the literature,
involving many disciplines from mathematics to field biology to the clinic. Unfortunately, a
result of this richness and cross-talk between levels of biological scale is that the use of language
can be somewhat contradictory, confusing and convoluted. Clear expression of meaning is crucial
for scientific endeavour, and so I will begin this thesis by setting out some definitions that carry
for the rest of the work. These definitions are based on the context in which the terms are most
commonly used, as well as canonical definitions set out by the forefathers of the circadian field,
who used this language to describe their careful and ground-breaking observations almost 60
years ago [3–6].
The word “circadian” is rooted in the Latin words circa (roughly) and dies (day). Circadian
rhythms are endogenous biological oscillations that have a period length of roughly 24 hours
in constant environmental conditions. The period length is “temperature compensated”. This
means that period length is maintained roughly constant over a wide range of temperatures.
Whereas most enzymatic reactions double with every 10°C increase in temperature (Q10 =
2-3) [7], circadian period length changes much less (Q10 = 0.8-1.4) [8]. This is a functional
prerequisite of a useful clock, since they need to be precise despite changes in weather or climate
[5]. Finally, they can be entrained to exogenous stimuli, i.e. environmental parameters that
show 24h oscillations due to the rotation of the Earth – these environmental parameters are
called “zeitgebers”. These are the fundamental “Empirical Generalisations” that were set out
by Pittendrigh based on the collection of careful observations and experimentation presented
2 General introduction
at the Cold Spring Harbour Symposium of 1960 [4]. The term “circadian” first came into use
around this time, and it was formally defined at this seminal meeting to facilitate understanding
of myriad observations of endogenous biological rhythms that approximated 24 hours, and to
guide subsequent research into them [4]. This definition of “circadian” is important because it is
often used in error when describing experiments. If an experiment is conducted in the presence
of a zeitgeber (e.g. light-dark cycles), then these conditions are referred to as “diurnal”.
Key measurable parameters of oscillations are period length, phase and amplitude (Figure
1.1). Period length is the length of time taken to complete a full cycle of an oscillation. Amplitude
is the difference between the peak and the mean value of the signal. Relative amplitude is the
peak-to-trough difference, divided by the mean value of the signal. Damping is the rate of
change of the amplitude over time. Phase is the progress of an oscillator through its cycle, and
a phase shift refers to a displacement of this along the time axis, either delaying or advancing.
Recordings of an oscillation are often detrended using a 24-hour moving average, thus removing
the baseline and allowing these parameters to be measured more precisely, usually by non-linear
regression (see Chapter 2 for more details).
An “oscillator” is a process that can generate rhythms. The period length of a circadian
oscillator is roughly 24 hours, thus approximating the rotation of the Earth.
A “clock” is an oscillator that is self-sustaining and does not damp over time. Note that
damping in cell culture experiments at the population level is caused by loss of synchrony
between cells that individually do not damp [9]. I will use “circadian clock” to refer to the
hypothetical minimum set of components that are necessary and sufficient to sustain a circadian
rhythm.
A “clock gene” is a gene whose product is then translated to a protein (also referred to as
“clock protein”) that subsequently directly or indirectly feeds back to inhibit its own transcription
in a rhythmic manner. The fidelity of circadian timekeeping is also regulated by the expression
of the clock genes. Examples are Bmal1, Per and Cry genes.
“Entrainment” is the synchronisation of a clock to a zeitgeber – an extrinsic signal that itself
oscillates with a 24-hour rhythm because of the rotation of the Earth (e.g. temperature cycles).
“Synchronisation” is the alignment of the phases of two or more oscillators. This is often
synonymous with entrainment but can also be applied to one-off perturbations (as opposed to
continually oscillating ones) that align the phases of multiple clocks (e.g. serum shock).
A “state variable” is a molecule whose abundance and/or post-translational modification state
determines the phase of the cellular clock.

















Figure 1.1 Features of Oscillations. Oscillations have measurable parameters. Amplitude is
the deviation of the signal from the baseline. When amplitude changes over time, the rate of
change is known as damping rate. Period length is the length of time taken to complete an
oscillation. Phase refers to the stage of the cycle that the system is in at any particular point in
time, and this is usually considered in the context of phase shifts or differences between datasets.
1.1.2 Circadian timekeeping at multiple levels of biological scale
Life may have existed on Earth over 3 billion years ago [10]. Throughout this time, organisms
have had to find ways to adapt to an environment that changes due to the rotation of the Earth.
This rotation causes daily variation in food availability, temperature and light. Endogenous
timing mechanisms allow organisms to predict these changes and adapt their behaviour and
physiology to the external cycles. This has been shown in bacteria, plants and mammals to confer
evolutionary advantage over organisms that do not have this internal timekeeping [11–17].
The first recorded observation of a circadian rhythm was made in 1729 by Jean-Jacques de
Mairan [5]: the daily opening and closing of the leaves of Mimosa pudica. De Mairan observed
that this persisted in constant darkness, showing that this behaviour is endogenously controlled
by a circadian timekeeping mechanism. Such rhythmicity has been observed at all levels of
biological scale, from the macroscopic behaviour of flies and humans to the activity of single
cells and even protein complexes. These oscillations are remarkable for their persistence and
precision – rhythms in behaviour can persist for over 2 years in some rodents, and the standard
deviation of the average period length of a mouse rhythm is around one minute [5].
In mammals, the suprachiasmatic nucleus (SCN) in the hypothalamus imparts circadian
coordination upon behaviour, physiology and cellular function through neuronal and hormonal
signalling [18–24]. However, since circadian regulation of cellular activity and gene expression
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persist ex vivo in almost all mammalian cell types tested [25–28], it is clear that the fundamental
unit of circadian timekeeping is the cell. An interesting exception is the mouse testis, where
PER1 protein and mRNA (see the next section for details about PER) were not found to be
rhythmic [29], although this does not rule out the presence of a circadian clock involving different
molecular components.
1.1.3 Rhythmic gene expression is coordinated by transcription/translation
feedback
Over 40% of protein-encoding genes are subject to circadian regulation in at least one tissue in
healthy young wild-type adult mice [30], with a similar proportion of the human genome under
diurnal regulation in healthy individuals [31]. Delayed transcriptional feedback repression of
clock genes has been proposed to drive rhythmic gene expression in mammals as well as other
eukaryotes; the clock gene circuitry behind these transcriptional-translational feedback loops
(TTFLs) has been described for several model organisms [32–34]. The cycling of clock protein
activity is the means by which cellular clocks organise most daily biological functions, and this
is supported by the strong phenotypes of clock gene mutants [35].
In mammalian cells, CLOCK and BMAL1 are basic helix-loop-helix (bHLH) – PER-ARNT-
SIM (PAS) transcription factors. CLOCK is semi-redundant with NPAS2, but recruitment of
BMAL1-containing complexes to the promoter regions of Period and Cryptochrome genes is
essential for their differential expression over the daily cycle (Figure 1.2). PER and CRY proteins
mediate the negative limb of the feedback loop by forming large macromolecular complexes
which bind and inhibit the transcriptional activity of BMAL1-containing complexes [36–39].
Thus transcription of many clock-controlled genes is repressed along with genomic loci for PER
and CRY themselves [40, 41]. These activating and repressing complexes function together
with enhancer elements in a tissue-specific manner to differentially recruit various histone and
chromatin remodelling complexes, resulting in large-scale changes in chromatin accessibility and
compaction [42, 40, 43, 34, 44]. This is the core TTFL in mammals, and the prevailing dogma
in the field (I will refer to it as the “TTFL model”) is that it is responsible for the generation of
cellular circadian rhythms [34].
Given the dynamic regulation of chromatin structure by TTFL components as described
above, it would be reasonable to suspect that there may be an interaction between the circadian
clock and the cell cycle, which also involves a great deal of chromatin remodelling. These two
cycles are indeed intertwined, and current competing theories posit that the circadian clock in
mammals may ‘gate’ cell cycle progression such that specific checkpoints are more likely to
proceed at certain times of day [45], or that there may be more complex coupling between the
cell cycle and the TTFL [46]. However, little is known about the molecular mechanisms linking
these processes.

































Figure 1.2 The mammalian TTFL coordinates the rhythmic transcription of the clock-
controlled genes (CCGs). The transcription factors BMAL1 and CLOCK activate the tran-
scription of the CCGs. Period (PER) and cryptochrome (CRY) proteins form a complex with
regulatory factors such as casein kinase 1 (CK1). Cryptochrome proteins license the nuclear
translocation of this complex, which goes on to inhibit the activity of BMAL1-containing com-
plexes. Since Per and Cry genes are also under the control of BMAL1-containing complexes,
PER and CRY proteins inhibit their own transcription. This negative feedback loop forms the
core of the TTFL. The accessory loops modulate the expression of CCGs, and are not essential
for TTFL function. See text for details.
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Several auxiliary feedback loops supplement this core TTFL, and their relative contributions
to cellular clock function varies between tissues [47, 48]. The best characterised auxiliary
loops involve the REV-ERB nuclear receptors and the transcription factor DBP (D-box binding
protein). The transcription of REV-ERBα (Nr1d1) and REV-ERBβ (Nr1d2) is activated by
CLOCK/BMAL1 complexes, and this results in the feedback repression of Bmal1 and other
targets that have ROR-binding promoter elements [49]. The rhythmic transcription of DBP is
also dependent on CLOCK/BMAL1 activity [50, 51]. DBP binds to D-box promoter elements,
and is antagonised by NFIL3 (nuclear factor, interleukin-3 regulated), which is itself regulated
by the activity of the REV-ERB-ROR loop activity [52, 53]. These auxiliary feedback loops
modify the rhythmic expression of clock controlled genes [54], but they are not essential for
basic TTFL function [48].
The processes described above are indispensable for the circadian coordination of gene
expression in mammalian cells. However, the explicit molecular mechanism for 24-hour period
determination is not fully understood. TTFLs are in fact commonly used in cell biology to
terminate a signalling process and return to baseline. The fundamental concept is the negative
feedback of gene products that simultaneously induce gene expression changes and directly
or indirectly lead to their own degradation [55]. This is the basis for the oscillations in the
developmental segmentation clock (roughly 2 hour period) [56, 57], the ERK signalling pathway
(roughly 3 hour period) [58, 59] and the NFκB pathway (roughly 4 hour period) [60]. The period
length in these cases reflect the time delays caused by RNA processing and translation, and the
oscillations damp after several cycles. This is fundamentally different to circadian oscillations
[61, 27]; the time constants are insufficient to account for the long time delay of 24 hours between
transcriptional activation of Per and Cry, and the degradation of their repressive complexes. For
this reason, post-translational regulation of clock protein activity by enzymes such as casein
kinases [62–68] is thought to be the basis for the lengthy delay (Figure 1.3A).
Post-transcriptional regulation of RNA processing and RNA silencing by small interfering
RNAs have been implicated in circadian control and the regulation of protein synthesis [69–80].
However, to my knowledge there has been no demonstration that their rhythmic regulation is
required for circadian timekeeping.
1.1.4 Problems with the TTFL model
The precise molecular mechanism for circadian period determination at the cellular level remains
unknown, despite the popularity of the TTFL model. In this section I will discuss some of the
findings in the literature which are not readily explained by the TTFL model. These discrepancies
suggest that circadian rhythm generation (and therefore period determination) may not in fact
require the TTFL.
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Figure 1.3 Two models for cellular circadian rhythm generation. A) The TTFL model. The
mechanism that generates the rhythms is the TTFL. Enzymes that mediate post-translational
modification of the clock proteins are invoked to give rise to the long 24-hour time delay. These
enzymes include casein kinases and glycogen synthase kinase. The output of this self-sustained
oscillation is the rhythmic expression of clock-controlled genes (CCGs) and therefore cellular
function. Some CCGs such as PER and CRY feed back to the TTFL to regulate its activity
as described in the text. B) The post-translational oscillator (PTO) model. In this alternative
model, there is a post-translational mechanism that is sufficient to generate circadian oscillations
– this PTO is self-sustaining. The TTFL is not necessary for circadian rhythm generation, but
it confers robustness and amplification to the PTO-generated oscillations. The TTFL uses this
timing information to control the expression of CCGs and thus cell function. The PTO may also
coordinate circadian regulation of cell function directly, independently of the TTFL. This figure
is adapted from Wong and O’Neill, 2018 [6].
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It has emerged that the rhythmic expression of central TTFL components, or ‘clock genes’,
is not actually essential for the persistence of circadian timekeeping at the cellular level. Rather,
all that is required is that the activity of TTFL components should lie within a permissive range
[81]. This has been shown for BMAL1 (or its paralog BMAL2) [82], CLOCK (or its paralog
NPAS2) [83], PER1 or PER2 [84], and CRY1 or CRY2 [85]. Furthermore, in complementation
assays, constitutive expression of BMAL1 or CRY1 or PER2 is sufficient to rescue circadian
gene expression rhythms in their respective single or double knockouts [84, 78, 48, 86]. However,
if PER2 or CRY1 proteins are overexpressed in knockout backgrounds, rhythmic transcription
is impaired [84, 87]. Similarly, in Drosophila melanogaster, constitutive expression of the
repressive TTFL components (per and tim) is sufficient for circadian rhythms in behaviour,
whilst overexpression or knockout abolishes it [88]. Finally, in the fungus Neurospora crassa,
circadian rhythms in the activity of FRQ protein (the major TTFL repressor protein in Neurospora,
functionally analogous to PER) can be decoupled from its stability: deletion of the F-box protein
that normally enables its degradation (FWD1) results in FRQ accumulation to constant levels
but whilst still maintaining activity rhythms [89]. Together, these findings suggest that rhythmic
clock protein activity rather than abundance is important for circadian transcriptional oscillations,
and that transcriptional-translational feedback reinforces this oscillation rather than generates it.
Moreover, these elegant genetic complementation experiments indicate that the critical TTFL
proteins only need to expressed within a permissive range for rhythms in their activity to be
observed. Put simply, rhythmic regulation of protein expression is not required for circadian
coordination of physiology, and rhythmic activity through post-translational modifications may
be sufficient.
In fact, proteomics studies have shown that the circadian transcription of DNA to mRNA
correlates very poorly with circadian rhythms in the abundance of the encoded proteins. Around
50% of rhythmic proteins in mouse liver and SCN have no corresponding cycling mRNA
[90, 91]. In addition, it was found in mouse liver that half of the cycling proteome showed
a phase delay of more than 6 hours relative to their corresponding mRNA and that 20% of
the cycling proteome had no cycling transcript at all [92], with similar findings under diurnal
conditions [93]. In cultured Drosophila S2 (Schneider 2) cells only 7% of rhythmic proteins
detected had corresponding rhythmic mRNAs [94], and in Neurospora crassa 41% of rhythmic
proteins did not arise from rhythmic mRNAs [95], suggesting that this discrepancy may be
common between many eukaryotes. Moreover, proteomics studies have revealed time-of-day
variations in the post-translational modification of FRQ in Neurospora crassa [96] and in
the mouse liver phosphoproteome and acetylome [97, 98]. These studies suggest that post-
translational regulation of proteins is critical for the circadian coordination of cell function,
whereas circadian rhythms in transcription may be insufficient to account for the full range of
circadian coordination of cellular function.
The most important problem for the TTFL model is that circadian rhythms have been
observed in eukaryotic cells in the absence of transcription in multiple independent scenarios. A
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TTFL-based model would predict that circadian period be sensitive to changes in transcription
rate. However, period length and temperature compensation in cultured NIH3T3 fibroblasts is
robust against inhibition of RNA polymerase II [99]. Furthermore, circadian rhythms have been
observed in isolated red blood cells (which do not have organelles and therefore no capacity for
transcription) from both mice and humans in the following parameters: oxidised peroxiredoxin
(PRX-SO2/3) abundance, membrane physiology and NAD(P)H concentration [100–103]. In fact,
rhythms in the absence of transcription were observed almost 60 years ago in a macroscopic alga,
Acetabularia mediterranea [104, 105], where circadian rhythms in chloroplast migration persist
over many days despite removal of the cell nucleus. Circadian rhythms in phosphorylation also
persist in the absence of translation in the red alga Cyanidioschyzon merolae [106], and circadian
rhythms in the bioluminescence and photosynthesis in Lingulodinium polyedrum do not require
rhythmic changes in RNA abundance [107]. Finally, circadian rhythms in ion transport and
PRX-SO2/3 abundance persist in the picoeukaryotic alga Ostreococcus tauri even in constant
darkness, where all RNA production ceases [108–110]. The oscillators responsible for driving
these diverse non-transcriptional eukaryotic circadian rhythms are still unknown, and so it is
unclear whether these represent unusual cellular specialisations to specific niches, or whether
they result from the same post-translational mechanism that drives circadian rhythmicity in other
cellular contexts. In the next section I will explore the evidence for the latter possibility.
1.1.5 An alternative model: the post-translational oscillator (PTO)
In light of the problems noted above, an alternative model is that a post-translational mechanism is
responsible for circadian rhythm generation, and this does not require transcriptional-translational
feedback loops (Figure 1.3B) [111–114, 6]. First, I will describe the precedent for this PTO
model, which is set by the entirely post-translational clock that has been elucidated in the
cyanobacterium Synechococcus elongatus. I will then discuss some candidates for mammalian
PTO components.
In S. elongatus there is a circadian rhythm in KaiC protein phosphorylation and complex
formation with KaiA/B that is temperature compensated, and this may be reconstituted in vitro
with just the purified recombinant proteins (KaiA, B and C) together with Mg.ATP [115]. There
are some similarities between this oscillator and mammalian post-translational timekeeping
mechanisms. First, KaiC is a slow Ser/Thr phosphotransferase, with turnover rate (kcat) in the
order of hours [116]; in parallel, CK1δ also has a slow kcat in the phosphorylation of PER peptide
substrates, in the order of minutes [117]. In comparison, most cellular kinases are roughly a
hundred-fold faster (10 s−1) [118–120]. Secondly, this KaiA/B/C post-translational oscillator is
sufficient to generate circadian rhythms in gene expression, whereas the cyanobacterial TTFL
alone cannot [121]. However, when the capacity for transcriptional feedback is removed, the
gene expression rhythms are less robust, suggesting that the TTFL in cyanobacteria stabilises the
PTO [121]. Finally, KaiC is primarily in large macromolecular complexes with many substrate
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effectors [122], where the dynamic exchange of subunits is key for timekeeping competence
[123, 124]. By comparison, CK1 also has multiple substrates and functions, and is a component
of large cytosolic macromolecular complexes with PER and CRY proteins [36]. The elucidation
of the cyanobacterial PTO and its conceptual similarities with post-translational processes
regulating mammalian timekeeping raises the possibility that a similar PTO may also exist in
mammals.
Many post-translational mechanisms have been implicated as regulating and being regulated
by circadian timekeeping, including acetylation, sumoylation, glycosylation, cysteine oxidation
and phosphorylation [125–130]. In addition, countless other essential cellular processes have
been identified as exhibiting circadian regulation, with many also feeding back to affect the
phase, amplitude or period of clock gene expression. Some examples include global protein
synthesis rates [131, 75], ion transport [132], cAMP/Ca2+ signalling [133], redox balance
[134, 135], mitochondrial metabolism [136] and the actin cytoskeleton [137]. It is perhaps
unsurprising that pharmacological or genetic perturbation of many cellular processes can affect
circadian gene expression. In particular, the activity of these processes may be permissive for the
observed circadian rhythms, without being involved in rhythm generation itself. An essential
timekeeping mechanism is a cellular process that contributes to rhythm generation and/or period
determination, and its rhythmic regulation is necessary for any circadian rhythm to be observed
[6]. Therefore, an appropriate test for essentiality involves clamping the activity of a process
at a level equal to its average over the course of a circadian cycle. If the process is essential to
circadian timekeeping, then circadian rhythmicity would cease. If the process is non-essential
for circadian timekeeping, then circadian rhythmicity would persist. Such experiments have
ruled out redox balance [135] and BMAL1 abundance [48, 138] as essential variables of the
timekeeping mechanism.
With this definition of essentiality in mind, the list of possible components of the mammalian
PTO is greatly simplified. Not all post-translational processes have been equally scrutinised, but
the candidates I will list have been reported multiple times, pharmacologically and genetically,
to directly affect the temporal activity of clock protein transcription factors. These important
candidates include: the proteasomal degradation machinery [139–143, 51, 144], casein kinase I
(CK1) [145, 64, 146, 66, 147], casein kinase II (CK2) [148–150], glycogen synthase kinase 3
(GSK3) [151–153, 67, 154–156], and protein phosphatase 1 (PP1) [63, 157, 146, 158].
The enzymes listed above are proposed to contribute to cellular timekeeping by effecting
the site-specific phosphorylation of clock proteins. Phosphorylation has many consequences for
clock proteins depending on the context, including promoting nuclear entry [159, 152, 160, 161],
regulation of transcriptional activity [162–165, 78, 166–168] and promoting hyperphosphoryla-
tion leading to ubiquitin-mediated proteasomal degradation [169, 170, 144]. In addition, it has
recently been shown that the period length of the circadian rhythms in membrane electrophys-
iology in red blood cells is sensitive to CK1 and CK2 inhibition [100]. In the same paper, it
was found that CK1 activity was necessary for temperature compensation in the red blood cells.
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Finally, it is worth noting that the rate of CK1 enzymatic activity is intrinsically temperature
compensated for clock protein substrates [171, 172], indicating that CK1 activity may be critical
for this fundamental feature of circadian rhythms. Together, these remarkable findings suggest
strongly that phosphorylation is an important PTO candidate, particularly involving CK1 activity.
1.1.6 Implications for the evolution of circadian rhythms
The TTFL model and the PTO model have different implications for the evolution of circadian
rhythms in eukaryotes [6]. The TTFL model suggests that circadian rhythms are likely to
have evolved at least thrice in eukaryotes, in each case retaining the fundamental concept of
transcriptional feedback repression generating oscillations whilst recruiting the same set of
post-translational regulatory mechanisms as a delay timer to achieve 24-hour periodicity. In
this convergent evolution TTFL model, all the examples of circadian rhythms in the absence
of transcriptional feedback repression (such as in red blood cells) represent specific and recent
adaptations to environmental and physiological niches. In contrast, the PTO model suggests
a divergent evolutionary history: an evolutionarily ancient post-translational mechanism for
generating circadian timekeeping was present in the last common eukaryotic ancestor. Over time,
organism- and cell-type specific transcriptional effectors (“clock proteins”) were recruited as
multicellular organisms and different phyla arose. The resultant transcriptional feedback loops
were evolutionarily advantageous as they confer robustness to timekeeping by the PTO.
1.2 Quantitative proteomics
1.2.1 An introduction to proteomics
Cells are complex systems crowded with macromolecular machines that are primarily composed
of proteins, and these effect biological processes [173]. Traditional methods of studying proteins
have been mainly antibody-based and biased towards small subsets for which high-quality
assays have been available [174]. Recently the simultaneous identification and quantification
of thousands of proteins in biological samples has become possible with mass-spectrometry
(MS)-based methods [175–177]. Hence MS-based proteomics has become an invaluable tool to
quantitatively measure the biochemical state of cells and tissues.
The experimental workflow for the proteomics presented in this thesis is described in detail in
Chapter 2, but I will outline the basic concepts here to provide context for my results. Biological
samples containing proteins are typically digested with trypsin, thus liberating short peptides.
For complex samples such as cell lysates, biochemical fractionation of these peptides is usually
performed to aid analysis [178]. The fractions are then separated by liquid chromatography (LC),
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and as they elute they are subjected to electrospray ionisation [179] before being directly sprayed
into the mass spectrometer.
The mass spectrometer performs two levels of measurement in tandem [178]. The first
level is referred to as “MS1”, and this is a measurement of the mass-to-charge ratio (m/z) of
peptide molecular ions. The molecular ions are then fragmented. The second level is referred
to as “MS2”, and this is a measurement of the m/z values of the fragment ions of a specific
peptide ion. This workflow is therefore referred to as “LC-MS/MS”. The fragment ion pattern
information is combined with the MS1 measurement to enable confident identification of peptides
and subsequent mapping to proteins [180]. The signal intensities of the peptides or fragment
ions are used to estimate relative changes in abundance across samples.
LC-MS/MS involves many steps, and technical variability may be introduced at several stages.
Strategies have been developed to improve the reliability of quantification, and these are based
on isotopic labelling, which includes chemical isotopic labelling, metabolic isotopic labelling
and isobaric tagging [181, 175]. Recently label-free approaches have become more popular
due to simpler experimental design and sample preparation [182, 183]. However, label-free
quantification requires multiple runs, which requires more material and reduces throughput
compared to isotopic labelling [176]. Another disadvantage is that the measurement precision is
comparatively poor [184].
1.2.2 Quantification methods
A common method for isotopic labelling in cell culture studies is to add heavy-labelled amino
acids (“SILAC”, stable isotope labelling with amino acids in cell culture) to the culture medium
so that the labelled amino acids are eventually incorporated into all proteins. This allows samples
to be labelled with different isotopes and then combined for MS analysis. Therefore relative
quantification is achieved in a single run, resulting in high measurement precision. A major
limitation is that the complexity of the MS1 spectrum is greatly increased with the number of
samples because each label has a different mass. This limits confidence of peptide identification,
and so only 2 or 3 samples can be compared in a single experiment.
Another method is known as isobaric tagging, and this has some advantages over isotopic
labelling. Isobaric tags covalently modify peptides, and so they do not require long periods
of incubation for amino acid incorporation since they are applied to the lysate. They use the
distribution of heavy isotopes in the tag to encode different conditions. Thus each tag has an
identical total mass, and so MS1 spectrum complexity is unaffected by the number of samples.
Therefore the number of conditions that can be compared in an isobaric tag experiment far
exceeds that of SILAC.
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The most commonly used isobaric tags are TMT (tandem mass tag) [185] and iTRAQ
(isobaric tag for relative and absolute quantitation) [186]. TMT is available with up to 11-
plex reagents, whereas iTRAQ is only available with up to 8-plex. Therefore TMT allows
the comparison of more samples simultaneously, and is therefore most ideal for circadian
experiments that generate many samples across several timepoints.
1.2.3 Post-translational modifications
Advances in MS have made it possible to identify and quantify post-translational modifications
(PTMs) of proteins [187]. A wide range of PTMs including phosphorylation, acetylation and
several others have been implicated in the control of circadian rhythm [125–130]. A common
feature of most of these PTMs is their rhythmicity, and so the study of dynamic changes in PTMs
across time is desirable for understanding their relationship with the circadian clock. One of
the most common PTMs of clock proteins is phosphorylation, and this is essential for circadian
rhythm generation in multiple species [96, 188]. Phosphorylation is also the most common PTM
in the cell [189, 190]. Therefore to understand the cell-autonomous circadian coordination of the
proteome, a phosphoproteomics approach is valuable.
Due to the low stoichiometric amount of phosphorylated proteins in the proteome, enrich-
ment of phosphopeptides prior to LC-MS/MS is carried out [191]. Many approaches have been
developed [192], including IMAC (immobilised metal ion affinity chromatography) and MOAC
(metal oxide affinity chromatography). IMAC uses the electrostatic interactions between im-
mobilised positive metal ions such as Fe3+ and negatively charged phosphate groups to capture
phosphopeptides [193]. Similarly, MOAC uses the affinity of metals within metal oxide particles
such as TiO2 to retain the phosphopeptides [194]. Non-specific binding is reduced using washes
that are described in Chapter 2. In my experimental workflow, both IMAC and MOAC are used
to maximise the efficiency of phosphopeptide enrichment.
1.3 Protein homeostasis
1.3.1 Introduction to protein homeostasis
All cells must regulate synthesis, folding and degradation of thousands of proteins to maintain
their abundances at the levels necessary for proper cellular function. This regulation is known
as protein homeostasis, and this is often shortened to “proteostasis”. Linguistically this is
problematic because “proteostasis” implies a static population of proteins, whereas protein
homeostasis more correctly describes the dynamic equilibrium of maintaining protein abundance

















Figure 1.4 The proteostasis network. The abundance of thousands of proteins must be main-
tained at levels necessary for proper cellular function. In addition, the proteins must be in their
‘native state’ to be functional, i.e. the correct 3-dimensional structure. The proteostasis network
achieves this via a large network of machinery that mediates translation and co-translational pro-
tein quality control (PQC), maintaining the conformational stability of proteins using molecular
chaperones, and protein degradation via the proteasome or autophagy pathways. See text for
details.
that monitor and regulate protein expression, folding, assembly, localisation and degradation
[195, 196].
Imbalance can be caused by having too much or too little protein or having proteins that
are incorrectly folded and therefore non-functional. In a general sense, excessive imbalance is
considered a form of cellular stress. The cell contains a range of sensors that detect such stresses
and initiate signalling cascades aimed at restoring protein homeostasis. The main outputs of
stress sensors typically involve a reduction in the rate of translation (to minimise exacerbation of
the imbalance) and increased protein degradation and protein maturation capacities. The result of
these activities is a return to equilibrium, or the establishment of a new set point of equilibrium.
1.3.2 The proteostasis network
The cellular machinery for ensuring a balanced proteome as described above can be broadly
divided into three linked processes: protein synthesis, maintaining conformational stability and
protein degradation (Figure 1.4) [195].
A key step in protein synthesis is the translation of messenger RNA (mRNA) into an amino
acid sequence. This process is performed by ribosomes, which are large complexes formed of
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RNA and protein. Within this enzyme, transfer RNA (tRNA) base-pairs with mRNA which
results in the formation of a peptide bond between the growing nascent polypeptide and the
incoming amino acid carried by the tRNA [197]. In mammalian cells, around 3 million ribosomes
work to synthesise the proteome, consuming up to 75% of the cellular energy resource in the form
of ATP [198]. This demonstrates the importance of translation, as it is a significant energetic
investment for the cell.
For the most part, newly synthesised proteins must form defined 3D structures to function
correctly. An important exception to this rule is proteins that have intrinsically disordered
regions (IDRs), which lack a stable tertiary structure unless they interact with partner molecules
[199, 200]. The folded (or native) state of proteins is thermodynamically favourable, but to
achieve this efficiently and to avoid forming kinetically stable but biologically unfavourable
intermediates many proteins require molecular chaperones to aid with the folding process
[201, 202]. It is important to remember that the cell is a highly complex environment crowded
with macromolecules, and this increases the effective concentrations of proteins, thus increasing
effective association constants by several orders of magnitude relative to dilute solutions [203].
In addition, translating ribosomes are organised in polysomes (multiple ribosomes translating in
tandem on one mRNA molecule), and therefore many nascent polypeptides are often in close
proximity. A consequence of this is that many nascent polypeptides require co-translational
recruitment of chaperones such as Hsp70 to stabilise them [204]. These molecular chaperones
promote folding by ATP-dependent and ATP-independent processes, consisting of sequential
binding to and release from proteins at exposed hydrophobic amino acid residues [205].
Molecular chaperones also participate in the maintenance of conformational stability of
proteins after synthesis is complete. Many chaperones are constitutively expressed in the cell,
including members of the HSP70 and HSP90 families [206, 207]. These maintain proteins
in solution and reverse unfolding to preserve functional structures. Some chaperones such as
clusterin and haptoglobin even operate in the extracellular space to maintain conformational
stability of secreted proteins [208].
Protein degradation is important for adjusting the abundance of functional proteins during
normal cellular processes such as cell division and responding to environmental changes [195].
Two main pathways are responsible for protein degradation: the ubiquitin-proteasome system
(UPS) and the autophagosomal-lysosomal pathway. The UPS is primary degradation route for
proteins with short half-life, whereas autophagy is the primary route for proteins with a long
half-life [209].
1.3.3 The integrated stress response (ISR)
In response to imbalances in the proteome, the proteostasis network is used to restore homeostasis.
Several pathways have been described, that are triggered as a result of sensors detecting cellular
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stress. These include the heat shock response in the cytoplasm [210], the unfolded protein
response in the endoplasmic reticulum [211], stress responses in the mitochondria, Golgi and
lysosomes [212, 213], and the integrated stress response, which is a common pathway activated
in response to a wide range of stress stimuli [214].
I will provide a brief overview of the integrated stress response (ISR), since this is of relevance
to the work in the later chapters. In this response, 4 kinases act as sensors that detect a range
of physiological changes that may disrupt cellular homeostasis. These kinases phosphorylate
eukaryotic translation initiation factor 2 alpha (eIF2α), which leads to a global inhibition of
translation, with a simultaneous induction of the transcription of specific genes that restore
homeostasis, including activating transcription factor 4 (ATF4) [214] (Figure 1.5).
The four eIF2α kinases are PERK (PKR-like ER kinase), PKR (double-stranded RNA-
dependent protein kinase), HRI (haeme-regulated eIF2α kinase), and GCN2 (general control
non-derepressible 2). Each one is activated by distinct physiological or environmental parameters,
which trigger dimerization and autophosphorylation of the kinase (Figure 1.5) [215]. This signal
is switched off by dephosphorylation, mediated by a protein phosphatase 1 (PP1) complex.
Crucially, GADD34 (also known as PPP1R15A) regulates the phosphatase activity of this
complex by targeting the enzyme to eIF2α [216]. GADD34 expression is induced by ATF4
downstream of eIF2α phosphorylation, thus forming a negative-feedback loop to restore protein
homeostasis [216].
eIF2α is at the core of the ISR. It is the main regulatory subunit of the eIF2 complex because
it contains both the RNA-binding and phosphorylation sites. This is part of the larger pre-
initiation complex (PIC) that licenses the initiation of translation, by recognising and recruiting
the 5’methylguanine cap of mRNA before migrating to the AUG start codon [217, 218]. Thus
eIF2 is central in the process of cap-dependent translation of mRNA. ISR activation leads to
the phosphorylation of eIF2α , which blocks the formation of the PIC. Hence there is a global
attenuation of cap-dependent translation. Paradoxically, a small subset of mRNAs including
ATF4 and GADD34 are preferentially translated because they do not require cap recognition,
but instead have alternative mechanisms for translation initiation involving re-initiation using
alternative AUG start codons or directly recruiting ribosomes to internal ribosome entry sites
[219, 217, 220].
ATF4 is the best understood effector of the ISR [214]. In addition to its role during the
ISR it has an important role in many processes across different tissues, such as development
[221], lipid metabolism and thermoregulation [222, 223]. The increased translation of ATF4
mRNA during ISR activation leads to the transcriptional upregulation of stress-responsive genes.
The identities of the stress-responsive genes that are upregulated is context-dependent, and the
cell modulates this response by transcriptional, translational and post-translational regulation of
ATF4 expression, as well as through a large number of interacting partners [224, 214]. Hence
the ultimate outcome of the ISR is dependent on the nature of the stress, its duration and severity,
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Figure 1.5 The integrated stress response. The integrated stress response (ISR) is a common
pathway that is activated in response to a wide range of stress stimuli. 4 kinases sense different
physiological changes; upon activation they dimerise and phosphorylate eIF2α . This leads to the
attenuation of cap-dependent translation, and the simultaneous upregulation of cap-independent
translation of mRNAs including ATF4 and GADD34. ATF4 is a transcription factor that activates
the transcription of many stress-responsive genes. GADD34 expression is also induced by the
transcriptional activity of ATF4, and in complex with PP1 it facilitates the dephosphorylation
of phospho-eIF2α , thus forming a negative feedback loop to turn off the pathway. See text for
details.
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the extent of eIF2α phosphorylation and ATF4 translation, as well as the expression of other
transcription factors. Moreover, a short-lived ISR is associated with the restoration of protein
homeostasis, whilst a prolonged ISR can lead to a cellular adaptation or a death response [225].
In summary, the proteostasis network primarily functions to regulate protein synthesis,
folding and degradation under normal conditions. Sensors expressed by the cell detect stress
stimuli and recruit certain components of the proteostasis network to re-establish homeostasis
after acute non-physiological perturbation. This is self-limiting: negative feedback is used to
turn the stress response off. In cases of low-level chronic stress induction, cells are still able
to achieve protein homeostasis, albeit with a different set point, for example by increasing the
capacity for folding and protein degradation [209, 225].
1.4 Overview of the thesis
The overall goal of this thesis was to investigate the cellular mechanism for circadian rhythm
generation and how it regulates the proteome. To achieve this I primarily used cell culture,
employing biochemical, pharmacological and mass-spectrometry techniques. I extracted the
fibroblasts from mice expressing the PER2 protein endogenously fused to firefly luciferase
(PER2::LUC) [28], allowing real-time reporting of circadian rhythms in cell culture. As described
above, the fundamental unit of circadian timekeeping is the cell. At the organism level, mice show
daily rhythms in feeding even when housed in constant darkness, and this has been demonstrated
to drive rhythmic gene expression through endocrine signalling [226–229]. Therefore cell
culture systems were appropriate for my purposes, since they enable exposure to truly constant
conditions at the cellular level.
In Chapter 3 I used this experimental system to assess the effects of a drug called picrotoxin.
This drug shortens circadian period length via an unknown mechanism, and the goal of this
chapter was to improve understanding of TTFL function through the characterisation of the
mechanism of drug action. My experiments revealed that picrotoxin has profound effects on the
TTFL as a strong synchronising factor.
In the remaining chapters I used cells from CRY1−/−; CRY2−/− mice [230]. This double
knockout is used to genetically abolish TTFL function. In Chapter 4 I performed proteomics and
phosphoproteomics to explore the circadian regulation of the proteome and how the absence of a
TTFL impacts upon this. Surprisingly I found that circadian regulation of the proteome persists
without a TTFL, thus supporting the PTO model of circadian rhythm generation. I went on to
explore some specific predictions made by this big data approach, revealing antiphasic rhythmic
regulation of cellular protein and ion concentrations.
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In Chapter 5 I explored the rhythmic regulation of PER2 activity in CRY1−/−; CRY2−/−
cells using the PER2::LUC reporter. The PTO model predicts that this should persist in the
absence of a TTFL, and I presented a number of experimental manipulations suggesting that the
ability to observe this phenomenon may be dependent on the state of the proteostasis network
in these cells. In addition, I hypothesised that a major function of CRY is to maintain protein
homeostasis. In Chapter 6 I took these observations further, examining the role of CRY in
cellular proteostasis. I found that in the absence of CRY, cellular protein homeostasis was
disrupted, and this also has consequences to the health of the organism as a whole. Furthermore,
I explored the link between circadian rhythmicity and disruption of protein homeostasis. In the
final chapter I discussed how my findings change our understanding of circadian rhythms through
the characterisation of the cell-autonomous circadian regulation of the proteome, and support of
the PTO model for circadian rhythm generation. Moreover, I propose a new interpretation of the




2.1 Mammalian cell culture
All animal work was licensed by the Home Office under the Animals (Scientific Procedures)
Act 1986, with Local Ethical Review by the Medical Research Council and the University of
Cambridge, UK. Fibroblasts homozygous for PER2::LUCIFERASE [28] were extracted from
adult mouse lung tissue and and then serial passage was used as described previously to induce
spontaneous immortalisation [62, 231]. Fibroblasts were cultured in Dulbecco’s Modified Eagle
Medium (DMEM), supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin (Gibco)
and 10% FetalClone III serum (HyClone, Thermo Fisher). All cells were confirmed to be free of
Mycoplasma. Unless stated otherwise, confluent cell cultures were used during experiments to
abolish any effects of cell division, since these cells display contact inhibition.
2.2 General statistics
P values are annotated in figures with asterisks, where the number of asterisks indicates the
significance (Table 2.1). Technical replicates are denoted as “n” in the figures or figure legends
(e.g. n=3), and biological replicates are denoted as “N”.
Table 2.1 P value representation with asterisks.
Symbol P value
Ns. P > 0.05
* P ≤ 0.05
** P ≤ 0.01
*** P ≤ 0.001
**** P ≤ 0.0001
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2.3 Longitudinal bioluminescent reporter experiments
Cellular bioluminescence assays were carried out in “air medium” as described below, and
modifications are reported in the text. Air medium was based on DMEM without glucose,
L-glutamine, phenol red, sodium pyruvate and sodium bicarbonate (Sigma). The following were
added: 0.35 g/L sodium bicarbonate (Sigma), 5 g/L glucose (Sigma), 20 mM MOPS (VWR),
penicillin/streptomycin solution (as above), Glutamax (Thermo Fisher), B27 (Thermo Fisher), 1
mM potassium luciferin solution (Biosyth), 1% FetalClone III serum. The medium was adjusted
to pH 7.6 at room temperature, and osmolality adjusted to 350-360 mOsm/kg using sodium
chloride. Temperature cycles (12 hours 37°C – 12 hours 32°C) were used for at least 3 days to
synchronise the cells before being changed from normal culture medium (supplemented with
0.3 mM Luciferin) into air medium. Longitudinal recordings of bioluminescence were obtained
using a Lumicycle (Actimetrics), LB962 plate reader (Berthold technologies) or an ALLIGATOR
(Cairn Research). Bioluminescence was recorded as counts per second (cps) in the Lumicycle
and plate reader, and ALLIGATOR measurements were reported as relative luminescence units
(RLU).
Data from longitudinal bioluminescence recordings were analysed using Prism Graphpad
8 (San Diego, Ca). A 24-hour moving average was used to detrend data, and so circa-24 hour
rhythms can more easily be observed and measured. Detrending in this way removes changes in
baseline that occur on a timescale greater than a day, and so circadian changes are not detected,
and no new 24-hour rhythms are introduced by this method. Then a circadian damped cosine
wave was fitted by least-squares to determine period, phase and amplitude. The formula is as
follows:




Where m is the baseline gradient, c is the displacement in the y-axis, k is the damping rate, a
is the amplitude, r is the phase and p is the period. The first 24 hours of each recording were
omitted because this represents the transient effects of medium change on clock gene expression.
In Chapter 5, rhythmicity of bioluminescence recordings was assessed by comparing the fit of
this equation to the null hypothesis of a straight line using the Extra sum-of-squares F test in
Prism Graphpad 8 (San Diego, CA). If fitting to the damped cosine was preferred (p≤0.05) then
the recording was deemed “rhythmic”.
“Robustness” is a measure of the strength of rhythmicity, which is proportional to the relative
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k is the damping rate from the cosine fitting. In some cases, rhythms increased in amplitude over
time, and so the absolute value of k is used in this calculation. Relative amplitude is the value of
a from the cosine fitting, normalised for the average baseline over the time period used for the
fitting.
2.4 Luciferase assays after picrotoxin treatment
Cells cultured in DMEM with 10% FetalClone III serum and 0.3 mM luciferin were exposed
to temperature cycles for at least 3 days before medium was changed and they were shifted to
constant 37°C. Parallel longitudinal bioluminescence recordings were taken to determine the
phase of drug addition. Cells were lysed at 4-hour intervals after drug treatment using the same
buffer as described in Section 2.13, but with 1% TX-100 instead of digitonin. Samples were then
flash frozen and stored at -20°C until the end of the collection period. After thawing, 10 µl of the
samples were plated in triplicate with 80 µl assay buffer as described in Section 2.13, omitting
luciferin. Luciferase assays were initiated by automated injection of 10 µl luciferin solution, and
bioluminescence immediately recorded.
2.5 Biochemical characterisation of picrotoxin activity
1 µg thioredoxin (TRX) was empirically determined to be the optimal amount to run on SDS
PAGE (data not shown). Reaction volume was set as 10 µL, and pH-adjusted phosphate-buffered
saline was used to dilute reagents. First, 8.55 µM TRX was reduced by incubation with 1 mM
TCEP at room temperature for 30 minutes. The samples were then run through a desalting column
before the reactions with 100 µM N-ethylmaleimide (NEM) were carried out at room temperature
for 60 minutes. Picrotoxin was then incubated with the appropriate samples overnight at 70°C.
Reaction products were boiled in LDS sample buffer before running on NuPAGET M NovexT M
4-12% Bis-Tris Protein Gels (Thermo Fisher), and stained with Colloidal Coomassie Blue Stain
(Severn Biotech).
2.6 Proteomics and phosphoproteomics
Dr Sew Peak Chew performed the enzymatic digestion, TMT labelling, HPLC fractionation,
enrichment of phosphopeptides, LC-MS/MS and peptide/protein identification.
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2.6.1 Sample preparation
A timecourse was carried out as described below in section 2.9. At each timepoint cells were
washed twice in ice cold PBS and then lysed at room temperature in 100 µL lysis buffer (8 M
urea, 20 mM Tris, pH 8) for 20 minutes. The lysis buffer was prepared the day before sampling
began, and frozen in 1 mL aliquots. At each timepoint, one aliquot was defrosted at room
temperature (23°C) whilst shaking at 700 rpm for 5 minutes. After lysis the cells were scraped
and technical replicates were combined before flash freezing in liquid nitrogen and storage at
-80°C.
After defrosting the samples were sonicated for 2 minutes and the protein concentration was
measured using a BCA assay (Pierce). 12 pooled samples were created by combining a portion
of each experimental sample such that each sample/pool contained an equal amount of protein.
All samples were then flash frozen in liquid nitrogen and stored at -80°C.
2.6.2 Enzymatic Digestion
Each sample (256 µg) was reduced with 5 mM DTT at 56°C for 30 minutes and then alkylated
with 10 mM iodoacetamide in the dark at room temperature for 30 minutes. They were then
digested with mass spectrometry grade Lys-C (Promega) at a protein:Lys-C ratio of 100:1 (w/w)
for 4 hours at 25°C. Next, the samples were diluted to 1.5 M urea using 20 mM HEPES (pH
8.5) and digested at 30°C overnight with trypsin (Promega) at a ratio of 70:1 (w/w). Digestion
was quenched by the addition of trifluoroacetic acid (TFA) to a final concentration of 1%.
Any precipitates were removed by centrifugation at 13000g for 15 minutes. The supernatants
were desalted using homemade C18 stage tips containing 3M Empore extraction disks (Sigma)
and 5 mg of Poros R3 resin (Applied Biosystems). Bound peptides were eluted with 30-80%
acetonitrile (MeCN) in 0.1% TFA and lyophilized.
2.6.3 TMT (Tandem mass tag) peptide labelling
The lyophilized peptides from each sample were resuspended in 100 µl of 2.5% MeCN, 250
mM triethylammonium bicarbonate. According to manufacturer’s instructions, 0.8 mg of each
TMT 10plex reagent (Thermo) was reconstituted in 41 µl of anhydrous MeCN. The peptides
from each time point were labelled with a distinct TMT tag for 75 minutes at room temperature.
The labelling reaction was quenched by incubation with 8 µl 5% hydroxylamine for 30 min. The
labelled peptides from all time points per experiment were combined into a single sample and
partially dried to remove MeCN in a SpeedVac (Thermo Scientific). After this, the sample was
desalted as before and the eluted peptides were lyophilized.
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2.6.4 Basic pH Reverse-Phase HPLC fractionation
The TMT labelled peptides were subjected to off-line High Performance Liquid Chromatography
(HPLC) fractionation, using an XBridge BEH130 C18, 3.5 µm, 4.6 mm x 250 mm column with
an XBridge BEH C18 3.5 µm Van Guard cartridge (Waters), connected to an Ultimate 3000
Nano/Capillary LC System (Dionex). Peptide mixtures were resolubilized in solvent A (5%
MeCN, 95% 10 mM ammonium bicarbonate, pH 8) and separated with a gradient of 1-90%
solvent B (90% MeCN, 10% 10 mM ammonium bicarbonate, pH 8) over 60 minutes at a flow
rate of 500 µl/min. A total of 60 fractions were collected. They were combined into 20 fractions
and lyophilized and desalted as before. 5% of the total eluate from each fraction was taken out
for proteome LC-MS/MS analysis and the rest was used for phosphopeptide enrichment.
2.6.5 Enrichment of phosphopeptides
All 20 fractions of peptide mixture were enriched first using PHOS-Select iron affinity gel, an
Iron (III) Immobilised Metal Chelate Affinity Chromatography (IMAC) resin (Sigma). Desalted
peptides were resuspended in 30% MeCN, 0.25 M acetic acid (loading solution) and 30 µl of
IMAC beads, previously equilibrated with the loading solution, was added. After 60 minutes
incubation at room temperature, beads were transferred to a homemade C8 (3M Empore) stage
tip and washed 3 times with loading solution. Phosphopeptides were eluted sequentially with 0.4
M NH3, 30% MeCN, 0.4 M NH3 and 20 µl of 50% MeCN, 0.1% TFA. The flow-through from
the C8 stage tips was collected and combined into 10 fractions, and used for titanium dioxide
(TiO2) phosphopeptide enrichment. For this, the total volume of flow-through was made up to
50% MeCN, 2 M lactic acid (loading buffer) and incubated with 1-2 mg TiO2 beads (Titansphere,
GL Sciences, Japan) at room temperature for 1 hour. The beads were transferred into C8 stage
tips, washed in the tip twice with the loading buffer and once with 50% MeCN, 0.1% TFA.
Phosphopeptides were then eluted sequentially with 50 mM K2HPO4 (pH 10) followed by 50%
MeCN, 50 mM K2HPO4 (pH 10) and 50% MeCN, 0.1% TFA.
The first 10 fractions of IMAC and the 10 fractions of TiO2 enriched phosphopeptides were
combined, and the other 10 fractions from IMAC enrichment were combined into 5 fractions,
thus making a total of 15 fractions for phosphoproteomics analysis. Phosphopeptide solution
from these fractions were acidified, partially dried, and desalted with a C18 Stage tip that
contained 1.5 µl of Poros R3 resin. These were then partially dried again and thus ready for mass
spectrometry analysis.
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2.6.6 LC MS/MS
The fractionated peptides were analysed by LC-MS/MS using a fully automated Ultimate 3000
RSLC nano System (Thermo) fitted with a 100 µm x 2 cm PepMap100 C18 nano trap column
and a 75 µm × 25 cm reverse phase C18 nano column (Aclaim PepMap, Thermo). Samples
were separated using a binary gradient consisting of buffer A (2% MeCN, 0.1% formic acid)
and buffer B (80% MeCN, 0.1% formic acid), and eluted at 300 nL/min with an acetonitrile
gradient. The outlet of the nano column was directly interfaced via a nanospray ion source to a
Q Exactive Plus mass spectrometer (Thermo). The mass spectrometer was operated in standard
data-dependent mode, performing a MS full-scan in the m/z range of 350-1600, with a resolution
of 70000. This was followed by MS2 acquisitions of the 15 most intense ions with a resolution
of 35000 and Normalised Collision Energy (NCE) of 33%. MS target values of 3e6 and MS2
target values of 1e5 were used. The isolation window of precursor ion was set at 0.7 Da and
sequenced peptides were excluded for 40 seconds.
2.6.7 Spectral processing and peptide and protein identification
The acquired raw files from LC-MS/MS were processed using MaxQuant (Cox and Mann) with
the integrated Andromeda search engine (v1.6.3.3). MS/MS spectra were quantified with reporter
ion MS2 from TMT 10plex experiments and searched against the Mus musculus UniProt Fasta
database (Dec 2016). Carbamidomethylation of cysteines was set as fixed modification, while
methionine oxidation, N-terminal acetylation and phosphorylation (STY) (for phosphoproteomics
group only) were set as variable modifications. Protein quantification requirements were set at 1
unique and razor peptide. In the identification tab, second peptides and match between runs were
not selected. Other parameters in MaxQuant were set to default values.
The MaxQuant output file was then processed with Perseus (v1.6.2.3). Reporter ion intensities
were uploaded to Perseus. The data was filtered: identifications from the reverse database were
removed, only identified by site, potential contaminants were removed and we only considered
proteins with ≥1 unique and razor peptide. Then all columns with an intensity “less or equal to
zero” were converted to “NAN” and exported as a .txt file.
The MaxQuant output file with phosphor (STY) sites table was also processed with Perseus
software (v1.6.2.3). The data was filtered: identifications from the reverse database were
removed, only identified by site, potential contaminants were removed and we only considered
phosphopeptides with localization probability ≥0.75. Then all columns with intensity “less or
equal to zero” were converted to “NAN” and exported as a .txt file.
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2.6.8 Bioinformatics
All data handling was done using R v3.5.1. Only proteins present in all of the samples and pools
were included for analysis, and since the sample for timepoint 12 was missing for CRY1−/−;
CRY2−/−, abundance values were inferred for each protein by taking the mean of the two
neighbouring timepoints. Sample loading normalisation was carried out by taking the sum of
all intensities for each time point and normalising to the mean of these, since an equal amount
of protein was used for each TMT labelling reaction. This was followed by internal reference
scaling (IRS) to allow for comparisons between TMT experiments [232]: for each TMT 10plex
experiment the arithmetic mean abundance for each protein in both pools was calculated. Then
the mean of these means was calculated and used to normalise the values for each protein for all
the samples.
Rhythmicity was tested using the RAIN (Rhythmicity Analysis Incorporating Non-parametric
methods) algorithm [233], and multiple testing was corrected for using the adaptive Benjamini-
Hochberg method. Proteins with a corrected p ≤ 0.05 were deemed significant. Relative
amplitude of rhythmic proteins was calculated by detrending the data using a 24-hour moving
average and dividing the resultant range by the average normalised protein abundance. To include
only proteins with a biologically relevant level of oscillation, only those with relative amplitude
≥ 10% were taken for further analysis (See Chapter 4 for details). Metacycle is a package
written in R combining 3 statistical methods of rhythm analysis [234]: ARSER, JTK_CYCLE,
and Lomb-Scargle methods. Within this package I used the meta2d function to analyse my data,
and compared the outputs in Chapter 4.
Phosphoproteomics data were handled in the same way, except that normalised phospho-
peptide abundances were adjusted according to the changes in abundance of the corresponding
protein from the normalised total proteome data. Hence changes in phosphorylation were de-
coupled from changes in the total amount of protein. These adjusted values were then used for
rhythmicity analysis.
Gene ontology analysis was performed using online tools (www.geneontology.org), and
functional annotation clustering was performed using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) v6.8. All functional annotation was performed using the list
of all proteins detected in our experiment as the background. Kinase recognition motifs were
screened using a custom script written in Python v2.7 by Dr Tim Stevens.
2.7 Cell volume measurements
Cell volume measurements were performed by Dr Alessandra Stangherlin. WT cardiac fibroblasts
were transfected with pCDNA3.1 tdTomato and diluted 1:2 with control cells (transfected with
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no DNA). Cell mixtures were then seeded in µslides (IBIDI, 80826), grown to confluence and
entrained by temperature cycles. 24 hours before recording began, medium was changed to
air medium supplemented with 1% Hyclone III and the plates were sealed. Z-stacks were
acquired every hour for 2.5-3 days using a Leica SP8 confocal microscope. Imaris software
(Oxford instruments) was used for 3D reconstruction, tracking and determination of cell volume.
Comparison of fit was done using GraphPad Prism 8 as described above (Chapter 2.3).
2.8 Western blotting
For Western blots, proteins were run on NuPAGET M NovexT M 4-12% Bis-Tris Protein Gels
(Thermo Fisher) before transferring to nitrocellulose membranes. For transfer, the iBlot system
(Thermo Fisher) was used. Membranes were blocked using 5% milk powder (Marvel) or 0.125%
BSA (Sigma) and 0.125% milk powder (Marvel) in TBS containing 0.1% Tween-20 (TBST)
for 30 minutes at room temperature then incubated with primary antibody at 4°C overnight.
HRP-conjugated secondary antibodies (Thermo Fisher) diluted 1:10000 in blocking buffer were
incubated with the blots for 1 hour at room temperature. Chemiluminescence was detected in a
Biorad chemidoc using Immobilon reagent (Millipore). Protein loading was checked by staining
gels with Colloidal Coomassie Blue Stain (Severn Biotech). Densitometric analysis was carried
out using Image Lab 4.1 (Biorad Laboratories 2012).
2.9 Timecourse experiments: general structure
Cells were plated at a near-confluent density (roughly 27,000 cells per cm2) and cultured in
DMEM with 10% FetalClone III serum for one week in a temperature-controlled incubator
that was programmed to oscillate between 32°C and 37°C, with transitions every 12 hours.
The cells received a medium change at the transition between 37°C and 32°C after 4 days.
After another 3 days the cells received another medium change at the same transition time into
medium containing either 10% or 1% serum, and the incubator was programmed to remain at
37°C constantly. At this time, a subset of cells received medium containing 1 mM luciferin,
and these were placed into an ALLIGATOR for bioluminescent recording. After 24 hours,
sampling began, with 3 hour intervals, and continuing for 3 days. The nature of the sampling
varied according to the specific experiment, and details will be discussed in separate sections.
Timecourse experiments were performed in 12-hour shifts with Dr Alessandra Stangherlin or
Estere Seinkmane.
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2.10 Measurement of cellular protein content
Confluent monolayers of cells were washed twice with ice-cold PBS. Cells were then incubated
with 200 µL digitonin lysis buffer (50 mM Tris pH 7.4, 0.01% digitonin, 5 mM EDTA, 150 mM
NaCl, 1 U/mL Benzonase, protease and phosphatase inhibitors) on ice for 15 minutes. After this,
lysates were collected, and then the cells were incubated with 200 µL RIPA buffer (50 mM Tris
pH 7.4, 1% SDS, 5 mM EDTA, 150 mM NaCl, 1 U/mL Benzonase, protease and phosphatase
inhibitors), on ice for 15 minutes. Cells lysates were then scraped and collected and all samples
were flash frozen in liquid nitrogen. Protein concentration was measured for all the samples at
once after thawing. RIPA lysates were sonicated at high power for 10 seconds at 4°C to shear
genomic DNA. RIPA lysates and digitonin lysates were clarified by centrifugation at 21,000 g
for 15 minutes at 4°C.
To measure protein concentration using intrinsic tryptophan fluorescence, 10 µL of each
sample was transferred into a UV-transparent 384 well plate (Corning 4681) in triplicate or
quadruplicate. After brief centrifugation of the plate, quantification was carried out using a
Tecan Spark 10M microplate reader, with excitation at 280 nm and emission at 350 nm. Protein
concentration of 10 µL lysate was also measured in 96-well plates using the bicinchoninic
acid assay (BCA assay, Pierce), according to the manufacturer’s instructions. For both assays,
standards were made using bovine serum albumin (Fisher Scientific), dissolved using the same
lysis buffer as the lysates being measured. Standard curves were fitted to a quadratic curve using
Prism Graphpad 8 (San Diego, Ca), and protein concentrations were interpolated. Coomassie
staining was also used to measure relative changes in protein content. Lysates were run on
NuPAGET M NovexT M 4-12% Bis-Tris Protein Gels (Thermo Fisher) and stained with Colloidal
Coomassie Blue Stain (Severn Biotech). Using ImageJ, regions of interest were drawn over
whole lanes and average intensity was measured.
Each technique has its advantages and disadvantages. The BCA assay (Thermo) may be
confounded by reducing metabolites that are able to induce a colour change by reducing copper
II to copper I. Intrinsic tryptophan fluorescence may be confounded by free tryptophan and
folding state. Coomassie staining on a gel is difficult to quantify and binds in a similar way to the
BCA reagent. In terms of advantages, BCA is reliable, samples can be recovered after intrinsic
tryptophan fluorescence, and Coomassie is easy to visualise. After the first experiment I only
used BCA assay and intrinsic tryptophan fluorescence due to their reliability, independent modes
of measurement, and limited sample sizes.
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2.11 Measurement of the effective diffusion coefficient of quan-
tum dots
Quantum dot synthesis was carried out by Thomas Pons, and conjugation was carried out by
Joseph (hitherto referred to as Joe) Watson. I carried out dilution of quantum dots and application
to cell cultures. Joe Watson then performed image acquisition, effective diffusion coefficient
calculation and the preparation of images for presentation.
CdSe/CdS/ZnS core/shell quantum dots (QDs) were synthesised using a high temperature
reaction of metal carboxylates and sulphur and selenium precursors in octadecene as described
previously [235], and then conjugated to streptavidin followed by incubation with biotinylated
Cell Penetrating Poly Disulphides (CPD) [236] overnight at 4°C. On the day of the experiments,
QD-CPD conjugates were diluted to a final 1 nM concentration in growth medium without serum,
and then added onto cells in a time-course experiment.
WT and CRY1−/−; CRY2−/− fibroblasts were seeded in 35 mm dishes (WPI) and grown
to confluence, differentially entrained using temperature cycles. QD motion was imaged at
predicted troughs and peaks of protein oscillations: 24, 36, 48 and 60 hours after medium change
(normal growth medium as described above but with 1% serum and supplemented with 10 mM
HEPES). Cells were incubated with 1 nM QDs for 1 hour, washed twice with PBS then imaged
at 37°C at atmospheric conditions, maintained using a temperature-controlled chamber (Digital
Pixel). All treatments were performed at 37°C and using the conditioned medium from the same
dishes to prevent any perturbations caused by medium change. For each time point, several
time-lapse recordings from 4 replicate dishes were acquired, and these were then pooled for
analysis.
Imaging was performed by Joe Watson using spinning disk confocal microscopy on a setup
custom-built by Dr Emmanuel Derivery. This was based on a Nikon Ti stand, 100X PLAN
APO NA 1.45 oil immersion objective, a Yokogawa CSUX1 spinning disk head followed by
1.2X relay optics and a Photometrics Prime 95B back-illuminated sCMOS camera operated by
Metamorph (Molecular Devices). To maximise sensitivity, the camera was configured in 12 bit
dynamic range mode (gain 1), and the camera was synchronised with the spinning disc wheel
and operated in pseudo global shutter mode where lasers only switched on when all lines were
exposing – this avoided imaging artefacts. To prevent focus drift during fast acquisitions, the
stand was equipped with hardware autofocus. QDs were excited by a 488 nm laser (150 mW
OBIS mounted in a Cairn laser launch) and single band emission filters mounted in a fast Cairn
Optospin filter wheel were used - Chroma 595/50 for QDs. Each acquisition consisted of 1000
frames acquired at 62.5 Hz (10 ms exposure, 6 ms readout).
Estimation of the effective diffusion coefficient of QDs was performed in Fiji and Mat-
lab 2017b (Mathworks) using custom codes written by Dr Emmanuel Derivery. In brief, QD
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position was determined using 2D Gaussian fitting, and QD trajectories were tracked using
code originally developed by David Grier, John Crocker and Eric Weeks in Matlab 2017b
(http://site.physics.georgetown.edu/matlab/index.html). For each track, the mean square displace-
ment (MSD) of segments of increasing duration was then computed and fitted to a subdiffusion
model captured by the function MSD(t) = 4Dtα where D is the effective diffusion coefficient.
MSD curves were filtered to retain only those with a good fit (R2 > 0.9) and with α > 0.5 in order
to exclude immobile particles. Effective diffusion of these filtered tracks was then accurately
estimated by fitting the first 50 points of their MSD curve by the function MSD(t) = 4Dt. The
effective diffusion coefficient D was then averaged across all filtered tracks to give an estimate
of the effective diffusion coefficient for a given field of view (average number of filtered tracks
per field of view was 1125 ± 42). The effective diffusion coefficients per field of view were then
averaged for each timepoint of the circadian time-course (between 84-135 fields of view across 4
cell culture dishes for each genotype at each time point).
2.12 Measurement of intracellular ion content
Sample dilution was performed by Dr Alessandra Stangherlin and ICP-MS was performed by Dr
Jason Day.
Confluent monolayers of cells were washed on ice with iso-osmotic buffer A (300 mM
sucrose, 10 mM Tris base, 1 mM EDTA, pH 7.4 adjusted with phosphoric acid, 330-340 mOsm
adjusted with sucrose/HPLC water), followed by iso-osmotic buffer B (300 mM sucrose, 10
mM Tris base, 1 mM EDTA, pH 7.4 adjusted with acetic acid, 330-340 mOsm adjusted with
sucrose/HPLC water). This osmolarity was chosen to match the culture medium. Iso-osmotic
buffer A contains phosphoric acid which displaces lipid bound ions. Iso-osmotic buffer B
contains acetic acid which removes traces of phosphates. Cells were then incubated for 30
minutes at room temperature in 200 µL ICP-MS cell lysis buffer (65% nitric acid, 0.1 mg/mL
(100 ppb) cerium). Lysates were then collected and stored at -80°C. All samples were thawed
simultaneously and diluted using HPLC water to a final concentration of 5% nitric acid. Diluted
samples were analysed by inductively-coupled plasma mass spectrometry (ICP-MS) using the
NexION 350D ICP-MS (PerkinElmer Inc.).
2.13 Luciferase folding assays
Cells cultured in DMEM with 10% FetalClone III serum and 0.3 mM luciferin were exposed to
temperature cycles for at least 3 days before they were shifted to constant 37°C. At desired time-
points cell plasma membranes were permeabilised to extract cytosol using the following buffer:
100 mM potassium phosphate buffer pH 7.8, 10 mM MgSO4, 1 mM ATP, 1 mM EDTA, 100
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mM 2-mercaptoethanol, 0.01% Digitonin (Sigma), 10% glycerol, 1 mM NaF, 1 mM Na3VO4,
and protease inhibitors. After incubation at 4°C for 20 minutes, the lysate was either used
immediately or flash frozen in liquid nitrogen. Boiled lysate controls were obtained by heating
lysate samples at 95°C for 10 minutes.
Recombinant luciferase (Promega) was denatured by heating at 45°C for 35 mins (see
Chapter 6 for details), before being returned to 4°C. A final concentration of 10 nM was used,
except when non-denatured luciferase was used as a positive control, where 100 pM was used.
Luciferase assays in solution were carried out as previously described [132], with modifications
as follows. On ice, cytosol extract was mixed with recombinant luciferase at a volume ratio
of 9:1 and incubated at 37°C for one hour for folding to occur, before 10 µl in triplicate was
plated into individual wells of a 96-well plate. 90 µl of luciferase assay buffer was added to
each well by automated injection (Tecan Spark 10M microplate reader) and bioluminescence
immediately recorded in counts per second. The luciferase assay buffer consisted of 10 mM
MgSO4, 30 mM Hepes, 300 µM Luciferin, 1 mM ATP, 10 mM 2-mercaptoethanol, 1 mg/ml
BSA. In addition, a control assay was carried out before incubation for refolding. Denatured
luciferase incubated with lysis buffer was used as a control for residual activity and spontaneous
refolding; the average activity was subtracted from the values recorded from cytosol/luciferase
mixes. Then, the values recorded from the samples incubated at 37°C were divided by the values
recorded from the pre-folding control plate – this fold-change from the control is the folding
activity of the cytosol extract.
2.14 Proteasome activity assays
Around 20,000 cells per well were plated in a 96-well plate, and on the following day they
were changed into the appropriate experimental medium for 3 hours. 10 µM epoxomicin in the
experimental medium was used as negative control.
The ProteasomeGlo Cell-Based Assay (Promega) was used to measure proteasome catalytic
activity. Chymotrypsin-like, trypsin-like and caspase-like activities were measured separately
using the relevant substrates from Promega (Suc-LLVY-Glo, Z-LRR-Glo, Z-nLPnLD-Glo re-
spectively). Assay reagents were prepared according to the manufacturer’s instructions. The
96-well plate was equilibrated to room temperature, and a volume of assay reagent equal to
the volume of medium was added to each well before shaking at 700 rpm for 2 minutes. The
plate was incubated at room temperature for a further 10 minutes, and then luminescence was
measured using the Tecan Spark 10M microplate reader, recording counts for 1 second. The
luminescence readings from the epoxomicin controls represent background protease activity, and
so this was subtracted from all other recordings. The luminescence readings from cells changed
to exactly the same medium as they were plated in represented “baseline” proteasome activity.
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Proteasome activity in response to different concentrations of serum and drugs were expressed
as fold-changes from this baseline level.
2.15 Measurement of translation rate
For radiolabelling of cells, a 6-well plate containing confluent monolayer cultures was used. 24
hours after plating, the cells were changed into medium containing 1% serum and 35S-methionine
at a concentration of 0.1 mCi/mL. After 10 minutes of incubation on a heat pad, the cells were
washed with PBS before lysis with RIPA buffer at room temperature. Samples were reduced with
LDS sample buffer with 0.25% 2-mercaptoethanol and run on a gel. The gel was stained with
Coomassie and vacuum-dried. The dried gel was exposed to a phosphor screen (GE Healthcare)
overnight. Phosphor screen autoradiography was performed using a Typhoon FLA 7000 imager
(GE Healthcare). Imaging of the Coomassie stain was performed using a Biorad chemidoc and
densitometric analysis was performed in Image J.
Metabolic labelling with L-azidohomoalanine (AHA) was also used to measure translation
rate. This non-canonical amino acid is incorporated into newly synthesised proteins in place of
methionine, giving them the unique chemical properties of the azide group. This allows click
chemistry tagging with a reporter containing an alkyne group in a highly specific reaction, so that
the abundance of newly synthesised proteins may be quantified [237, 238]. The experiment was
carried out according to the manufacturer’s instructions (Thermo). Briefly, cells were washed
twice in warm PBS and methionine-free and serum-free medium was added, incubating for 1
hour at 37°C. After this, the medium was replaced with methionine-free and serum-free medium
containing Click-IT AHA (Thermo) at a final concentration of 100 µM before incubation for
2 hours at 37°C. Cells were then washed thrice with ice cold PBS and lysed with RIPA buffer
on ice. Lysates were collected by scraping then flash frozen. This protocol was carried out at
two separate time points, 12 hours apart. All lysates were defrosted and protein concentration
was quantified using BCA assay (Thermo). Click reactions were then performed at the same
time according to manufacturer’s instructions including the use of proprietary reaction buffers
(Thermo). Biotin alkyne (Thermo) was used as the detection reagent at a working concentration
of 20 µM, and 17.7 µg protein was used for each reaction. Reduced LDS sample buffer was then
added before running the lysates on a gel and Western blotting as described above. Biotin was
probed for using streptavidin-HRP (1:2000, Cell Signalling).
2.16 Metabolic profiling of cells in culture
To characterise the metabolic profile of cells in culture I used metabolic assays from Seahorse
Biosciences [239, 240] to measure extracellular acidification rate (ECAR) and oxygen consump-
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tion rate (OCR) according to manufacturer’s instructions (Agilent), and with guidance from
Dr Marco Sciacovelli and Dr Christian Frezza for machine operation. 18,000 cells per well
were plated in a 24-well cell culture microplate (Agilent) and incubated at 37°C overnight to
adhere the cells. Empty wells in positions recommended by the manufacturer were used to assess
background. Cells were then changed into warm “Seahorse medium” (DMEM without phenol
red or bicarbonate, 4.5 g/L glucose, 1 mM pyruvate, 4 mM glutamine), and incubated for 30
minutes in a CO2-free incubator at 37°C for equilibration. An Agilent Seahorse XFe24 Analyser
was then used to measure OCR and ECAR, with injection of antimycin diluted in Seahorse
medium at a working concentration of 1 µM after the assay as a negative control.
2.17 Mouse behaviour experiments
2.17.1 General structure for mouse behavioural recordings
Mouse behavioural experiments were conducted at Ares unless stated otherwise. The following
people helped with the laborious weighing protocols and setting up cages: Dr John O’Neill, Dr
Andrew Beale, Dr Nina Rzechorzek, and Martin Reed. Jo Chesham kindly provided weighing
data from the Hastings Lab CRY1−/−; CRY2−/− PER2::LUC mouse colony to supplement my
own data. Post-mortems were carried out by many helpful members of the Ares staff, and Dr
Marisa Coetzee supervised these activities and authorised histopathology reports, which were
provided by Abbey Veterinary Services.
WT PER2::LUC and CRY1−/−; CRY2−/− PER2::LUC mice were used, with age ranging
from 7-11 weeks, and equal numbers of males and females where possible. Mice were individu-
ally housed in a temperature and humidity-controlled circadian cabinet (Phenome Technologies)
and locomotor activity was monitored by both wheel-running and infra-red motion detection.
Mice were entrained using 12 hour light (400 lux), 12 hour dark (LD) cycles for at least 1 week
before being subjected to constant darkness (DD) for at least 2 weeks. Locomotor activity was
analysed using ClockLab (Actimetrics).
Throughout the experiments the mice received weekly water bottle and food changes. There
were 3 visual checks per week, using night vision goggles where necessary, and daily PC checks
remotely. Cage setup was standardised with equal amounts of bedding and the running wheels
were maintained regularly to ease movement and reduce noise. Mice were weighed before
beginning experiments and during experiments when indicated in specific protocols.
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2.17.2 Mouse behaviour experiments with ixazomib treatment
An initial experiment to examine drug tolerance was conducted at the Laboratory of Molecular
Biology in the Biomedical Services facility, with help from Dr Marisa Coetzee, Dr John O’Neill
and Claire Knox. Mice were individually housed and drinking water was supplemented with 10%
blackcurrant and apple squash (Co-operative Foodstores Limited) to mask the taste of the drug.
1 male and one female (treatment group) both received 50 µg/mL ixazomib in the supplemented
drinking water (ixazomib stock concentration was 50 mg/mL in DMSO). 1 male and one female
(control group) received 0.1% DMSO. Water and food consumption as well as mouse weights
were recorded daily. Treatment and control group water was swapped after two days. Two
mouse behaviour experiments were carried out as described above, whilst closely monitoring
drug-treated mice daily for adverse effects. In these experiments, 35 µg/mL ixazomib was used
due to mild weight loss observed in the tolerance experiment. This concentration was tolerated
for the duration of the treatment (7 days) with no signs of distress.
2.18 Details of antibodies and drugs
Table 2.2 Antibodies.
Antibody name/target Host species Catalogue number Manufacturer
Anti-mouse-HRP Goat A4416 Sigma
Anti-rabbit-HRP Goat A6154 Sigma
Anti-rat-HRP Goat 629520 Thermo
HSP90 non-specific Mouse ab13492 Abcam
HSP70 non-specific Mouse ab2787 Abcam
Tubulin YL1-2 Rat in-house
Proteasome 20S α1-7 Mouse ab22674 Abcam
eIF2α Mouse AhO0802 Thermo
Phospho-eIF2α-S51 Rabbit ab32157 Abcam
Histone H3 Rabbit ab1791 Abcam















Pharmacological manipulation of a state
variable by picrotoxin
3.1 Introduction
3.1.1 Pharmacological screens to interrogate the clock mechanism
Genetic networks comprising transcriptional feedback loops are important for circadian regula-
tion in all organisms. In mammalian cells, Bmal1-containing complexes rhythmically activate the
transcription of the clock-controlled genes. These complexes are in turn rhythmically inhibited
by complexes containing PER and CRY proteins. Cell-based assays using cultured fibroblasts
have been used to screen for pharmacologically active compounds that affect clock function
[241, 171]. The advantage of this experimental system is that cultured fibroblasts lack intercellu-
lar coupling, and so perturbations may be revealed that would otherwise be masked in a system
with robust coupling such as the SCN. Such screens may be useful for discovering biological
mechanisms driving and regulating the circadian clock [3].
A recent screen of 1260 pharmacologically active compounds were tested with mouse and
human cell lines to find out why the cellular clock is flexible yet robust to environmental changes
[171]. Whilst many drugs increased period length, only 4 shortened it: picrotoxin, ketoconazole,
amsacrine and SB216763 (a GSK3 inhibitor). Whilst many drugs increased period length,
only 4 shortened it: picrotoxin, ketoconazole, amsacrine and SB216763 (a GSK3 inhibitor).
Ketoconazole acts through the glucocorticoid receptor [242], and modulation of this is known
to affect circadian rhythms in cell culture [243, 244]. Amsacrine is a DNA intercalating agent
and topoisomerase inhibitor and thus causes DNA damage. Period shortening upon amsacrine
treatment has been observed before [110, 151], and it has been proposed that DNA damage may
act as a zeitgeber [245]. GSK3 inhibition is already known to affect circadian period length
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[151]. Picrotoxin was of particular interest because of its large effect size and its mysterious
mechanism of action on the circadian clock. Picrotoxin is a classic irreversible GABAA receptor
antagonist but it was found that this drug reversibly and dose-dependently shortens period length
in several human and mouse tissues, independent of cys-loop receptors [246, 247]. However, the
molecular mechanism of action on cellular circadian timekeeping remains unknown.
3.1.2 Aims of this chapter
A better understanding of the mechanism of picrotoxin action may provide insight into important
clock regulators and how they may be pharmacologically targeted. More generally, this will give
some insight into the robustness of the cell-autonomous circadian timekeeping mechanism. In
addition, picrotoxin is often used in neuroscience research for its GABA antagonism property;
understanding its role as a circadian clock regulator would clarify any confounding effects drug
treatment may have for these experimental uses. Hence the aim of the study in this chapter was
to find the molecular target of picrotoxin.
3.2 Results and discussion
3.2.1 Picrotoxin treatment is a strong synchroniser
First I resolved to repeat the observations of Freeman et al. [246] to be confident of the effect of
picrotoxin in my own hands. In my cell cultures, picrotoxin treatment caused an acute induction
of PER2::LUC activity followed by rapid damping (Figure 3.1A). In addition, there was dose-
dependent shortening of period (Figure 3.1B), with the same effect size as previously observed
in different tissues [246]. This is a replication of previous findings, so I was confident that my
experimental system and technique was appropriate for studying the effects of this drug.
The strong induction of PER2::LUC activity suggested that picrotoxin treatment may be a
large perturbation of the cellular clock. Large perturbations such as serum shock or glucocorticoid
treatment tend to reset the phase of the clock [248, 243]. Hence I decided to conduct an
experiment where cells were treated with 100 µM picrotoxin at various times of day (Figure
3.1C,D). This concentration was chosen because of the clear period shortening effect, whilst
avoiding extreme damping that makes quantification of period length unreliable. This experiment
allows plotting of a phase-response curve (Figure 3.1D), which shows how much the phase is
changed as a function of time of drug treatment. I found that there was “type 0 phase-resetting”,
i.e. phase was always reset to the same point no matter what the phase of drug addition (Figure
3.1C, D). This suggests that picrotoxin is a strong synchroniser, capable of resetting the clock
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regardless of its original phase. Therefore it is likely that the cellular target of picrotoxin is a
state variable of the clock.
3.2.2 Picrotoxin increases PER2::LUC half-life
Next, I reasoned that since picrotoxin had a strong effect on PER2::LUC activity and phase, it
was likely that picrotoxin targets PER2. More specifically, an increase in half life could lead to
rapid accumulation of PER2::LUC molecules, resulting in the increase in PER2::LUC activity.
To test this, I cultured cells in the absence of luciferin in the medium, and collected cell lysates
at various times (Figure 3.2A). I then performed luciferase assays on the lysates to measure the
amount of PER2::LUC molecules were present relative to control at the time of collection. This
is preferable to the longitudinal bioluminescence assays, where luciferase activity is a function
of the amount of luciferase enzyme synthesised over the preceding 2 hours [132]. These acute
luciferase assays showed that levels of PER2 were higher after picrotoxin treatment compared to
vehicle (Figure 3.2A). This suggested that there were indeed more molecules of PER2 in cells
that had been treated with picrotoxin.
This finding could be explained by a change in half-life of PER2::LUC. To test this I treated
cells with a saturating concentration (10 µM) of the protein synthesis inhibitor cycloheximide
(CHX). This resulted in a decay in bioluminescence that was readily fit with an exponential decay
model. This technique showed that PER2::LUC half-life was increased by a small (roughly 12
minutes) but significant amount (Figure 3.2C).
These results suggest that picrotoxin may affect the circadian clock either directly or indirectly
through the stabilisation of PER2.
3.2.3 Picrotoxin has some irreversible effects
During my experiments I observed an unexpected phenomenon that was not reported previously.
Upon wash-off, the effect of period shortening was reversible as seen before (Figure 3.3A,
B), although there was a dose-dependent irreversible phase advance and increase in amplitude
relative to controls (Figure 3.3B, C). The reference point used to calculate relative phase was
the time of the second peak after the wash, in the vehicle-treated condition (Figure 3.3A, top
green arrow). This residual effect of picrotoxin suggested that the drug may bind to its target
covalently or with very high affinity, and that the target is long-lived in the cell.

















































































Figure 3.1 Picrotoxin shortens period length and resets circadian phase. A) Longitudinal
bioluminescence recordings of fibroblasts treated with 100 µM picrotoxin or DMSO vehicle at
the time indicated by the blue arrow. Mean±SEM, representative of N=3. B) Dose-response
curve showing period-shortening effect of picrotoxin. The period length of the vehicle condition
(i.e. 0 µM) is annotated in red. P<0.0001, one-way ANOVA, mean±SD. C) Examples of
detrended bioluminescence traces showing that phase is set to the same point irrespective of
time of 100 µM picrotoxin addition. Mean±SD. This experiment was performed with the help of
Daniel Fernando, who carried out some of the time points and performed the initial analysis. D)
Phase-response curve showing type 0 resetting. Mean±SD.
















































































Figure 3.2 Picrotoxin increases the stability of PER2::LUC. A) Acute luciferase activity as-
says showing increased PER2::LUC levels. X-axis is time after medium change. Drug/vehicle
was added at T=3h. P<0.0001, 2-way ANOVA, Holm-Sidak post-test. Mean±SD. B) Longi-
tudinal bioluminescence recording performed in parallel to A) for reference. Mean±SEM. C)
PER2::LUC half-life measured from exponential decay curves generated by addition of 10 µM
cycloheximide on its own (“CHX only”), at the same time as (“PTX + CHX”), or 2 hours after
(“CHX 2h after PTX”), addition of picrotoxin, Student’s t test, n=4, representative data shown of
N=2.







































































































Figure 3.3 The irreversible effects of picrotoxin. A) Longitudinal bioluminescence showing
the wash-off after drug treatment. Mean±SEM. Green arrows show the features used to manually
measure phase and amplitude. B) Quantification of period length in A), comparing drug treatment
(red) and wash-off (black). The period lengths for the vehicle treatment and subsequent wash are
annotated in magenta and brown respectively on the y-axis. Two-way ANOVA, Sidak’s multiple
comparisons test, mean±SD. C) There is a dose-dependent phase advance after picrotoxin wash-
off (p<0.0001, one-way ANOVA, mean±SD). D) There is also a dose-dependent increase in
amplitude after picrotoxin wash-off (p<0.001, one-way ANOVA, mean±SD).
3.2 Results and discussion 43
3.2.4 Removal of Picrotoxin is a strong synchroniser
The formulation of “air medium” is described in Chapter 2. It contains factors that act as strong
synchronising cues, including B27 and serum. When these factors are added to cells, they induce
PER2 expression, thus synchronising the cellular clocks. B27 and serum have different strengths
of synchronisation, so when they are added separately the cells are synchronised to different
phases (Figure 3.4A). Given the finding that picrotoxin has effects even upon wash-off, I sought
to test whether this was dependent on the synchronising cues in the medium.
The relaxation of the picrotoxin effect caused by the wash abolished the differential response
to B27 and serum, instead acting as a very strong resetting signal itself (Figure 3.4B). This
indicates that picrotoxin must be targeting a state variable of the clock.
3.2.5 Picrotoxin biochemical characterisation
Picrotoxin is in fact an equimolar mixture of two different compounds: picrotin and picrotoxinin
(Figure 3.5A). Both have similar functional groups, and I hypothesised that the epoxide group
may be the reactive moiety responsible for covalently binding to thiol groups on its protein target.
To test this, I used recombinant human thioredoxin (TRX) as a model protein, since it contains
two cysteines that would be accessible to picrotoxin. Ideally this would allow me to analyse the
picrotoxin-bound protein by mass spectrometry, thus generating a “fingerprint” that could be
used to search the proteome of treated cells for picrotoxin binding.
I designed three reactions that would test my hypothesis (Figure 3.5B). Reaction 1 was the
reaction between TRX and picrotoxin. Reaction 2 was the well characterised alkylation of thiol
groups by N-ethylmaleimide (NEM), which results in a near-irreversible modification. Reaction
3 is the incubation of the product of reaction 2 with picrotoxin; picrotoxin should not be able to
bind to the modified TRX. I hoped to observe these reaction products on a gel, with the product
of reaction 1 shifted up by 600 Da due to the added mass from picrotoxin modification, and
the products of reactions 1 and 3 both shifted by only 250 Da (due to alkylation by NEM),
confirming that picrotoxin was indeed reacting to the thiol groups rather than another part of the
protein.
A representative image of the reaction products is shown in Figure 3.5C. There was an
upwards shift relative to control associated with the reactions in which NEM was present
(reactions 2 and 3), suggesting that this reaction worked. However, there was no shift when
incubated with picrotoxin (reaction 1), and no difference between reactions 2 and 3, suggesting
that picrotoxin was not binding to thioredoxin. I tested several different pH conditions, reaction
times and different temperatures, but all showed the same pattern. I also tried using BSA and














































Figure 3.4 Picrotoxin removal is a strong zeitgeber. A) Bioluminescence recordings of cells
all treated with DMSO (control) diluted in air medium containing B27 and serum. Where
indicated by the blue arrow, cells were washed with medium containing various combinations of
B27 and serum or neither. The red arrow indicates phase variation after the wash. Mean±SEM.
Relative to control (B27 + serum), the phase ranged between -3.5 h (phase delay) and +13.1
h (phase advance). B) Bioluminescence recordings of cells treated with 100 µM picrotoxin
dissolved in air medium containing B27 and serum. Where indicated by the blue arrow, cells
were washed with medium containing various combinations of B27 and serum or neither. The
red arrow indicates phase alignment after the wash. Mean±SEM. Relative to control (B27 +
serum), the phase ranged between -2.8 h and +4.8 h.
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lysozyme as model proteins as they have more cysteine groups so a larger shift would be seen,
but no effect was seen (data not shown).
3.3 Conclusions
3.3.1 Summary of findings
The primary aim of this study was not met, since I did not find the target of picrotoxin. I have
confirmed previous observations [246] that picrotoxin reversibly shortens period length. In
addition I have found evidence that picrotoxin treatment stabilises the repressive PER2 complex,
explaining the initial PER2::LUC induction and rapid damping. There is also evidence for
residual effects of picrotoxin following wash-off, suggesting that the mechanism of binding to
its target could be covalent or very high affinity, although chemical characterisation has so far
been inconclusive.
The current model of the TTFL predicts that processes that stabilise clock proteins would slow
turnover and thus lengthen period [249]. In agreement with this, the drug KL001 stabilises CRY
and lengthens period [250]. However contradictory findings have been reported. For example,
recently synthesised KL001 derivatives stabilise CRY1 and shorten period [251]. In addition
it has been found that CRY1 can determine circadian period independently of degradation rate
and that the combinatorial phosphorylation of several sites may be more important for period
determination [117]. The complex relationship between protein stability and period length is
not unique to mammals. For example it has previously been noted that stability of FRQ in
Neurospora crassa, which has a function in the fungal clock analogous to that of PER2, can
be uncoupled from period determination [89]. Thus the observation that picrotoxin shortens
period despite stabilising PER2 contradicts the standard model, but similar observations have
been made before.
I propose that picrotoxin may stabilise PER2 protein, thus increasing its half-life and resulting
in period shortening. The initial induction of PER2::LUC activity may be associated with
synchronisation of phase between individual cells – this would need to be tested using single cell
bioluminescence imaging in the future. The small increase of half-life of roughly 12 minutes
may be enough to shorten period by more than 2 hours, but mathematical modelling would be
needed in the future to test this. Picrotoxin likely binds to its target via high affinity interactions,
and this could either directly or indirectly result in the effect on PER2 protein. For example,
picrotoxin may inhibit CK1, a kinase that targets PER2 for degradation, thus indirectly affecting
half-life. Different approaches to finding the target of picrotoxin are needed to explore these
possibilities further.
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Figure 3.5 Assaying the biochemical properties of picrotoxin. A) Picrotoxin is an equimolar
mixture of picrotin (C15H18O7) and picrotoxinin (C15H16O6). Epoxide groups are highlighted in
red. B) Schematic diagrams of 3 reactions used to test the biochemical properties of picrotoxin.
Reaction 1 is the hypothesised reaction between a thiol group on a protein and the epoxide group
on the picrotoxin molecule. Reaction 2 is the known irreversible alkylation of thiol groups by
N-ethylmaleimide (NEM). Reaction 3 represents the alkylated thiol group being unreactive to
picrotoxin. C) The reactions in B) were performed using thioredoxin (TRX) as the model protein,
and the products were run on a gel, along with TRX alone as a control. A representative image of
such a gel is shown, where reactions took place on ice for 90 mins at different pH values. TRX
has a molecular weight of 11.7 kDa, picrotoxinin 292 Da, picrotin 310 Da and NEM 125 Da.
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3.3.2 Future strategies to find the target of picrotoxin
To test the chemical reactivity of picrotoxin with a functional assay, I would incubate the drug
with various hypothetical targets prior to treatment. For example, picrotoxin may be incubated
with thioredoxin and then applied to cells. If there is attenuation of the period shortening effect
of picrotoxin, that would suggest that thioredoxin has bound and inactivated the drug.
It would be informative to explore the structural effects of picrotoxin on the PER2 complex.
PER2 is targeted for degradation through multi-site phosphorylation by CK1 [252, 253]. Assess-
ing the phosphorylation status of PER2 after picrotoxin treatment by immunoprecipitation of
tagged PER2 and western blot would be useful for this.
Another useful technique is drug affinity responsive target stability (DARTS) [254, 255].
This involves adding the drug to a cell lysate, resulting in target protein binding to the drug, thus
reducing its susceptibility to proteolysis. When the samples are then run on a gel with uncut
controls, targets should remain visible upon protein staining with Coomassie blue. These bands
can then be cut out and proteins identified by mass spectrometry.
These three approaches together would shed light upon the target of the drug as well as its






4.1.1 Current understanding – circadian proteomics
As described in Chapter 1, quantitative proteomics is a powerful tool for understanding cellular
processes at the systems level. Several circadian proteomics studies have been done using mouse
tissues in vivo [93, 256, 91, 257, 92] and in SCN slices ex vivo [90]. Whilst the mice in these
studies were kept in constant darkness, they still exhibit daily rhythms in feeding that have
been shown to drive rhythmic gene expression in the liver [227–229], and so the results do not
represent the output of the cell-autonomous circadian clock. To understand the cell-autonomous
circadian proteome, cell culture systems are ideal since they allow for exposure to truly constant
conditions at the cellular level. This would result in a better understanding of the cellular clock
rather than the processes involved in responding to feeding cues and light conditions.
To my knowledge, the only published study addressing cell-autonomous circadian regulation
of the mammalian cellular proteome was performed using cultured fibroblasts in vitro by our
laboratory using SILAC and mass spectrometry [137]. In this study, 1608 proteins were identified
across the time course, and 237 of these showed a circadian rhythm in abundance. This is far
fewer than previous studies of the circadian proteome using SILAC (3132 in Robles and Mann
2014 [92], 5827 in Mauvoisin et al. 2014 [93]). The protein extraction method is the most likely
reason for this discrepancy.
The first in vivo circadian phosphoproteome was characterised in mouse liver, and revealed
the importance of circadian regulation in many signalling pathways [98]. This has since been
carried out for mouse hippocampus, and this study showed the importance of circadian regulation
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of phosphorylation in synaptic and cytoskeletal processes [258]. Together, these studies suggest
that the circadian regulation of phosphorylation is important in the physiology of multiple tissues
in mammals. The circadian phosphoproteome has also been characterised in Arabidopsis [259]
and Neurospora [95], suggesting that the physiological importance of the rhythmic regulation
of phosphorylation at the proteome level may be conserved among eukaryotic species. To my
knowledge, the circadian phosphoproteome has not hitherto been characterised at the cellular
level in mammals, and so the cell-autonomous contribution to the circadian control of the
phosphoproteome is unknown.
4.1.2 Aims for this chapter
Cells have evolved elaborate mechanisms to regulate the function of proteins in time and
space. Whilst the spatial control of cell biology is relatively well understood [260] we are only
beginning to appreciate the temporal control of cellular function. To improve understanding
of this, I sought to characterise the cell-autonomous circadian control of the cellular proteome
and phosphoproteome. More specifically, I wished to assess the contribution of the TTFL to
the temporal control of the proteome, and so I compared wild type (WT) cells to CRY1−/−;
CRY2−/− (CKO) cells. As described in Chapter 1, CKO cells have no functional TTFL, and so
they represent a negative control in this experiment.
4.2 Results and discussion
4.2.1 Experimental design
A time course experiment was carried out as described in Chapter 2. Once confluent, cells were
entrained for 7 days in temperature cycles. Following this, the medium was changed and the
cells were put into constant 37°C, and sample collection began 24 hours later. The experiment
was designed so that there were 3 technical replicates per time point, i.e. 3 wells in a 6-well
plate per genotype. Detection of the total proteome required very little protein – in the order of 2
µg, but technical replicates were pooled to maximise the amount of protein for phosphopeptide
enrichment. Sample preparation is described in detail in Chapter 2, but I will outline the key
points here (Figure 4.1). Briefly, the aim was to create several pool samples including all time
points of both genotypes to enable comparisons between TMT runs. As a result, each 10-plex
TMT experiment included 8 experimental samples and 2 pools. Enzymatic digestion, TMT
labelling and fractionation were performed by Dr Sew Peak Chew.




















every 3 hours, 3 days
Figure 4.1 Proteomics and phosphoproteomics experimental workflow. At 3-hour intervals
over 3 days, confluent monolayers of primary fibroblasts cultured at constant 37°C were lysed
in 8 M urea. For both genotypes, 3 technical replicates were combined into one sample. 12
pooled samples were created, and all samples were adjusted to the same protein concentration
for trypsin digestion. Peptides were labelled using 10-plex TMT: each set was comprised of 8
time-course samples and two pooled samples. The 10 labelled samples were mixed and split into
proteomics and phosphoproteomics workflows. This was repeated for each set of TMT reagents,
hence 6 sets in total were used. Peptide and protein identification was performed in MaxQuant,
and the data was cleaned using Perseus. The resulting quantitative data was normalized and
analysed using statistical tools in RStudio.
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4.2.2 Data analysis
Peptide and protein identification were also performed by Dr Sew Peak Chew using Maxquant
and Perseus software applications as described in Chapter 2. I used the R programming language
for subsequent bioinformatic analysis due to the extensive statistical libraries available. The
sample loading normalisation required proteins to be present in all samples and pools because
this method assumes that an equal amount of protein was loaded into the mass spectrometer for
each sample. Internal reference scaling (IRS) permits the comparison of protein levels between
TMT experiments because all the pools theoretically contain the same amount of every protein.
This technique was first described by Phillip A. Wilmarth [232].
Several statistical tests have been developed for the analysis of rhythmicity. Non-parametric
methods do not make assumptions related to experimental noise and the nature of the underlying
model, by analysing the ranks of values rather than the measured values themselves. The
JTK_CYCLE programme uses this type of method for rhythm detection, but it is not suitable
for detecting waveforms that are not sinusoidal in shape. The RAIN (Rhythmicity Analysis
Incorporating Non-parametric methods) algorithm was created to address this problem, and it
was shown to out-perform JTK_CYCLE in sensitivity [233]. I therefore chose to use the RAIN
algorithm and compared it against Metacycle, which is a programme that combines 3 different
methods of rhythm detection for reliability: JTK_CYCLE, ARSER (ARS) and Lomb-Scargle
(LS) [234].
I used the WT dataset to compare Metacycle with RAIN. Metacycle found 135 rhythmic
proteins, and 76% of these were also detected as rhythmic by RAIN (Figure 4.2A). RAIN
found 589 rhythmic proteins, 487 of which were not detected by Metacycle. This is in line
with the increased sensitivity, particularly for non-sinusoidal waveforms, reported by Thaben
and Westermark in their original publication [233]. For this reason I decided to use the RAIN
algorithm for the rest of my analyses.
The presence of rhythmicity does not guarantee biological relevance; if a protein shows very
small changes in abundance over the circadian cycle, this is unlikely to be functionally relevant. I
sought a statistical method to generate a threshold for this. The distribution of relative amplitudes
of rhythmic proteins in WT cells was used to decide an inclusion threshold for proteins that
varied in abundance significantly. The cumulative distribution function of relative amplitude is
shown in Figure 4.2B, with the median and quartiles annotated. The 25% quartile was situated
at a relative amplitude of approximately 0.1, and I set this as my threshold. Hence the bottom
quartile of each dataset was considered functionally arrhythmic.
























Rhythmic proteins detected in WT cells
Relative amplitudes in WT cells
From RAIN:
n=589
Figure 4.2 Definitions of rhythmicity – statistical and functional. A) In the WT dataset, the
RAIN algorithm detected 589 rhythmic proteins. Metacycle detected 135 rhythmic proteins,
and 102 of these were also detected by RAIN. Given this overlap and the known advantages of
RAIN (see text), this algorithm was used as a statistical definition of rhythmicity. B) Relative
amplitudes of the proteins detected as rhythmic by RAIN were calculated. They are plotted here
as a cumulative distribution function, with the 25%, 50%, 75% and 100% quartiles annotated.
Proteins with relative amplitude below the 25% quartile were deemed functionally arrhythmic.
This corresponded to a relative amplitude of 10%, and so this was the threshold used in the
analysis of the rest of the dataset.




































Figure 4.3 Benchmarking using CRY1. A) The relative abundance of CRY1 detected in
the WT dataset is plotted. It was not found statistically rhythmic by RAIN (p=0.07), but it
was fit by a damped cosine wave in preference to a straight line (Extra sum-of-squares F test,
p=0.01). The damped cosine is plotted in red. B) Longitudinal bioluminescence recording of WT
PER2::LUC fibroblasts, performed simultaneously with the proteomics experiment as a phase
marker. Mean±SEM.
4.2.3 Validation with clock proteins
I used the WT dataset to confirm whether my bioinformatic processing hitherto had been
appropriate or if I had made mathematical errors. To do this I sought out known clock proteins to
examine the circadian profile. CRY1 was the only clock protein detected in all the WT samples
(it was not detected in the CKO samples at all) (Figure 4.3A). CRY1 abundance was rhythmic
with a phase slightly delayed relative to the parallel PER2::LUC recording (Figure 4.3B). CRY1
protein rhythms at the cell autonomous level have not been reported before, but it is known that
the phase of its mRNA is similarly delayed relative to that of Per2 mRNA [34]. Since this agreed
with expectations, I was confident that my normalisation and analysis method was appropriate.
4.2.4 Coverage
My data analysis included 5718 proteins that were present in all samples and pools. For
phosphoproteomics, this number was 3164 phosphopeptides. 7% of the wild-type proteome was
rhythmic with a relative amplitude of ≥10% (Figure 4.4A). The previous proteomics study from
our lab using cells in culture found that roughly 15% were rhythmic [137] and the discrepancy
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is likely due to the large difference in overall coverage. However, the figure of 15% is similar
to studies using mouse tissues in vivo [93, 256, 91, 257, 92]. Studies using mouse tissues are
not examining temporal coordination by the endogenous cellular clock because of the presence
of physiological zeitgebers like feeding rhythms resulting in daily rhythms of insulin which is
known to entrain the TTFL and drive rhythmic gene expression [226, 227]. Hence previous
studies are likely to have over-estimated the proportion of the proteome under cell-autonomous
circadian control. Furthermore, none of those studies filtered out proteins with low relative
amplitude. Indeed, in a study using SCN slices ex vivo the authors estimate between 6-13% of
the proteome being under rhythmic control [90].
3164 phosphopeptides were detected in all the samples, of which 8.8% were rhythmic
with a relative amplitude ≥10% in wild-type cells (Figure 4.4B). There have been no similar
experiments in cell culture, although a study with mouse liver gave a figure of 25% of detected
phosphopeptides being under circadian control [98] with a large amplitude as defined by fold-
change. This study had a much larger coverage, with over 20,000 phosphopeptides detected,
probably due to the large amount of material available in livers. The same caveat regarding
non-cell autonomous control of the proteome as described above applies here. Strikingly a larger
proportion of the detected proteome (18.2%) and phosphoproteome (17.9%) was rhythmic in
CKO relative to WT cells (Figure 4.4B).
The findings here are not compatible with the current paradigm for timekeeping mechanism
within the circadian field as described in Chapter 1, that the TTFL is required for the generation of
circadian rhythms in mammalian cells (i.e. the TTFL model). If the post-translational oscillator
(PTO) model is correct, a naïve assumption might be that whilst some proteins may be rhythmic
in CKO cells, the number would be far fewer since there is no signal amplification by the TTFL.
The fact that a larger proportion of the proteome and phosphoproteome is under rhythmic control
means that something more interesting may be afoot. More specifically, the TTFL could be
suppressing rhythms instead of generating them. To find out more, I explored the identities of
the rhythmic proteins and phosphopeptides.
4.2.5 Rhythms in cellular ion content
I inspected the proteins and phosphopeptides that were rhythmic in both genotypes, since these
represent direct outputs of TTFL-independent timekeeping, and may even include components
of the clock mechanism itself. There were 156 proteins and 65 phosphopeptides that were
rhythmic in both genotypes (Figure 4.5A, Appendix Table 1, Appendix Table 2). The 156
rhythmic proteins were highly enriched for transmembrane ion transporters (Figure 4.5B). The
electroneutral co-transporter Na-K-Cl (NKCC1, Slc12a2) was rhythmic in abundance (Figure
4.5D, Appendix Table 1), suggesting that rhythmic ion fluxes may be driven by these oscillations.
Circadian regulation in the abundance and activity of these ion channels has also been seen in




























































Figure 4.4 Global features of the circadian proteome and phosphoproteome. A) 5718 pro-
teins were detected in all samples and pools. Of these, 7% were rhythmic in WT and 18%
in CKO. The heatmaps show min-max normalized plots for all the rhythmic proteins in WT
(left) and CKO (right) as a visual representation of the efficacy of the data processing method.
Each row is a protein (sorted by phase), and each column is a time point from the time-course
experiment (3h intervals over 3 days). B) 3164 phosphopeptides were detected in all the samples
and pools. Of these, 9% were rhythmic in WT and 17% in CKO. The corresponding heatmaps
also show the efficacy of the data processing. Each row is a phosphopeptide (sorted by phase),
and each column is a time point from the time-course experiment (3h intervals over 3 days). C),
D) Venn diagrams showing the numbers of rhythmic proteins and phosphopeptides for WT and
CKO cells, with the overlaps annotated.
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other studies in vivo [261] and in vitro [262]. Working with Dr Alessandra Stangherlin and Dr
Jason Day, we found that ion concentrations were under rhythmic control, including sodium and
potassium (Figure 4.5C). Other ions such as iron were not rhythmic in WT (p=0.06, RAIN) but
rhythmic in CKO (p<0.001, RAIN). Sodium and potassium were rhythmic in both WT and CKO
(p<0.0001, RAIN). Rhythms in magnesium and potassium have been observed before [109], and
my results supplement this by expanding the number of ions measured.
Oxidative Stress Response 1 (OSR1, Osxr1), is a kinase that interacts with [263] and regulates
NKCC1 activity [264]. OSR1 exists in a complex with the protein kinase WNK1 (With No
Lysine [K]), and this complex is required for NKCC1 function [265]. In my phosphoproteomics
dataset, phosphosite S339 in OSR1 was rhythmic in both WT and CKO (Figure 4.5E, Appendix
Table 2). The relative amplitude of this oscillation was around 20%, suggesting that it may be
physiologically significant. Together, these findings suggest that rhythmic ion flux may be driven
by rhythmic OSR1 activity. In the future, this result will be validated by western blot against
this phosphosite. In addition, genetic and pharmacological inhibition would be useful to test the
contribution of this pathway in the circadian regulation of intracellular ion content.
Since such changes in ion concentrations would likely result in a change in osmolarity of the
intracellular environment if unbuffered, we decided to test for circadian changes in cell volume.
Dr Alessandra Stangherlin found that the majority of WT cells showed no circadian rhythm in
cell volume (Figure 4.5F). Whilst 16% of cells did exhibit a circadian change in cell volume,
this cannot explain the magnitude of ion rhythms at the population level, which was in the order
of 50% relative amplitude (Figure 4.8A, B). Given the nature of the protocol when establishing
primary cell lines (Chapter 2), it is plausible that there may be some heterogeneity in the cell
culture, resulting in this phenomenon. It may be that the cells that do have circadian variation in
volume may have a different process regulating this, and in the future cell sorting may be a way
to assess this if a suitable biomarker is found.
In summary, the observed rhythms in intracellular ion concentrations were likely to be
generated by rhythms in plasma membrane transporter activity. Furthermore, I hypothesised that
since intracellular osmolarity must be defended [266], another process must be responsible for
compensating for the changes in ion concentration. Almost 25% of the cell by weight is protein
[203] so I explored the proteomics dataset to find out whether changes in global protein content
could contribute to this compensation.
4.2.6 Rhythms in cytosolic protein concentration
It seemed feasible that the protein content of the cell may change to compensate for the rhythmic
variations in intracellular ion concentration to maintain osmostasis. Circadian rhythms in
translation have been reported before [267–269], and OSR1 is phosphorylated by the mammalian
target of rapamycin complex 2 (mTORC2) [270]. mTORC2 has many functions including the
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Figure 4.5 Circadian regulation of cellular ion content. A), B) GO analysis and DAVID
functional annotation of the proteins that were rhythmic in both genotypes. C) ICP-MS was used
to measure concentrations of various ions in a time-course conducted under the same conditions
as the proteomics experiment, representative of 3 timecourse experiments that were carried out
(N=3). Sodium (Na), potassium (K) and iron (Fe) are plotted here. The top row is WT data,
the bottom row is CKO. Benjamini-Hochberg-corrected p-values were generated by the RAIN
algorithm and annotated using asterisk symbols. Red lines are damped cosines fit to the data for
illustration only. Mean±SEM, n=4 throughout. D) NKCC1 protein (Slc12a2) relative abundance
is plotted here, obtained from the quantitative proteomics dataset. Damped cosine fitting is also
plotted for visualisation only. RAIN-generated corrected p-values are annotated as asterisks:
p=0.049 for WT, p=0.002 for CKO. E) OSR1 pS339 phosphosite relative abundance is plotted
here, obtained from the quantitative proteomics dataset. Damped cosine fitting is also plotted
for visualisation only. RAIN-generated corrected p-values are annotated as asterisks: p=0.001
for WT, p=0.03 for CKO. F) WT cell volume data collected by Dr Alessandra Stangherlin
across a 3-day time-course, with 1 hour resolution. P-values are annotated symbolically with
asterisks, generated by the extra sum-of-squares F test comparing a circadian damped cosine and
straight line. Damped cosine and straight line fits are plotted along with time-course data from
representative rhythmic (blue) and non-rhythmic (grey) cells.
regulation of translation [271]. I therefore hypothesised that circadian rhythms in translation and
ion flux may be linked. To test this I first interrogated the proteomics dataset to look for evidence
of phase clustering amongst the rhythmic proteins.
To do this, I used the phase information from the RAIN algorithm estimation – this is the
time at which the oscillation of any given protein is at its peak. The phase is reported as number
between 3 hours and 24 hours, in 3-hour intervals. Since a rhythm is cyclical, the maximum
value for phase is 24 hours. These values correspond to “experimental time”, i.e. the time point
at which a sample was collected. For example, if the peak abundance of a protein occurred
at “experimental time 24 hours”, this means that the peaks occur in samples taken at the very
beginning of the experiment, 24 hours later, or 72 hours later. I plotted a histogram of these
values in a circular form to visually aid the assessment of phase distribution (Figure 4.6). The
phase distribution of rhythmic proteins in wild-type cells was clustered at experimental time T24
(Figure 4.6A), and relative to this, the distribution of rhythmic phosphopeptides is more spread
out (Figure 4.6B). This phase clustering also occurs in CKO cells, suggesting that this temporal
organisation is independent of the TTFL. The main disadvantage of this analysis is that it does
not take into account the absolute abundance of proteins or the relative amplitude of oscillation.
However, it is a useful indicator of temporal organisation of protein abundance globally.
Phase clustering of proteins has been observed in proteomics studies in other laboratories
[95, 98], so this may be a conserved phenomenon. Given this phase clustering, I hypothesised
that there may be rhythms in the protein content of the cell. I reasoned that whole cell lysates may
contain many structural proteins with long half-lives that would not show circadian rhythmicity,
and this could mask the ability to observe rhythms in the abundance of soluble, free proteins in
the cytosol.
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proteins
Phase of rhythmic 
phosphopeptides
Figure 4.6 Phase clustering of rhythmic proteins and phosphopeptides. A) Circular his-
tograms were plotted, taking phase information from the RAIN algorithm output for each protein.
Concentric circles represent the counts scale, with the outermost circle marking the upper end
of the counts. The time scale between 3-24h is annotated as the spokes in the circle. B) Phase
diagrams were also plotted for the rhythmic phosphopeptides.
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To test this, I used a lysis buffer based on 0.01% digitonin to extract cytosolic proteins.
Digitonin is a plant glycoside that permeabilises membranes by forming complexes with mem-
brane cholesterol. Because of this, digitonin selectively disrupts the plasma membrane, since
other intracellular membranes such as those of the mitochondria and endoplasmic reticulum
have relatively little cholesterol [272–274]. Upon complex formation with cholesterol, pores
are formed that allow the passage of molecules with molecular weights of at least 200 kDa
[274]. The concentration of digitonin determines the amount of protein extracted, and between
0.01-0.08% (w/v) only soluble cytosolic proteins are released [275]. The process of cytosolic
protein extraction is complete after just 2 minutes of incubation with digitonin at 0°C [275], so
this is a fast and convenient method compared to other methods such as subcellular fractionation
[276].
Using this method I carried out a timecourse experiment, simultaneously performing ICP-MS
to measure ion concentration. I found that there were rhythms in cytosolic protein concentration
in antiphase to the rhythms in potassium content, and this was also recapitulated in CKO cells
(Figure 4.7A). I chose the concentration of digitonin to be 0.01% as this the lower end of
the range described above for cytosolic extraction. It would be informative to test a range of
concentrations to investigate the extent of cytosolic extraction in my cell type – it is plausible
that only the most labile proteins are released using this concentration. In comparison the total
protein extracted using RIPA buffer was not rhythmic (Figure 4.7A), but gradually decreasing
over time – this may be due to increased protein degradation as a function of time in culture, and
this could be tested in future using autophagy markers.
I resolved to validate this finding using an independent method of measurement. The
cytoplasm is a crowded environment, and proteins contribute a significant amount to this [203].
The diffusion of macromolecules in such an environment is inversely proportional to their
concentration, so I predicted that the rate of diffusion of large particles in the cytoplasm would
be higher at the nadir of cytosolic protein concentration. To test this, I collaborated with Joe
Watson and Dr Emmanuel Derivery to measure the diffusion of inert quantum dots (QDs). These
are nanoparticles roughly 18 nm in diameter that are taken up into the cytoplasm, and they are
fluorescent so they may be imaged using confocal microscopy (see Chapter 2 for details of
synthesis, imaging and quantification). A similar technique has been used in a recent study that
demonstrated the control of biophysical properties of the cytoplasm by mTORC1, likely through
ribosomal biogenesis [277]. If my hypothesis was correct, then these quantum dots would show
greater diffusion at the trough of cytosolic protein concentration, and less diffusion at the peak
of cytosolic protein concentration. Measurements were taken at 12-hour intervals and diffusion
coefficient was calculated at each time point (Figure 4.7B, C). Figure 4.7B shows examples of
images with software tracking overlaid, illustrating the types of movements displayed by the
QDs.
In both genotypes there was a time-of-day difference in diffusion coefficient, but this may be
due to the lower diffusion coefficient seen in the last time point – Sidak’s multiple comparisons
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post-hoc test found no statistically significant difference between 36 hours after the start of the
experiment compared to 24 hours (Figure 4.7C). However, there was a trend, with a decrease
of 3% between 24h and 36h, and an increase of 8% between 36h and 48h in WT cells, and
differences of 5% and 20% respectively in CKO cells. Thus the lower diffusion coefficient
corresponds to the peak of the cytosolic protein concentration illustrated in Figure 4.7A. The
reason for the small effect size is likely related to the fact that macromolecules other than
proteins also contribute to molecular crowding in the cytoplasm. Further biological replicates
are needed to confirm this result, particularly whether the measurements at 60h were real, or
a technical artefact. This is a functionally relevant experiment, because even small changes in
macromolecular crowding affects protein function, as will be explored later. Finally, there were
statistically significant differences between WT and CKO cells at 3 of the 4 timepoints, with
an effect size of around 16% throughout. This suggests that there is a substantial difference in
cytoplasmic crowding between the genotypes, which may have important consequences for the
protein homeostasis network. This is explored in more detail in Chapter 6.
These findings suggest that the rhythmic abundance of labile cytosolic proteins may be
buffering the changes in osmolarity caused by the rhythms in ion concentrations reported above.
An alternative interpretation is that the causal effects are in the other direction, i.e. the rhythms in
protein cause the rhythms in ions to buffer osmolarity. Since it is a cyclical process the causality
is difficult to unravel. Dr Alessandra Stangherlin has taken this aspect of the project further
(Stangherlin et al., in review), and more detailed discussion is beyond the scope of this chapter.
4.2.7 Regulation of protein:ion ratio
Colloidal solutes have greater relative osmotic potential compared with small ionic solutes [278],
and so small changes in soluble protein concentration require stoichiometrically larger changes
in ion concentration to maintain osmotic homeostasis. I was intrigued to find out if this was
reflected in my dataset, so I measured the relative amplitudes of the protein and ion oscillations.
The relative amplitudes for both protein concentration and ion content were greater in CKO cells
compared to WT (Figure 4.8A, B). Potassium is the most abundant intracellular cation, so I used
potassium concentration as a proxy for “ion content”. This is consistent with the greater relative
osmotic potential of proteins relative to ions.
Because of this I then calculated protein:ion ratio for each timepoint. This is an indicator of
the contribution of colloidal and ionic solutes to cytoplasmic osmolarity. For each time point I
calculated the average protein concentration between technical replicates, and divided this by the
potassium ion concentration. I found that protein:ion ratio was not constant, but rhythmic in WT
cells (Figure 4.8C). Notably, CKO cells had a higher average protein:ion ratio (Figure 4.8D) as
well as greater relative amplitude (Figure 4.8E), suggesting that these cells may be less able to
maintain osmotic homeostasis compared to WT. Maintaining cellular osmotic homeostasis is









































































































































































Figure 4.7 Cytosolic protein concentration is rhythmic in antiphase to ions. A) From one
time-course experiment, ions, cytosolic proteins and total protein were extracted in parallel
samples. The presented experiment is representative of 3 timecourse experiments that were
carried out (N=3). Parallel PER2::LUC recordings were also performed and plotted below as a
phase marker. Blue lines indicate the antiphasic oscillations in cytosolic protein and potassium
concentration. Mean±SEM, p values from RAIN, red lines are fits by a damped cosine or a
straight line. B) Above: representative images of quantum dots (QD) with diffusion paths
annotated. Below: The same images, just showing the diffusion paths. Scale bar 5 µm. The
quantum dot synthesis, imaging, image analysis and figure preparation was performed by Joe
Watson, and I cultured the cells and loaded them with the quantum dots at each time point. C)
Diffusion coefficient was plotted for each timepoint for both genotypes. There was time-of-day
variation in both genotypes (2-way ANOVA with Sidak’s multiple comparisons test, p<0.0001
for time effect, mean±SEM). N=84-135 fields of view across 4 separate dishes of cells at each
time point.
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important for regulating protein function [266], and so the findings here suggest that CKO cells
may have impaired protein homeostasis. This will be explored further in Chapter 6.
The greater relative amplitude of cytosolic protein concentration oscillations in CKO cells
could be achieved in two ways: more proteins being under rhythmic control relative to WT
or increased amplitude of proteins that are also rhythmic in WT. I plotted probability density
histograms from the proteomics dataset to test the distribution of relative amplitude amongst the
rhythmic proteins. I found that rhythmic proteins in CKO cells had a higher relative amplitude
but there was only a 1% difference, and so this is unlikely to account for the greater relative
amplitude of cytosolic protein concentration (Figure 4.8F). This suggests that the greater relative
amplitude of oscillations of protein concentration is primarily due to the fact that more proteins
are rhythmic in CKO cells compared to WT.
4.2.8 Insights into the clock mechanism
To gain more insight into the mechanism driving these rhythms, I turned to the rhythmic
phosphoproteome. Dr Tim Stevens kindly wrote a script using the Python programming language
for the identification of kinase recognition motifs amongst the phosphopeptide sequences in my
dataset. GSK3 and CK1 are kinases that have been widely implicated in period determination of
the circadian clock [139, 146, 113, 149]. They have also been implicated in PTO models of the
circadian clock [100, 6], and so I expected these kinases to be highly represented in the rhythmic
phosphoproteome.
I used this script to analyse the sequences of phosphopeptides found to be rhythmic in
both WT and CKO. I used the set of all phosphopeptides in my dataset as the background, i.e.
including non-rhythmic phosphopeptides. Thus I could detect and count kinase recognition
motifs in both sets of phosphopeptides. Compared to the background, I found that kinases
typically associated with period determination (e.g. GSK3 and CK1) were not over-represented
(Figure 4.9). However, these kinases have some of the largest number of motifs in the background
dataset. It may be that altering their function by genetic or pharmacological means may have
a major effect on period length due to non-TTFL-specific perturbation of cellular physiology.
Kinases whose recognition motifs that were over-represented in the rhythmic pool were CAMK2,
CHK1, CHK2, NEK-1, PKA, PKB, PKC and PKD. It is possible that some these kinases are
therefore instrumental in rhythm generation.
If phosphorylation is crucial to circadian rhythm generation, the specific identities of the
phosphopeptides that are rhythmic in both genotypes may give insight into the mechanism. For
example, beta-catenin and Ppp1 regulatory subunit 12A were interesting hits. Beta-catenin is
a target of GSK3 in the Wnt signalling [279], suggesting that the pathway is under rhythmic
regulation as a direct output of the post-translational oscillator. Ppp1 regulatory subunit 12A is
a regulator of protein phosphatase 1. Protein phosphatases have been implicated in circadian
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Figure 4.8 Protein:ion ratio is dysregulated in the absence of CRY. A) Relative amplitude
of cytosolic protein oscillations from Figure 4.7 is greater in CKO compared to WT (Student’s
t test with Welch correction, mean±SEM). B) Relative amplitude of potassium concentration
oscillations from Figure 4.7 is greater in CKO compared to WT (Student’s t test with Welch
correction, mean±SEM). C) Protein:ion ratio was calculated from the cytosolic protein and
potassium concentrations in Figure 4.7. For each time point, the average cytosolic protein
concentration was divided by the potassium concentration of each biological replicate. Mean±SD.
P were values calculated by RAIN and annotated using asterisks in the legend. D) Average
protein:ion ratio was greater in CKO compared to WT (Student’s t test with Welch correction,
mean±SEM). E) Relative amplitude of protein:ion ratio was also greater in CKO compared to
WT (Student’s t test with Welch correction, mean±SEM). F) Distributions of relative amplitudes
of rhythmic proteins from the proteomics dataset (WT and CKO analysed separately). Probability
density is plotted on the y-axis to make it easier to compare WT (grey) and CKO (red). One-sided
Kolmogorov-Smirnov test for alternative hypothesis CKO is greater than WT, p=0.003. WT
median = 0.15, CKO median = 0.16.
regulation in the context of dephosphorylation of TTFL components [146, 113, 188]. In general,
their activity and specificity are poorly understood relative to kinases, and this antagonistic role
may in fact turn out to be crucial for circadian timekeeping.
4.3 Conclusions
4.3.1 Summary of findings
Using proteomics and phosphoproteomics approaches I have characterised the circadian coordi-
nation of the proteome, and subsequently uncovered reciprocal regulation of intracellular ion
and soluble protein concentration. Furthermore, this is independent of the TTFL, and there are
some rhythmic hits from the phosphoproteomics data that will be interesting to follow-up on in
the future as potential clock components. Due to limitations of time, experimental validation
of targets by western blot was not achieved, and this is an important next step. Furthermore,
proteomic study of the proteins liberated by digitonin lysis is needed to confirm the identity of
the proteins referred to as ‘cytosolic’ here, and this should be tested by alternative methods of
cytosol extraction, such as differential centrifugation.
4.3.2 Evidence for a post-translational oscillator
The presence of rhythms in CKO cells lends evidence to the post-translational oscillator (PTO)
model described in Chapter 1. Moreover, some direct outputs of the PTO exist, for example the
antiphasic rhythms in cellular ion content and cytosolic protein concentration, and potentially













Figure 4.9 Kinase binding predictions from phosphopeptide sequences. Using the phospho-
proteomics dataset, phosphopeptides sequences were analysed, with the number of kinase binding
motifs counted for a panel of 25 kinases present in the PHOSIDA database. Phosphopeptides that
were rhythmic in both genotypes (blue) were compared to the background of phosphopeptides
present in all samples and pools (red).
it seems plausible that a PTO may directly or indirectly rhythmically phosphorylate and/or
dephosphorylate OSR1, through rhythmic regulation of kinase and phosphatase activity. A way
to test this would be to treat cells with kinase inhibitors and carry out a time-course experiment. If
protein and ion rhythms are abolished, this would support the hypothesis that rhythmic regulation
of kinase activity is necessary for rhythm generation. However the multiple off-target effects of
kinase inhibitors may confound this line of enquiry.
This would give rise to rhythms in the activity of electroneutral ion transporters, subsequently
leading to the observed rhythms in ion abundance (Figure 4.10). Rhythms in labile cytosolic
proteins may be driven by rhythms in translation or degradation of proteins. This may be
tested in future by measuring translation and degradation rate using radiolabelled methionine in
pulse-chase experiments. Alternatively, the observed rhythms may represent daily rhythms in
digitonin extraction from cells. The amount of protein released by this method could be affected
by compartmentalisation of proteins or even the phase-separation of proteins into condensations
that may not be able to exit the cell. This should be tested in the future by alternative methods of
cytosolic protein extraction such as fractionation by centrifugation. In addition, fluorescently
labelling cytosolic proteins known to phase separate would enable testing of whether proteins in
condensations are liberated by digitonin.
My results show that protein and ion rhythms are likely direct outputs of the PTO. However,
it is possible that these may also be mechanistically related, as depicted by dotted arrows in
Figure 4.10. For example, rhythms in translation have been reported before that are driven by
rhythmic mTOR activity [78]. mTORC2 is known to phosphorylate OSR1 [270], which may
be a way in which rhythms in the control of translation feed in to regulate rhythms in ion flux
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simultaneously. In Chapter 5 I examine the post-translational oscillator more closely, and show
more evidence of its activity.
4.3.3 Novel roles of the TTFL
The finding that more proteins and phosphopeptides were rhythmic in CKO cells is striking. The
data suggest that the TTFL may be supressing the rhythmicity of many proteins, decreasing the
amplitude of oscillations of protein:ion ratio, thus maintaining osmostasis. To test if this is truly
an effect of the TTFL it would be valuable to carry out proteomics experiments and time-course
experiments measuring protein and ion concentrations using different clock gene knockouts,
such as Bmal1.
Osmotic homeostasis must be maintained to prevent disordered protein aggregation and
preserve enzyme function [266, 280]. The cytosol is a crowded environment [203], and proteins
constitute up to 26% of the cell by weight depending on cell type [203]. Therefore small
changes in protein concentration may result in large changes in osmotic potential unless this
is counterbalanced. The fact that the amplitude of oscillations in protein:ion ratio are greater
in CKO cells suggests that there may be a dysregulation in protein and osmotic homeostasis in

















Figure 4.10 Model for the generation of 24-hour rhythms in cytosolic protein concentra-
tion and ion content. A self-sustaining post-translational oscillator may have direct outputs
including the rhythmic phosphorylation and/or dephosphorylation of OSR1. This would lead
to rhythms in sodium-potassium cotransporter activity, resulting in rhythms of intracellular ion
content, particularly potassium (the most abundant intracellular cation). In order to maintain
osmostasis, the concentration of labile cytosolic proteins must also oscillate but in antiphase
to reduce the fluctuations in protein:ratio. These oscillations in labile cytosolic proteins may
be driven by rhythmic changes in translation, degradation or compartmentalisation of proteins.
The TTFL does not generate these rhythms, but may suppress them, since they are present with
greater relative amplitude in CKO cells.

Chapter 5
PER2 links the post-translational oscillator
with transcriptional feedback repression
5.1 Introduction
5.1.1 Cellular mechanisms of circadian rhythm generation
As described in Chapter 1, circadian rhythms in transcription in mammalian cells are thought to
be driven by the transcriptional translational feedback loop (TTFL). The negative limb of the
feedback loop is mediated by complexes containing PER and CRY proteins, which translocate to
the nucleus to inhibit transcriptional activity of BMAL1-containing complexes.
When CRY1 and CRY2 are both knocked out in mice, their daily rhythms of locomotor
activity observed in 12h:12h light:dark cycles are not sustained under constant conditions [230].
On the cellular level it has been shown that PER and CRY proteins are components of large
macromolecular complexes that effect the repressive arm of the feedback loop, directly binding
to BMAL1-containing complexes and inhibiting transcriptional activity [36–39]. This occurs at
multiple genomic loci including their own, and so their repressive activity is rhythmic [40, 41].
Because CRY activity is essential for the nuclear repression of BMAL1 activity [281–283], CKO
mice and cells have no functioning TTFL.
As described in Chapter 1, the TTFL is generally regarded as the process that generates
cell-autonomous circadian rhythms. However, central TTFL components such as BMAL1,
CLOCK, PER1, PER2, CRY1 or CRY2 do not need to be expressed rhythmically for cellular
circadian timekeeping to persist, but rather their activity simply needs to lie within a permissive
range [81, 84, 85, 83, 284, 82]. There is also a huge discrepancy between the cycling proteome
and corresponding mRNA profiles (See Chapter 1 for more details). Post-transcriptional and
post-translational mechanisms are usually invoked to explain these differences.
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All major types of post-translational protein modification have been described as regulating
or being regulated by the cellular clock [125, 126, 285, 128–130]. Several processes essential for
cellular function show circadian regulation in vitro and in vivo, such as global protein synthesis
rates [131, 75], ion transport [109], cAMP/Ca2+ signalling [133], mitochondrial metabolism
[136], redox balance [134, 135] and the actin cytoskeleton [137]. Many of these clock outputs
also feedback to affect the period, phase or amplitude of clock gene expression rhythms. Hence
the cell is a highly complex, cyclical system with many interlocking clock outputs and inputs,
making it difficult to distinguish cause and consequence when our main experimental reporter is
oscillations of clock gene expression.
The observation of circadian rhythms in systems without transcriptional-translational feed-
back loops (See Chapter 1 for more details) has led to the hypothesis that in eukaryotes a
post-translational oscillator (PTO) may be responsible for the generation of cellular circadian
timekeeping [111, 6]. In addition, some studies have observed circadian rhythms using the
PER2::LUC reporter in SCN slices obtained from CRY1−/−; CRY2−/− (CKO) mice [286, 287],
and even in mouse behaviour under certain conditions [288]. At the time, these reports were
explained by neuronal network effects in the developing mouse brain. This explanation is
unsatisfactory however, because it does not provide any cause-effect relationships that can be
tested to increase our understanding of the system.
5.1.2 Circadian rhythms in CRY1−/−; CRY2−/− fibroblasts
Dr Marrit Putker and others in the lab observed PER2::LUC rhythms in CKO fibroblasts and
characterised them before I began my project. I will therefore briefly summarise this substantial
body of work to provide context to my own contribution. PER2::LUC rhythms in CKO cells were
temperature compensated (Appendix figure 1A), and they could be entrained using temperature
cycles (Appendix figure 1B). Hence they are true circadian rhythms as defined in Chapter 1.
In agreement with prior literature mentioned above, there was no residual TTFL in these cells
or in CKO mouse embryonic fibroblasts, as there was no measurable oscillation in clock gene
transcripts, assayed using qPCR and transcriptional reporters (Appendix figure 1C, D).
Moreover, the half-life of PER2::LUC showed time-of-day variation (Appendix figure 2A,
B), suggesting that regulation of PER2::LUC half-life may be a mechanism for generating
the observed rhythms. This finding also suggests that post-translational modification could be
instrumental in rhythm generation, since PER2 degradation is modulated by kinase activity.
Strikingly, the CKO period length was sensitive to CK1 inhibition, just as in the WT cells
(Appendix figure 2C, D), suggesting that the mechanism for period determination may involve
these kinases, and not the TTFL.
Altogether, this provides strong evidence for the presence of a post-translational oscillator
(PTO) that is responsible for generating circadian timing in mammalian cells, and that it involves
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CK1. However, the ability to observe these rhythms in PER2::LUC activity was variable (Figure
5.1A).
5.1.3 Aims of this chapter
In Chapter 4 I found that many proteins were under circadian regulation in CKO cells. Following
this, I showed that cellular ion content and cytosolic protein concentration are under circadian
control. This supports the post-translational oscillator (PTO) model, and suggests that there are
many direct outputs of the PTO, including the regulation of osmotic homeostasis.
To try and understand how this timekeeping is achieved, I turned to the PER2::LUC reporter.
PER2 is subject to many PTMs, and I hypothesised that if the PTO model is true, then there
should be detectable rhythmic regulation of PER2 activity in CKO cells. I therefore built upon
the experiments described above that were performed by Dr Marrit Putker and others in our
laboratory, and in this chapter I explore the variability of the CKO rhythms and discuss possible
mechanistic underpinnings.
5.2 Results and discussion
5.2.1 Variability in PER2::LUC rhythms between multiple cell lines
I created 16 independent primary cell lines using the methods described in Chapter 2. Of
these, 11 were plated out (5x WT and 6x CKO) around passage 5 in an experiment to record
bioluminescence. Of the 6 CKO lines, 4 were significantly rhythmic, i.e. they were better fit
with a damped cosine with 24 hour periodicity compared with the null hypothesis as described
in Chapter 2.
There were significant differences in circadian period between cell lines (Figure 5.1B), with
means between 22.7 and 24.8 hours, but no significant differences in period length between
sexes, irrespective of genotype (Figure 5.1C). Therefore, whilst it does not matter from which
sex fibroblast cultures are obtained, absolute period measurements must be interpreted with
caution, and studies should be carried out using the same cell line throughout if possible. Hence,
throughout this thesis cell lines 11 and 12 were used for all experiments.
There was also greater variation in the period measurements from CKO cells compared to
wild-type, between technical replicates within experiments (Figure 5.1D). Analysing several
experiments performed by myself and by Dr Marrit Putker previously, there was also more varia-
tion in period length between experiments (Figure 5.1E). In addition, out of all the experiments
performed by myself, 61% of CKO cultures were arrhythmic, and 39% were rhythmic, compared
74 PER2 links the post-translational oscillator with transcriptional feedback repression
with 100% of WT cultures. To understand the source of this variability, I attempted to find a set
of experimental conditions where rhythms in this reporter were always present.
5.2.2 PER2 has large regions of disorder
The PER2::LUC reporter is a protein fusion, and so its observed behaviour depends on the
availability of the mRNA, translation rate, protein folding efficiency, and protein degradation
rate, as well as luciferin availability. Folding efficiency and degradation rate may be affected
by the presence of intrinsically disordered regions in the protein structure. Clock proteins
have been reported to be enriched for disordered regions [289]. To characterise the disorder
in mPER2 (Mus musculus PER2, Uniprot ID: O54943), I used two independent databases to
predict disordered regions. I also used the sequence of firefly luciferase (Uniprot ID: Q27758)
appended to the mPER2 sequence, so that I could more accurately assess the behaviour of the
PER2::LUC reporter in the context of the experiments reported in this chapter. SPOT-Disorder-
Single uses neural networks to predict the disorder of each individual amino acid [290]. In
contrast, IUPred2A makes estimations of the strength of interactions between residues in order
to predict disorder [291]. By inspection these two mechanistically differing methods agreed with
each other, and SPOT labelled 730 amino acids as disordered out of 1806, which is roughly 40%
(Figure 5.2A, B, C).
In chapter 4 I showed that the regulation of protein:ion ratio is disrupted in CKO cells.
I hypothesised that the high disorder content of PER2 may render its activity susceptible to
changes in protein:ion ratio. This is because intrinsically disordered proteins undergo phase-
separation upon molecular crowding, and this affects protein function and accessibility to
post-translational modification enzymes [292]. Keeping the osmolarity of the medium constant, I
varied experimental conditions and applied pharmacological manipulations to metabolically alter
cellular protein:ion ratio and assessed its affect on the presence of rhythmicity and its robustness
in CKO cultures.
5.2.3 Increased contact inhibition
Primary fibroblasts in culture exhibit contact inhibition – the attenuation of proliferation and
locomotion upon cell-cell contact [293]. When a cell stops dividing, there is a proteome-wide
modulation of protein degradation, enhancing break-down of long-lived proteins to avoid their
accumulation [294]. I hypothesised that given enough time in culture, this transition could alter
protein:ion ratio and thus affect the activity of PER2::LUC.
To test this, I carried out two experiments a month apart, using the same cells in the same
plates, and between these experiments the cells were kept in entrainment as described in Chapter






























































































































Figure 5.1 Characterisation of PER2::LUC rhythmicity in CKO cells. A) Examples of lon-
gitudinal bioluminescence recordings of WT and CKO cells, from two independent experiments
and using the same experimental conditions, demonstrating variability. Representative traces
shown. B) Period measurements from a selection of male and female PER2::LUC cell lines,
either WT or CKO. Individual cell lines are identified by number, e.g. cell line 11 is from a
female WT mouse, and cell line 4 is from a male CKO mouse. Mean±SEM, n=3. C) There are
no differences in period length between sexes. Data from A) are grouped by sex, mean±SEM,
p=0.996 (WT), p=0.999 (CKO) 2-way ANOVA with Sidak’s multiple comparisons test. For
males n=6 per genotype, for females n=9 per genotype. D) CKO cells display greater intra-
experimental variability in period length compared to WT. Standard deviation in period length
between technical replicates are plotted, using data from 20 independent longitudinal biolumines-
cence experiments. The CKO data points are paired with their WT control from their respective
experiments. Paired t test. E) CKO cells also have greater inter-experimental variability in period
length compared to WT. Mean period length was calculated from 25 experiments and WT-CKO
pairs plotted. In CKO cells there was greater variance between experiments, as well as shorter
period length compared to WT. Paired t test.
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Figure 5.2 The structure of PER2::LUC is around 40% disordered. A) Schematic diagram
of the known structural domains of PER2::LUC, including PAS domains, CK1 and CRY binding
domains. B) Colour-coded disorder classifications predicted by SPOT-Disorder-Single: red =
disordered, blue = ordered. Probability of disorder is plotted below for each amino acid as
predicted by SPOT-Disorder-Single [290]. C) Probability of disorder for each amino acid as
predicted by IUPred2A [291].
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2, with the medium changed each week. In both experiments I measured the robustness of the
PER2::LUC rhythms using the calculation described in Chapter 2.3. Briefly, robustness is the
strength of the oscillation, proportional to the relative amplitude and inversely proportional to
the damping rate. In other words, a robust oscillation has a large relative amplitude and shows
little damping. An oscillation that is not robust shows a very low amplitude and rapid damping.
The robustness of PER2::LUC oscillations was much greater after 1 month of culture in
wild-type cells (Figure 5.3A), agreeing with previous observations of increased robustness with
confluence [295]. In addition, after 1 month of culture, rhythmicity could be observed in CKO
cells that did not show rhythmicity beforehand (Figure 5.3B). The increased time in temperature
entrainment may have also contributed to increased robustness due to more synchrony between
individual cells. This could be tested in future by varying the amount of time in entrainment,
whilst keeping the total amount of time in culture constant.
There is a possibility that the cell cultures are not homogeneous, and are in fact composed of
rhythmic and non-rhythmic cells. If a rhythmic subtype outgrows the non-rhythmic cells this
could also explain these results. Single cell imaging would be useful to define these populations
if present. However, if this hypothesis is true, then one would also expect cells of a higher
passage to be more rhythmic since there would be more time for this competition to occur. In
fact I found that higher passage cells showed less robust rhythms (Figure 5.3C). This may be due
to unpredictable transformation mutations that occur during serial passage, and the attenuation
of contact inhibition [293]. Furthermore, CKO cells may be more susceptible to transformation
because CRY proteins are involved in a macromolecular complex that targets the oncogene
c-myc for degradation [296], as will be discussed further in the next chapter.
5.2.4 Reduced metabolic activity
The glucose concentration in standard tissue culture medium is 4.5 g/L, whereas physiological
concentrations are around 1 g/L [297]. Metabolism and translation rate are closely linked
[298], and so I hypothesised that changing glucose concentration may affect the translation of
PER2::LUC, thus affecting the apparent rhythmicity of this reporter. I measured PER2::LUC
rhythmicity in WT and CKO cells across a range of glucose concentrations (Figure 5.4A, B). I
found that in CKO cells, robustness of rhythms increased as glucose concentration decreased
from 5 g/L to 1 g/L (Figure 5.4D, E). In contrast, WT cells showed increased robustness with the
higher glucose concentration (Figure 5.4C, E). It would be informative to measure ATP levels in
WT and CKO cells in the different culture conditions to find out whether there is a corresponding
difference in metabolic activity.
It seemed plausible that increasing glucose concentration may increase robustness in WT
cells by increasing the translation of the PER2::LUC reporter. However, in CKO cells, such
an increase in translation may result in disrupted protein homeostasis that may in turn inhibit
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Figure 5.3 Robustness is increased by length of time in culture and passage number. A)
Robustness of independent WT cell lines, identified by numbers from Figure 5.1. Experiment
2 was conducted 1 month after Experiment 1, using exactly the same cells in the same dishes.
Cell lines are named as for Figure 5.2. Individual replicates are plotted. 2-way ANOVA with
Sidak’s multiple comparisons test. B) Detrended PER2::LUC bioluminescence of WT and
CKO lines in Experiment 1 and Experiment 2. WT line number 11 is shown as a reference.
CKO lines 4 and 12 are plotted, demonstrating the presence of rhythmicity in Experiment 2.
Mean±SEM. C) Detrended PER2::LUC bioluminescence of WT and CKO lines, comparing
experiments performed with cells of passage 15 (P15) and 20 (P20). Mean±SEM. D) Robustness
quantifications of the data in C). Mean±SEM, 2-way ANOVA.
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PER2::LUC rhythmicity. In the absence of CRY, there is no rhythmic transcription of Per2
(Appendix Figure 1), and so the abundance of PER2::LUC is more dependent on rates of
translation and degradation. In the future a useful experiment would be to measure translation
rate in response to changes in glucose concentration acutely to test whether WT and CKO cells
are different. In Chapter 6 I explored the metabolic activity and protein homeostasis of CKO
cells in more detail under normal culture conditions, and I found that CKO cells were indeed
more metabolically active and more sensitive to proteotoxic stress. In the following sections of
this chapter I tried different experimental conditions to facilitate protein homeostasis.
5.2.5 Increased protein folding
As described in Chapter 1, protein folding is a key part of protein homeostasis. Misfolded
proteins have defective function and trigger cellular stress responses that aim to avoid toxic
aggregations [195]. Molecular chaperones play an active role in these responses. Given that
reducing metabolic activity increased robustness of PER2::LUC rhythmicity, I hypothesised that
a contributing factor may be the reduction of protein aggregation in the cytoplasm subsequent to
a decrease in translation rate.
4-phenyl butyrate (4PBA) is a short-chain fatty acid that acts as a ‘chemical chaperone’
because it prevents misfolding and aggregation of proteins in vitro [299]. Chemical chaperones
have been shown to increase the amplitude of PER2::LUC oscillations in WT mouse fibroblasts
obtained from tail tendon, likely through increasing protein folding capacity in the endoplasmic
reticulum [300]. Both WT and CKO cells showed increased robustness with 1 mM 4PBA
treatment when they had been pre-incubated with the drug prior to the medium change (Figure
5.5). Whilst at first glance the bioluminescence traces look scarcely rhythmic in the CKO cells,
they do fit to a rapidly damping circadian cosine wave in preference to the null hypothesis of
a straight line. In fact, these results are likely to be at the limit of detection for PER2::LUC
rhythmicity in CKO cells. This highlights the difficulty of observing rhythms in CKO cells using
this reporter, and in future studies investigating the generation of rhythms in this experimental
model, new reporters are needed. This is discussed at the end of the this chapter. To confirm the
effect on protein folding it would be useful to measure the effect of 4PBA treatment on stress
markers such as ATF4 and CHOP.
The requirement for pre-incubation with 4-PBA for there to be an effect on rhythmicity
suggests that the state of the protein folding machinery at the time of transfer to air medium
may be an important factor. The fact that the resulting rhythmicity is not robust but rapidly
damped suggests that under these conditions, whilst chaperone activity contributes to PER2::LUC
rhythms, it is not an important factor. Instead, I hypothesised that the protein:ion ratio in the
cytoplasm at the time of medium change is crucial for the observation of PER2::LUC rhythmicity
in CKO cells.







































































































Figure 5.4 Low glucose concentration increases robustness in CKO cells. A) Raw
PER2::LUC bioluminescence (representative traces shown) of WT cells in either 1 or 5 g/L
glucose. B) Raw PER2::LUC bioluminescence (representative traces shown) of CKO cells
in either 1 or 5 g/L glucose. C) Detrended PER2::LUC bioluminescence of WT cells in air
medium containing 1g/L (above, grey) or 5g/L (below, black) glucose. D) Detrended PER2::LUC
bioluminescence of CKO cells in air medium containing 1g/L (above, pink) or 5g/L (below, red)
glucose. E) Robustness quantifications of the data in A) and B). Mean±SEM, 2-way ANOVA.




















































































































Figure 5.5 Robustness is increased by 4-phenylbutyrate treatment. A) Raw PER2::LUC
bioluminescence (representative traces shown) of WT cells treated with 1 mM 4PBA or control.
B) Raw PER2::LUC bioluminescence (representative traces shown) of CKO cells treated with 1
mM 4PBA or control. C) Detrended PER2::LUC bioluminescence of WT cells treated with 1
mM 4-PBA (above, grey) or control (below, black). D) Detrended PER2::LUC bioluminescence
of CKO cells treated with 1 mM 4-PBA (above, pink) or control (below, red). E) Robustness
quantifications of the data in A) and B). Mean±SEM, 2-way ANOVA.
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5.2.6 Decreased synthesis of amino acids
The concentration of amino acids in culture medium has an impact on protein synthesis. I
hypothesised that reducing the concentration of amino acids would reduce protein synthesis
and thus give more robust PER2::LUC rhythms in CKO cells. Surprisingly, when a range of
concentrations of amino acids were used, there was increased robustness with greater amino
acid concentrations, although it was not statistically significant (Figure 5.6). Robustness was
increased in CKO cells by supplementing ordinary medium with non-essential amino acids
alone (Figure 5.7), suggesting that reducing the synthetic load of the cell may be an important
factor. These findings also suggest that CKO cells may have reduced proteasome activity, since
proteasome inhibition leads to a shortage of intracellular amino acids [301]. This will be explored
further in the next chapter.
5.2.7 Manipulations that did not promote rhythmicity
I tested many other variables that did not result in detectable rhythmicity in CKO cultures, and
they are listed below:
• Entrainment vs non-entrainment with temperature cycles
• Co-culture with WT cells
• Conditioned medium - WT or CKO donor, WT or CKO acceptor
• pH buffer - MOPS or bicarbonate
• Corticosterone, insulin, B27
• Myc inhibitor 10058-F4
• Rev-erbα inhibitor SR8278
• Inhibition of translation - cycloheximide, rapamycin
• Inhibition of chaperones - cycosporin A, radicicol, VER155008
• Activation of proteasome - PD169316
This list is not exhaustive, as several combinations of conditions were also tested. At the
time of testing they seemed to be reasonable variables to explore, although none resulted in the
observation of rhythmicity in CKO cells. Due to limitations of space I will not describe in further
detail the results of these experiments, but I will briefly summarise the reasoning behind them
here. Co-culture and conditioned medium experiments were testing the hypothesis that a secreted








































































































Figure 5.6 Increased amino acid concentration may increase robustness. A) Raw
PER2::LUC bioluminescence (representative traces shown) of WT cells in air medium containing
normal DMEM or DMEM with double the concentration of amino acids (2x DMEM). B) Raw
PER2::LUC bioluminescence (representative traces shown) of CKO cells in air medium contain-
ing normal DMEM or DMEM with double the concentration of amino acids (2x DMEM). C)
Detrended PER2::LUC bioluminescence of WT cells in air medium containing normal DMEM
(below, black) or DMEM with double the concentration of amino acids (2x DMEM, above,
grey). D) Detrended PER2::LUC bioluminescence of CKO cells in air medium containing
normal DMEM (below, black) or DMEM with double the concentration of amino acids (2x
DMEM, above, grey). E) Robustness quantifications of the data in A) and B). Mean±SEM,
2-way ANOVA, Sidak’s multiple comparisons: p = 0.9 for WT and p = 0.4 for CKO.
















































































































Figure 5.7 Supplementation with non-essential amino acids increases robustness. A) Raw
PER2::LUC bioluminescence (representative traces shown) of WT cells in air medium with
(+ NEAAs) or without (- NEAAs) non-essential amino acid (NEAA) supplement. B) Raw
PER2::LUC bioluminescence (representative traces shown) of CKO cells in air medium with (+
NEAAs) or without (- NEAAs) non-essential amino acid (NEAA) supplement. C) Detrended
PER2::LUC bioluminescence of WT cells in air medium with (above, grey) or without (below,
black) non-essential amino acid (NEAA) supplement. D) Detrended PER2::LUC biolumines-
cence of CKO cells in air medium with (above, pink) or without (below, red) non-essential amino
acid (NEAA) supplement. E) Robustness quantifications of the data in A) and B). Mean±SEM,
2-way ANOVA, Sidak’s multiple comparisons.
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factor may be critical for observing PER2::LUC rhythmicity, and testing the requirement of
entrainment was exploring the role of synchrony between cells in culture. Other pharmacological
and metabolic manipulations aimed at exploring the role of protein homeostasis.
The performance of these experiments in the face of such variation required mettle, as more
and more variables were discovered to be relevant over time, and to be dependent on the passage
of time itself. Whilst I have not tested every possible variable in every possible combination,
valuable conclusions and insights may still be drawn from the efforts. Looking back on all the
experiments reported in this chapter, the source of variation is likely to be closely related to
protein:ion ratio and its effect on the PER2::LUC reporter, and I will discuss this with a broader
outlook in the next section.
5.3 Conclusions
5.3.1 Summary of findings
PER2::LUC rhythmicity persists in CKO cells under certain conditions. Taking together all my
findings, I hypothesise that culture conditions and pharmacological manipulations that decrease
cellular protein content are most likely to result in PER2::LUC rhythmicity. To explain this, I
propose that it is the reduction in protein:ion ratio that is permissive for PER2::LUC rhythmicity.
As described in section 5.2.2, the protein sequence of PER2 contains large regions of intrinsic
disorder, and so it is plausible that PER2 may be rhythmically sequestered and released from
biomolecular condensates. This behaviour is likely to be sensitive to macromolecular crowding,
which is itself related to intracellular protein:ion ratio. This may in turn render PER2 proteins
differentially susceptible to modification by kinases or degradation by the proteasome [302].
Macromolecular crowding is also likely to be affected by osmolarity of culture medium.
A recent study showed that increased osmolarity of cell culture medium increased the period
length of PER2::LUC rhythms in MEFs through cellular stress signalling [303]. This suggests
that intracellular osmolarity is important in clock regulation. However, in this study extremes
of osmolarity were used – between 210 mOsm and 480 mOsm, whereas cell culture medium
is typically around 300-350 mOsm. In future work it would be valuable to find a way to
measure intracellular osmolarity, and to directly observe how physiological changes in cell
culture conditions affect this variable, and how this might impact on PER2 protein activity and
localisation.
Dr Marrit Putker demonstrated that the half-life of PER2:LUC in CKO cells showed time of
day variation, and this is likely to be the basis of the rhythmicity (Appendix Figure 2). She also
found that CK1 inhibition lengthened circadian period in CKO cells, just as it did in WT cells,
suggesting that CK1 is involved in period determination of the TTFL-independent oscillator
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(Appendix Figure 2). This is reminiscent of work done in red blood cells, which do not have a
nucleus, but still show circadian rhythmicity in multiple parameters, with period length that is
sensitive to the same kinase inhibition [100]. In this context therefore I interpret my findings
as observations of circadian rhythms in the post-translational modification of the PER2::LUC
reporter that are TTFL-independent, and sensitive to cellular protein:ion ratio. To confirm this
experimentally, cellular protein and ion concentrations should be measured in the different culture
conditions tested. In addition, it would be useful to measure post-translational modifications of
PER2 directly by Western blot to confirm the presence of rhythmicity. Unfortunately PER2 was
not detected in my proteomics and phosphoproteomics experiments, likely due to low abundance,
below the threshold for detection by mass spectrometry under the conditions of my workflow.
There are alternative interpretations of the work presented in this chapter. Despite exhaus-
tive efforts it was challenging to find out experimental conditions that permitted rhythms in
PER2::LUC to be easily observed. In addition, when they were observed, the robustness was
often very low. This suggests that the TTFL may be required for robustness of PER2::LUC
activity, but another conclusion could be that PER2::LUC was likely to be a poor reporter for the
PTO. Instead it would be valuable to create a new reporter, perhaps by targeting a protein with
high average abundance and high relative amplitude of oscillation as observed in the proteomics
dataset. Such an example is cell cycle progression protein 1 (CCPG1), which I found to be
rhythmic in both WT and CKO with relative amplitudes of 27% and 55% respectively (Appendix
Table 1). Creating an alternative reporter would be useful in future studies of the PTO as it
could enable longitudinal recordings of PTO activity in a TTFL-independent manner. Finally, it
would also be informative to use single-cell imaging to test whether the poor rhythmicity at the
population level could be explained by individually rhythmic cells that are out of phase.
5.3.2 Disorder amongst TTFL components
The role of intrinsic disorder in clock proteins has been explored in the literature, primarily
in the context of the FRQ (Frequency) protein in Neurospora, which requires the presence of
another “nanny” protein to stabilise its structure and prevent random proteasomal degradation
[289, 304, 305]. In mammals, disordered regions of TTFL components have been found to
be functionally relevant in regulation of circadian rhythms – for example the disorder in the
terminal activation domain of BMAL1 is important for its interaction with CRY1 and period
determination [306, 138].
CK1 is an important kinase that mediates both the priming and subsequent processive
phosphorylation of PER2, and this process has been proposed to determine period length [252].
For this to work, CK1 must have access to a large number of phosphorylation sites, and it has
been proposed that the structural flexibility of PER2 as a result of the disorder permits this
(Michael Brunner, personal comm.). Furthermore, FRQ also has structural flexibility that allows
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progressive phosphorylation, and so the use of a disordered protein as a molecular timer may
be conserved (Michael Brunner, personal comm., unpublished). Finally, PER2 and CRY1 have
been reported to form phase-separated nuclear droplets (Michael Brunner, unpublished) and this
may be a mechanism for protecting PER2 from degradation.
Hence disorder is functionally relevant in the circadian clock, but the precise identity of
the proteins involved does not matter. This very much echoes the discussion in Chapter 1
about the evolution of circadian rhythms in eukaryotes, where similar TTFL network motifs
are found between organisms, with different proteins being involved in the TTFLs, but post-
translational modification enzymes that determine periodicity are conserved. Therefore evolution
may have selected proteins such as PER and FRQ with particular biophysical properties that
make them good signal transducers, transmitting temporal information in the form of progressive
phosphorylation in a robust manner from the PTO to the gene expression machinery.
In this context, my data suggests that in the absence of CRY, PER2::LUC does not have the
supplementary regulation of the TTFL, and so it is subject to the direct outputs of the PTO, which
may include regulation of protein:ion ratio as discussed in Chapter 4. This affects the phase-
separation of disordered proteins, hence rhythmicity using this reporter can only be observed
when the conditions are right, i.e. when the protein:ion ratio permits rhythmic post-translational
modification of the disordered PER2::LUC. In the proteomics and phosphoproteomics data
presented in Chapter 4, PER2 peptides and phosphopeptides were not detected. However, it
would be useful in future analyses of these data to explore in further depth the rhythmic regulation
of other intrinsically disordered proteins. For example, fluorescently tagging a rhythmic cytosolic
protein with a similar amount of disorder to PER2 would allow observation of whether it is
present in aggregations, and whether this behaviour is dependent on changes in protein:ion ratio.
5.3.3 Evidence for the PTO model
The PTO model is supported by my experiments – the rhythmic modification of PER2 may be
the primary way in which the PTO provides input to the TTFL in WT cells. As such, PER2
acts as a signalling molecule that transmits timing information from a self-sustaining post-
translational oscillation to effect the rhythmic transcription of clock-controlled genes (Figure
5.8). This circuitry could provide amplification of the signal via transcriptional feedback, as well
as robustness since the TTFL regulates rhythmic PER2 transcription whilst the PTO regulates
rhythmic PER2 post-translational modification [6].
Moreover, without a TTFL to impart autoregulation of transcription, PER2::LUC is not a
special protein and it is subject to the global regulation of protein and ion content discussed
in Chapter 4. PER2::LUC is an intrinsically disordered protein, and I hypothesise that a
high protein:ion ratio may result in sequestration of PER2::LUC molecules in phase separated
compartments, thereby inhibiting the rhythmic regulation of PER2::LUC activity (Figure 5.8).
88 PER2 links the post-translational oscillator with transcriptional feedback repression
Throughout this chapter I have shown experimental manipulations that result in more robust
PER2::LUC rhythms in CKO cells, likely through reduction of cellular protein content. This
raises the possibility that CKO cells may have dysregulated protein homeostasis: this will be the














Figure 5.8 Model of PER2::LUC as a temporal signalling factor. PER2:LUC activity is the
primary way in which temporal information is conveyed from the post-translational oscillator
(PTO) to the transcriptional-translational feedback loop (TTFL), which then rhythmically regu-
lates the transcription of clock-controlled genes. The TTFL imparts robustness to PER2::LUC
rhythms in activity through the regulation of PER2::LUC transcription. In CRY-deficient cells,
there is no TTFL, but rhythmic post-translational modification of PER2::LUC may be observed
indirectly. However, this observation is sensitive to experimental conditions increasing pro-
tein:ion ratio. This is because intrinsically disordered proteins (IDPs) like PER2 are sensitive to
phase separation when protein concentration is increased. Phase separation alters the activity of







6.1.1 Non-timekeeping roles of cryptochromes
Beyond the TTFL, there is evidence that cryptochromes have important functions in cellular
protein homeostasis. For example, CRY1 and CRY2 are important components of the E3 ligase
complex that recruits c-MYC for degradation: SCFFBXL3 (Skp1, Cul1, F-box protein ubiquitin
ligase complex) [296]. MYC is an oncoprotein that transcriptionally activates many cellular
growth, proliferation and metabolic pathways, and so its levels are tightly controlled by protein
degradation [307]. In addition to c-myc, SCFFBXL3 has hundreds of potential targets [308],
making it an important regulator of protein degradation in the cell. Finally, CRY1 and CRY2 are
global transcriptional repressors, either acting directly [40] or indirectly via nuclear hormone
receptors [309, 310], suggesting that they regulate the expression of many genes independently
of Bmal1-containing complexes. These studies suggest that the loss of CRY1 and CRY2 proteins
would result in significant dysregulation of protein homeostasis.
If the loss of CRY1 and CRY2 results in dysregulation of protein homeostasis, it would be
reasonable to expect that there would be a phenotype at the organism level [196]. CKO mice
are behaviourally arrhythmic, but were originally reported to be otherwise healthy [230]. Since
then it has been found that CKO mice have impaired body growth, which is more pronounced in
males subsequent to dysregulated growth hormone release [311, 312]. CKO mice also have an
altered response to high fat diet, characterised by increased insulin secretion and lipid storage in
adipocytes [313]. Finally, female CKO mice have impaired fertility, and this is thought to be
age-dependent [314].
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6.1.2 Aims of this chapter
In Chapter 4 I showed that the temporal control of protein:ion ratio is dysregulated in CKO cells,
suggesting that they have defective protein and osmotic homeostasis. In Chapter 5 I showed
that whilst it is possible to observe rhythmic PER2::LUC activity in cells lacking cryptochromes
(CRY1−/−; CRY2−/−, CKO), this was dependent on changes in experimental conditions that
may alter cellular protein:ion ratio. These findings suggest that CRYs may be important for
cellular proteostasis. In this chapter I present my findings characterising the dysregulated
proteostasis in CKO cells and testing some of the consequences of this.
6.2 Results and discussion
6.2.1 CKO cells show defects in protein homeostasis
In Chapter 4 I found that CKO cells have a greater amplitude in oscillation of protein:ion ratio,
and that they have a higher protein:ion ratio on average. I hypothesised that this altered set point
may affect cellular osmostasis. Adding to this observation, I found that CKO cells have more
protein per cell (Figure 6.1A). To test this using an independent method, I turned to the quantum
dot (QD) experiment presented in Chapter 4 (Figure 4.7), and found that averaged over time,
the diffusion of QDs was reduced in CKO cells (Figure 6.1B). I hypothesised that since CKO
cells contain more protein than WT cells, they may be less able to regulate further changes in
cytosolic protein content.
To test the sensitivity to changes in protein content, I incubated cells in the absence of serum
for 24 hours before treating them with 10% serum. mTORC1 (mammalian target of rapamycin
complex 1) is a central node in cellular physiology, sensing a variety of stimuli including growth
factors and adjusting processes like protein synthesis and autophagy to increase or decrease cell
growth accordingly [315]. I hypothesised that any increase in cytosolic protein concentration in
response to such a serum pulse would be mediated by this pathway, and I tested this by inhibiting
mTORC1 with Torin 1 [316]. CKO cells showed an increase in cytosolic protein concentration
that was mTOR-dependent, since it was blocked by Torin 1 treatment (Figure 6.2). There was no
change in WT cells, which seemed to be able to buffer against this perturbation.
6.2.2 CKO cells have reduced proteasomal degradation compared to WT
If cellular protein content increases as a result of a perturbation, cells must degrade them to
restore protein homeostasis. I hypothesised that the result in Figure 6.2 may be explained by a
reduced capacity for protein degradation, since this would result in an inability to counteract the






































Figure 6.1 CKO cells have more protein in total than WT. A) Total protein mass per cell in
confluent WT and CKO cultures. Cells were grown in two 12-well plates; one was used for cell
counting and the other was used for lysis in RIPA buffer prior to protein quantification by BCA
assay. N = 6 wells. Mean±SEM, Student’s t test with Welch correction. B) Diffusion coefficient
of quantum dots, with data from all time points from the experiment in Figure 4.7 combined. "n"










































Figure 6.2 CKO cells are more sensitive to serum-induced changes in protein synthesis.
Cells were serum-starved for 24 hours before being changed into medium containing 10% serum
± Torin 1. After 4 hours treatment, cytosolic protein was extracted using 0.01% digitonin lysis
buffer, and then protein concentration was quantified using BCA assay. Controls were cells
changed into serum-free medium. Concentrations are plotted here as a percentage of the controls.
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increase in protein concentration after a serum pulse. To test this I searched the proteomics data
presented in Chapter 4 for proteasome subunits to test for differences in abundance. Proteasome
abundance was around 10% lower in CKO cells as measured by taking average values from the
quantitative proteomics reported in Chapter 4 (Figure 6.3A), as well as from western blots of the
20S proteasome (Figure 6.3B).
When examining such cellular processes it is important to assess the functionality as well
as the abundance of molecular players. I therefore used the ProteasomeGlo assay to measure
proteasome activity. This is described in more detail in Chapter 2.14. Briefly, this is a luciferase-
based method to measure the degradation of special substrates that are designed to be cleaved by
the proteasome, thus releasing the substrate for luciferase. Substrates are specific to chymotrypsin-
like, trypsin-like and caspase-like types of protease activity found in the proteasome. Using this
assay, I found that there was a 50% lower activity in all 3 types of proteasomal protease activity
(Figure 6.3C). This suggests that in CKO cells the lower abundance of proteasomal catalytic
subunits may contribute to lower proteasomal activity, but post-translational regulation is likely
to be the main contributor.
The consequence of this finding is that CKO cells may have a lower capacity for protein
degradation in response to increases in cellular protein content. Such perturbations may occur
after a serum pulse as in the experiment presented in Figure 6.2, or they may be physiological
changes such as the rhythms in cytosolic protein concentration presented in Chapter 4. I propose
that this may be an important factor contributing to the increased amplitude of oscillations in
protein concentration in CKO cells. In addition, the ability to degrade proteins is important in
the response to proteotoxic stress, and so one may predict that CKO cells may therefore be more
susceptible to stress-inducing stimuli. This hypothesis is explored later in this chapter.
6.2.3 CKO cells do not have altered basal translation rate
Since CKO cells had a reduced proteasome activity relative to WT, I decided to investigate
whether translation rate was also different. In order to maintain protein homeostasis, cells need
to adjust protein synthesis and protein degradation together in order to avoid accumulation of
proteins. In addition, it is plausible that an increased basal translation rate may also contribute
to the result in Figure 6.2, since this would present more of a challenge to the proteasomal
degradation machinery – hence an increase in translation due to serum pulse would push the
cellular protein concentration outside the limit of homeostasis for CKO cells. To measure this I
treated cells with 35S-methionine to radiolabel newly synthesised proteins, and I found that there
was no difference in translation rate between CKO and WT cells (Figure 6.4A).
I also measured translation rate using a technique based on azidohomoalanine (AHA). AHA
is a substitute for methionine, and so it is incorporated into newly synthesised proteins when
added to cell culture medium. AHA contains a bio-orthogonal azide moiety, and this may












































































































Figure 6.3 CKO cells have reduced proteasome activity. A) Relative abundance averaged
over time of catalytic proteasome subunits, quantified in the proteomics experiment presented
in Chapter 4. Trypsin-like (β2), chymotrypsin-like (β3) and caspase-like (β1) subunits are
shown. Mean±SEM, 2-way ANOVA. B) Western blots using an antibody that recognises all
7 α-subunits of the 20S proteasome, with anti-histone H3 as loading control. Quantification
shown below, mean±SEM, Student’s t test with Welch correction. C) Proteasome activity
measured using ProteasomeGlo Assay (Promega). Trypsin-like, chymotrypsin-like and caspase-
like activities were measured separately on the same 96-well plate. Mean±SEM, 2-way ANOVA.
Representative experiment shown, N=6.
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be chemically labelled with high specificity to an alkyne-containing molecule that acts as the
reporter. In my experiment I used biotin-alkyne, which can be detected by Western blot with
streptavidin-HRP. I used this method, labelling cells at 2 timepoints in the circadian cycle with
AHA. I found that there was no difference between WT and CKO, and there was a trend for
increased AHA incorporation at T33 relative to T21 in both genotypes (Figure 6.4B).
For both of these experiments there was only one biological replicate. More replicates would
be advisable to confirm that there was no difference in translation between WT and CKO cells.
In addition, carrying out measurements at different times of day would be useful for confirming
if circadian rhythms in translation also occur in CKO cells – this is known to be the case in WT
cells [78]. However, the results shown here suggest that there is no great difference in translation
rate – only a small difference would likely be detected by increasing replicate number. Therefore
it is reasonable to conclude that CKO cells are likely to have dysregulated protein homeostasis
subsequent to unbalanced protein synthesis and degradation – they have the same synthesis rate
as WT cells but half the rate of proteasomal degradation. Sequelae of this include the possibility
of protein accumulation in the cell (as seen in Figure 6.1), and the subsequent need to prevent
protein misfolding and aggregation using molecular chaperones. This is explored next.
6.2.4 Development of a method to measure cytosolic protein folding activ-
ity
In addition to regulating synthesis and degradation, protein homeostasis also includes regulation
of protein folding. To test the folding activity in cultured cells I developed a luciferase refolding
assay based on previous studies investigating chaperone activity [317]. Thermal denaturation
of firefly luciferase produces unfolded intermediates that are enzymatically inactive. In the
original assay, incubation with rabbit reticulocyte lysate-based buffer results in refolding through
ATP-dependent chaperones, and this is detected by the recovery of luciferase enzyme activity
[318, 319]. I wished to modify this assay to work with cytosolic extracts from primary fibroblasts,
thus measuring the folding activity of the cytosol.
I determined that partial denaturation by heating at 45°C for 35 minutes resulted in the
attenuation of luciferase activity, and this was the shortest incubation time required at this temper-
ature, beyond which little difference could be seen (Figure 6.5A). After incubating the denatured
luciferase alone at 37°C for 1 hour there was some degree of spontaneous refolding resulting in
increased luciferase activity (Figure 6.5B). However, incubation together with cytosolic extract
resulted in more efficient refolding, and this was abolished by boiling the cytosolic extract
prior to incubation (Figure 6.5B). This suggested that the refolding was dependent on an active
enzymatic process.

























































Figure 6.4 CKO cells do not have a different translation rate compared with WT. A) WT
and CKO cells were pulsed with 0.1 mCi/mL 35S-methionine to radiolabel newly synthesised
proteins. Phosphor screen autoradiographs, with Coomassie image below. B) Quantification
of A). Mean±SEM, Student’s t test with Welch correction. C) Representative Western blots
showing AHA incorporation by probing against biotin. Histone H3 was the loading control. The
two timepoints are referred to as experimental time 21 and 33 (T21 and T33), according to the
number of hours after the last medium change. D) Quantification of C). Mean±SEM, Student’s t
test with Welch correction.





































































































Figure 6.5 Development of a luciferase refolding assay. A) Optimisation showed that heating
for 35 minutes was optimal for thermal denaturation of luciferase. Recombinant luciferase was
mixed with cell lysate and heated at 45°C for 15-60 mins and bioluminescence was recorded.
Positive control (orange) was non-denatured luciferase with cell lysate. Negative control (blue)
was cell lysate alone. Mean±SD. B) Bioluminescence recordings were done before the incubation
for folding as well as afterwards. Thermally denatured luciferase was incubated with cell lysate,
boiled cell lysate, or buffer in the absence of cell lysate as a negative control. After folding, there
was some spontaneous refolding in the negative control, but much higher luciferase activity in
the samples with cell lysate. This was attenuated in samples with boiled cell lysate, suggesting
that the refolding is dependent on enzymatic activity. 2-way ANOVA with Dunnett’s multiple
comparisons test, comparing to control. C) Folding activity assays were performed with cell
lysates obtained from WT and CKO cells at two timepoints. “Folding activity” is the fold-change
of luciferase activity in the samples relative to the pre-assay control (see Chapter 2.12 for details).
Both genotypes showed time-of-day variation but the direction of change was opposite in CKO
(2-way ANOVA).
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By using the modified luciferase refolding assay, I found a time of day difference in folding
activity in the WT cells, and a disrupted pattern in CKO cells (Figure 6.5C). More specifically,
folding activity increased in WT cells by roughly 60% between the time points whilst folding
activity in CKO cells decreased by roughly 10%. Hence both the magnitude and direction of
change was different. It would be useful to conduct a time course experiment to test whether
there is in fact circadian regulation of folding activity in the cell. This would confirm whether
there is a rhythm in chaperone activity in WT and CKO cells, and whether this is disrupted in
CKO cells.
I sought to test whether there is a difference in abundance of chaperones in CKO cells relative
to WT. First I examined the quantitative proteomics dataset, focussing on the major HSP90 and
HSP70 isoforms as these are highly abundant molecular chaperones. I examined the constitutive
(Hsp90ab1) and inducible (Hsp90aa1) forms of HSP90 as well as the constitutive (Hspa8)
and inducible (Hspa1b) forms of HSP70. Constitutive forms are always expressed in the cell,
whilst inducible forms are primarily expressed in response to the presence of misfolded proteins.
Comparing the average expression across all time points, I found differences in expression level
in the constitutive isoform of HSP90 and both constitutive and inducible forms of HSP70 (Figure
6.6A). These differences were less than 10%, apart from the inducible form of HSP70, which
was 1.8 times more abundant in CKO cells relative to WT. This suggests that CKO cells have
a chronically increased expression of inducible HSP70, consistent with the presence of higher
concentrations of proteins that need to be folded.
I then attempted to quantify HSP expression by Western blot. I took samples at two time
points, 12 hours apart so that I could measure an average over time. I used primary antibodies
that recognised both inducible and constitutive forms of HSP90 and HSP70. This experiment
showed an increased expression of HSP90 in CKO cells relative to WT, and decreased expression
of HSP70 (Figure 6.6B, C). This does not align with the quantitative mass spectrometry data.
However, in future work it would be informative to use antibodies specific to inducible or
constitutive forms, and using a different loading control would be different, since there may have
been a time of day difference in tubulin abundance (Figure 6.6B). These technical factors may
explain the difference in result compared to the quantitative mass spectrometry.
6.2.5 CKO cells are more sensitive to stress
Since CKO cells have impaired protein folding and degradation as well as a higher basal protein
content, I hypothesised that they would be more sensitive to proteotoxic stress. The integrated
stress response is a cellular response to a diverse range of stimuli including ER stress and
amino acid deprivation [214]. The common event from all the stress-inducing stimuli is the
phosphorylation of eIF2α which leads to a shutdown of translation globally, whilst promoting
the synthesis of factors such as ATF4 to restore proteostasis [320].



































































Figure 6.6 Comparison of chaperone abundance in WT and CKO cells. A) Relative abun-
dance averaged over time of HSP90 and HSP70 isoforms, quantified in the proteomics exper-
iment presented in Chapter 4. Gene names are annotated, corresponding to inducible HSP90
(Hsp90aa1), constitutive HSP90 (Hsp90ab1), inducible HSP70 (Hspa1b) and constitutive HSP70
(Hspa8). Mean±SEM, multiple t tests. B) Western blots of whole cell lysates collected at 2 time
points, 12 hours apart (T=0h, T=12h). Antibodies used in this experiment against HSP90 and
HSP70 recognise both inducible and constitutive forms. Tubulin was the loading control. C)
Quantification of B), mean±SEM, multiple t tests with Holm-Sidak correction.
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I performed an experiment to measure the response to physiological stress inducers, using
different media as informed by the optimisation experiments described in Chapter 5. I found
that even changing into air medium with high glucose (5 g/L) resulted in increased expression of
phosphorylated eIF2α relative to WT (Figure 6.7A/B). This was not dependent on the length
of time in culture (Figure 6.7A/B). This was surprising since I did not expect the medium
change to be a stress-inducing perturbation, but it does suggest that CKO cells may have a
greater sensitivity. Under low glucose conditions, the CKO cells were also different to WT
(Figure 6.7C). Plotting the same data grouped by genotype, there was a small but significant
effect of glucose concentration on WT cells (Figure 6.7D), but not on CKO cells (Figure 6.7E).
Altogether, compared to WT, CKO cells expressed higher levels of phosphorylated eIF2α after a
medium change regardless of time in culture or glucose concentration. However, the level of
phosphorylated eIF2α after medium change decreased as a function of time in culture in both
genotypes, suggesting that confluence reduces sensitivity to medium change-induced stress.
To test the response to proteotoxic agents I treated cells with tunicamycin. Tunicamycin
inhibits GlcNAc phosphotransferase, which mediates the first step of protein glycosylation in the
ER, thus leading to the accumulation of misfolded proteins and induction of the unfolded protein
response (UPR) [321, 322]. I also included WT cells treated with KS15 – a drug designed to
inhibit both CRY1 and CRY2 [323, 324] to test for recapitulation of the CKO phenotype. CKO
cells had higher levels of phosphorylated eIF2α throughout the experiment (Figure 6.8A, B).
This suggests that they have an upregulated integrated stress response basally and in response
to tunicamycin. WT cells treated with KS15 did not have significantly higher phosphorylated
eIF2α levels relative to control, and in fact showed a trend for decreased phosphorylated eIF2α
levels (Figure 6.8A, B). This is likely because KS15 is not in fact an effective inhibitor of CRY
proteins, as I subsequently discovered – this is discussed later with reference to Figure 6.12,
where KS15 did not abolish rhythms, only shortening period by about 1 hour at the maximum
concentration permitted by its solubility. Other ways to recapitulate the CKO phenotype in WT
cells could be to use inhibitors of phosphatases of eIF2α . Such inhibitors include guanabenz
[325] and sephin1 [326], which have been touted as compounds that enhance survival of stressed
cells through prolongation of the ISR. Chronic treatment of WT cells with a low dose of these
compounds may increase eIF2α phosphorylation – this would be a useful tool to test the effect
this has on circadian rhythmicity. However, it would not reveal the mechanism for increased
phosphorylated eIF2α in CKO cells, and recent work has suggested that these compounds may
not in fact have any effect on the ISR [327].
6.2.6 Cryptochromes limit the rhythmic regulation of intrinsically disor-
dered proteins
Proteins that do not natively adopt a 3D structure are known as intrinsically disordered proteins
(IDPs) [200, 328]. IDPs may bind to different targets depending on protein concentration, and so
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Figure 6.7 CKO cells have a higher expression of phosphorylated eIF2α compared to WT.
A) Cells cultured for varying amounts of time (between 0 and 4 weeks) were changed into
medium containing high (5 g/L) or low (1 g/mL) glucose. 4 hours later they were lysed in RIPA
buffer. Representative Western blots shown, probing for phosphorylated eIF2α and tubulin
as loading control. B), C) Western blot quantifications are plotted here, grouped by glucose
concentration to show differences between genotypes. Mean±SEM, 2-way ANOVA. For high
glucose, p=0.0001 for genotype effect, for low glucose, p=0.004 for interaction. Asterisks
indicate statistically significant differences detected by Sidak’s multiple comparisons. D), E) The
same data is plotted but grouped as genotypes instead to demonstrate that there are no differences
between medium glucose concentration. For WT, p=0.03 for glucose effect, for CKO, p=0.37 for
glucose effect.
















































Figure 6.8 The loss of CRY results in increased phosphorylation of eIF2α in response to
tunicamycin. A) Cells treated with 500 nM tunicamycin (TUN) were lysed in RIPA buffer
at time points from 2-24 hours. WT cells were compared with WT cells treated with 50 µM
KS15 (CRY inhibitor) as well as CKO cells. A representative western blot is shown, with probes
against phosphorylated (above) and total (below) eIF2α . B) Quantification of the western blots
in A), including all replicates. Mean±SEM, n=4. 2-way ANOVA showed p<0.0001 for genotype
effect when comparing WT and CKO, p=0.03 for interaction between time and drug treatment
when comparing WT and WT with KS15, and p<0.0001 for genotype effect when comparing
CKO with WT with KS15.
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they are tightly regulated in the cell; defects in this lead to disease conditions including cancer and
neurodegeneration [329]. In addition, IDPs tend to form aggregates depending on concentration
and macromolecular crowding [330, 331]. Macromolecular crowding has a profound effect on
reaction rates [332], and so the circadian rhythms in cytosolic protein concentration observed in
Chapter 5 may have important functional consequences for IDP aggregation and cellular reaction
rates generally.
I hypothesised that if the cellular protein quality control mechanisms are impaired, then
levels of IDPs may be dysregulated. I tested this using the proteomics datasets presented in
Chapter 4 and sought to assess whether or not rhythmic proteins had higher levels of disorder
compared to the background (all proteins in the dataset including rhythmic and non-rhythmic).
I used the meta-predictor D2P2 [333], which draws from 9 independent algorithms to
inform predictions of disorder in the amino acid sequences of proteins. Dr Arun Prasad kindly
configured the database to allow my searches of several thousand proteins via the web application
programming interface, and he also wrote a Python script that enabled me to access the database.
I used this script to mine my datasets and create an output containing all the amino acids that are
predicted to be in disordered regions by at least 75% of databases. Hence I was able to record
the number of disordered amino acids for each protein and each phosphopeptide detected. Using
these numbers, I could use statistics to examine the distribution of disordered amino acids in
rhythmic proteins and phosphopeptides, comparing them to the background in each case.
In WT cells there was no statistically significant difference in the median number of disor-
dered amino acids among rhythmic proteins compared to background (Figure 6.9A) However,
there was a difference in CKO cells, with the median number in rhythmic proteins being lower
than in the background (Figure 6.9B). I created probability density plots to enable visual compar-
ison of disorder between rhythmic and background groups in a non-cumulative manner (Figure
6.9C,D). This allowed visualisation of any differences amongst specific ranges of disorder that
could be missed in a cumulative distribution function. Inspecting the probability density plots
more closely, both WT and CKO cells showed an enrichment in the rhythmic proteins with fewer
than 100 disordered amino acids (Figure 6.9C, D). This suggests that the abundance of proteins
with some disorder below a threshold of around 100 amino acids is more likely to be under
rhythmic control, and this is amplified in the absence of cryptochromes.
Phosphorylation is the most common post-translational modification in the cell [189, 190],
and most phosphorylation sites are within intrinsically disordered regions [334]. Due to its
double negative charge, phosphorylation is a key regulator of structure and function of IDPs
in the cell [335]. Since protein:ion ratio is under circadian control in the cell (Chapter 4), I
hypothesised that rhythmic phosphopeptides may be more likely to come from peptides with
higher disorder. From my phosphoproteomics dataset, there was no statistical difference in
WT cells in the median number disordered amino acids between rhythmic phosphopeptides
and background (Figure 6.9E). This was also the case in CKO cells (Figure 6.9F). However,
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examining the probability density plots in WT cells, rhythmic phosphopeptides were enriched
for parent proteins with more than 500 disordered amino acids (Figure 6.9G). In CKO cells the
enrichment was for parent proteins with more than 1000 disordered amino acids (Figure 6.9H).
Together, these findings suggest that rhythmic proteins may be enriched for those with up to
100 disordered amino acids, but rhythmic phosphopeptides may be enriched for those with larger
amounts of disorder. These differences were small, but seemed enhanced in CKO cells. Future
analyses taking into account protein abundance and specific composition of disordered regions
will be necessary to ascertain whether there is functional relevance. In particular, rhythms in
protein:ion ratio may affect molecular condensation of proteins, particularly if they have regions
of disorder.
6.2.7 CKO cells show a metabolic defect
Another consequence of dysregulated protein quality control in the absence of cryptochromes
may be abnormal cellular metabolism and so I hypothesised that CKO cells may have a different
metabolic profile to WT cells. To measure this I used the Seahorse assay [239, 240]. This is a
commercially available system where the experimenter seeds cells into a provided plate. Once the
cells have adhered, the medium is changed into one that lacks a pH buffer. A machine then uses a
probe to measure the extracellular pH changes over time to obtain extracellular acidification rate
(ECAR). This is a rough measure of glycolysis. Another probe is used to measure changes in
dissolved oxygen over time, thus obtaining oxygen consumption rate (OCR). This is a measure
of mitochondrial respiration. Experimental details are described in more depth in Chapter 2.16.
Using the Seahorse assay I found that CKO cells had a two-fold higher extracellular acidi-
fication rate (ECAR) than WT cells (Figure 6.10A), suggesting that they have a higher rate of
glycolysis. Oxygen consumption rate was also increased but to a lesser extent, so mitochondrial
respiration was less affected (Figure 6.10B). These observations were passage-dependent, since
there was no statistically significant difference when using cells of passage 20, only a trend
(Figure 6.10C, D). The passage-dependence suggests that CKO cells may be more sensitive to
cellular transformation compared to WT cells.
It has previously been found that CRY1−/−; CRY2−/− mouse embryonic fibroblasts (MEFs)
have reduced glycolytic gene expression and roughly 20% less lactate production [136]. The
experiment in this study was performed under different conditions to mine: MEFs were seeded 8
hours before lactate concentration in the medium was measured. It is plausible that the rate of
lactate production changes as a function of time spent in culture, and so the effect that I have
observed may only be seen after 24 hours in culture, once the cells have all attached and become
confluent.
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Figure 6.9 Disorder in the rhythmic proteome and phosphoproteome in WT and CKO
cells. A), B) Cumulative distribution function curves of amount of disorder in rhythmic and
background proteins in WT and CKO cells. There was no statistical difference in the median
number of disordered amino acids between rhythmic and background proteins in the WT, but
there was in CKO (2-sided Kolmogorov-Smirnov test, p=0.178 for WT [median = 50 for rhythmic,
60 for background], p<0.0001 for CKO [median = 42 for rhythmic, 58 for background]). C), D)
Probability density plots of disorder showing the distribution between rhythmic and background
proteins in both genotypes. In both genotypes there were proportionally more proteins in
the rhythmic set with less than 100 disordered amino acids (red arrows). E), F) Cumulative
distribution function curves of amount of disorder in rhythmic and background phosphopeptides
in WT and CKO cells. There was no statistical difference in the median number of disordered
amino acids between rhythmic and background phosphopeptides in WT or CKO (2- sided
Kolmogorov-Smirnov test, p=0.145 for WT [median = 242 for rhythmic, 205 for background],
p=0.166 for CKO [median = 215 for rhythmic, 202.5 for background]). G), H) Probability density
plots of disorder showing the distribution between rhythmic and background phosphopeptides in
both genotypes. In both genotypes there were proportionally more proteins in the rhythmic set
with more than 300 disordered amino acids (red arrows).
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Figure 6.10 CKO cells have a higher rate of glycolysis compared to WT cells. A) Seahorse
assays were performed with cells at passage 20 and at passage 30. Extracellular acidification
rate (ECAR) is plotted here, mean±SEM. 2-way ANOVA with Sidak’s multiple comparisons
test. N=3. B) Oxygen consumption rate (OCR) measured with Seahorse assays is plotted here,
mean±SEM. 2-way ANOVA with Sidak’s multiple comparisons test.
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Mouse ID CRY2 genotype Sex Age at death (weeks) Report findings
1 KO M 3
EMH, neutrophilic inflam-
mation in lungs
2 KO F 0.3
EMH, low liver glycogen,
bilateral hydronephrosis
3 KO F 8
EMH, bilateral hy-
dronephrosis
4 HET M 1
EMH, bilateral hy-
dronephrosis
5 HET F 0.6 EMH, low liver glycogen
6 KO F 20
EMH, severe lower uri-
nary tract inflammation
Table 6.1 Histopathology of CRY-deficient mice. 6 histopathological examinations were
carried out on mice that were moribund and culled as a result. All mice were CRY1−/− and the
CRY2 genotype is listed in the second column as homozygous knockout (KO) or heterozygous
(HET). Extra-medullary haematopoiesis (EMH) was found in all cases, and kidney pathology
was found in two-thirds.
6.2.8 CRY-deficient mice have physiological defects
Given the metabolic defect, I hypothesised that there may be a phenotype at the organism level.
By systematically weighing mice weekly, I found that both male and female CKO mice had a
smaller mass than wild-types after around 4 weeks, with the phenotype rescued by one copy
of CRY2 (Figure 6.11A, B). This agrees with the findings of the study mentioned above [311].
Despite this, CKO mice had a higher rate of food consumption (Figure 6.11C). This suggests
that there is inefficient use of energy in CKO mice, which may be related to the increased
glycolysis rate I observed at the cellular level. In line with a global cellular defect, I observed
a higher spontaneous death rate in adult CKO mice compared to WT controls (Figure 6.11D).
CRY1−/−; CRY2+/− mice were WT-like. Post-mortem and histopathology examinations were
carried out on 7 mice that underwent spontaneous death, and the most common finding was mild
extra-medullary haematopoiesis (EMH, a sign of systemic inflammation) (Table 6.1). This lends
support to the hypothesis of a generalised cellular defect. The cause of death was not confirmed
in the histopathology reports, but several of the mice likely died due to sepsis or electrolyte
disturbance secondary to kidney failure.
In the context of the other findings in this chapter, these results suggest that a general defect
in cellular protein homeostasis may result in chronically increased energy consumption, and a
consequence of this may be the systemic defects observable at the organism level, i.e. reduced
growth and systemic inflammation.
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Figure 6.11 CKO mice have health defects. A), B) Growth curves of male and female mice are
plotted with weekly weights recorded from mice with the following genotypes: WT, Cry1−/−;
Cry2+/− and Cry1−/−; Cry2−/−. Mean±SD. Extra sum-of-squares F test was used to test the
null hypothesis that one curve fits all sets. P values annotated as asterisks. C) Food consumption
measured over 1 week, normalised for mouse weight. Mean±SD, 2-way ANOVA. N=6 per sex
for WT, N=4 per sex for CKO. D) Spontaneous death rate among the 3 genotypes mentioned in
A), expressed as a percentage of the number of mice. The absolute numbers of deaths and total
population size are annotated on the bars. Only mice that had been weaned were included, and
unnatural causes of death (e.g. cage flooding) were excluded. Asterisk indicates significance
from Chi-squared test for trend, p=0.007. Comparing WT and CKO, Fisher’s exact test p=0.009.
Comparing WT and Het, Fisher’s exact test p=0.5.
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6.2.9 Pharmacological inhibition of rhythmicity in WT cells
To test the link between CRY and proteostasis further I sought to recapitulate my findings in WT
cells by pharmacologically inhibiting CRY1 and CRY2. To do this I treated cells with KS15, a
drug designed to inhibit both CRY1 and CRY2 [323, 324].
Measuring PER2::LUC bioluminescence, I found that there was no attenuation of rhythmicity
resembling CKO cells, only a small but significant, dose-dependent period shortening (Figure
6.12A, B). This matches findings previously reported using fibroblasts [323]. Hence it is unlikely
that KS15 completely inhibits CRY proteins even at the maximum concentration permitted by its
solubility. Alternatively, cellular uptake may be low, or the drug may be cleared very efficiently.
I hypothesised that disrupting protein homeostasis should abolish rhythms, since I showed the
reverse in Chapter 4, that manipulations that improved protein homeostasis seemed to correlate
with the restoration of rhythmicity in CKO cells. In this chapter I showed that CKO cells had
reduced proteasome activity, and so I predicted that mimicking this pharmacologically in WT
cells may result in a CKO-like phenotype with the PER2::LUC reporter. Proteasome inhibition
in WT cells with bortezomib and epoxomicin (within a narrow concentration range) reversibly
abolished rhythms (Figure 6.12C, D).
Together with the previous results in this chapter, this provides more evidence to support
the hypothesis that in the absence of cryptochromes, proteostasis is disrupted and this in turn
attenuates PER2::LUC rhythmicity. To test this in future work, pharmacologically treating WT
cells with a CRY activator such as KL001 would be useful – if the hypothesis is correct then
both proteostasis and PER2::LUC rhythmicity should be more robust than WT cells treated with
control.
6.2.10 Pharmacological inhibition of rhythmicity in WT animals
I sought to take this further and test whether it may be true on the whole organism level. The
circadian organisation of mouse behaviour is controlled by the suprachiasmatic nucleus (SCN) in
the hypothalamus. However at the cellular level, the same molecular machinery is responsible for
generating circadian rhythms in the SCN as the peripheral tissues. Since proteasome inhibition
reversibly abolished rhythms in cells, I hypothesised that the same may be true at the whole
organism level through effects on the SCN.
Ixazomib is an orally-available analogue of bortezomib [336–338]. As described in Chapter
2, I delivered ixazomib at 35 µg/mL in the drinking water, which was flavoured with blackcurrant
squash to mask the taste of the drug. Mouse activity was measured using two methods: a running
wheel and an infrared motion sensor.
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Figure 6.12 WT cells phenocopy CKO cells upon CRY inhibition or proteasome inhibition.
A) Detrended bioluminescence recordings of WT cells treated with 50 µM KS15 or DMSO con-
trol. Mean±SEM. B) KS15 treatment results in a dose dependent period shortening. Mean±SEM,
one-way ANOVA. C) Raw bioluminescence recordings of WT cells treated with 25 nM borte-
zomib and then washed after 5 days. Mean±SEM. D) Raw bioluminescence recordings of WT
cells treated with 234 nM epoxomicin and then washed after 5 days. Mean±SEM.
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In constant darkness (DD), mice retain their circadian organisation of behaviour – they are
more active during the expected dark phase of the cycle (Figure 6.13A, Appendix figure 3). In
CKO mice however, they show arrhythmic behaviour in DD despite being able to entrain to
LD cycles [230] (Appendix figure 3). I found that mice treated with ixazomib showed lower
amplitude rhythms in behaviour, i.e. they were more active during the expected light phase
and less active during the dark phase compared to controls (Figure 6.13B, C, D). This reduced
consolidation of behaviour to the dark phase is reminiscent of actograms of CKO mice [230]
(Appendix figure 3). The effect of ixazomib was reversible when the drug was ‘washed out’ by
changing the drinking water, and there was no effect on period length (Figure 6.13C, D). This is a
partial recapitulation of the effect of proteasome inhibition on the cellular level, and fits with the
prediction made. However, application of the drug to organotypic SCN slices would be useful to
understand the effect on behaviour in more detail, and drug availability to the SCN in an animal
must be tested. This is because competing hypotheses include the possibility that ixazomib
affects behaviour in a SCN-independent manner, or that circadian organisation of behaviour
depends on protein turnover in the SCN. In future, treating CKO mice with a proteasome activator
such as PD169316 would be useful as it would test the hypothesis that the reduced proteasome
activity ultimately leads to behavioural arrhythmicity.
6.3 Conclusions
6.3.1 Summary of findings
I found that CKO cells have impaired protein degradation and folding as well as disrupted
temporal regulation of intrinsically disordered protein abundance. I confirmed that a consequence
of this is an increased sensitivity to proteotoxic stress and dysregulated metabolic profile on the
cellular level, and reduced growth at the organism level. This could be partially recapitulated in
WT cells by pharmacologically targeting CRY proteins, and inducing proteotoxic stress resulted
in the reversible attenuation of PER2::LUC rhythmicity in vitro, and behavioural rhythmicity in
vivo.
I hypothesise that CRY proteins are needed to suppress oscillations in IDP abundance and
maintain protein homeostasis. Disordered proteins are inherently sensitive to proteasomal
degradation [302], and since CKO cells have a reduced proteasome activity they may need to
spend more energy on protein quality control in order to maintain proteostasis.
In future studies it will be important to find the precise mechanism behind these findings. As
described in section 6.2.2, the reduced proteasome activity in CKO cells relative to WT cannot
be fully explained by the small difference in proteasome abundance. Rather, it would be helpful

























































































































Figure 6.13 WT mice show decreased circadian organisation of activity when treated with
proteasome inhibitor ixazomib. A) Representative double-plotted actogram of a WT mouse
treated with DMSO control. For the first 7 days the mice were in 12h:12h light-dark cycles, and
had drinking water supplemented with blackcurrant squash. The mice then had their drinking
water changed to drug-containing blackcurrant squash (or DMSO control), and they were put into
constant darkness. After 7 days they were changed back to non-drug-containing blackcurrant
squash, but remained in constant darkness until the end of the experiment. B) Representative
double-plotted actogram of a WT mouse treated with 35 µg/mL ixazomib. C), D) Quantification
of amplitude of wheel-running activity cycles and infrared-measured total activity cycles during
treatment and during the post-drug treatment (‘wash’) period. Mean±SEM. E) Quantification of
period length of wheel-running activity cycles during treatment and wash periods. Mean±SEM.
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or indirect effect of CRY. Since CRY proteins are promiscuous transcriptional regulators [40]
as well as key components of an E3 ligase complex [296, 308], it is feasible that some of its
targets are involved in proteasome regulation. Some proteasome regulators were detected in
my proteomics and phosphoproteomics data, but experimental validation is needed, along with
pharmacological and genetic manipulations to delineate the mechanism.
6.3.2 Proteostasis and TTFL function
In Chapter 5 I described the observation of rhythmic post-translational regulation of PER2::LUC
activity, and the sensitivity to experimental conditions that affect protein:ion ratio. The findings
in this chapter suggest that CKO cells are less able to regulate protein:ion ratio, and this may
result in disrupted proteostasis. There are two possible mechanistic interpretations of this:
1. Loss of the TTFL leads to impaired protein homeostasis
2. Loss of CRY functions that are not related to the TTFL results in impaired protein
homeostasis
An experiment to distinguish the two possible mechanisms is to constitutively express
CRY1 and CRY2 at their average expression levels. If the first mechanism is correct, there
would be defects in proteostasis as described in this chapter. This would not be the case if the
second mechanism is correct, since the CRY proteins would be present, maintaining proteostasis
independently of the TTFL.
Another useful experiment would be to create an inducible knockout mouse – this would
test whether or not the health defects reported in this chapter are due to developmental effects.
Such an experiment has been carried out with BMAL1 knockout mice. It was reported in 2006
that BMAL1 knockout mice had a wide range of health problems, including reduced lifespan,
premature aging, cataracts and metabolic disorders [339]. At the time it was unclear whether or
not this was due to a defect in cellular timekeeping, or another unknown function of BMAL1. 10
years later a conditional knockout was made, and when BMAL1 was knocked out in adult mice,
the only health defects remaining were the ocular abnormalities and brain astrogliosis [340].
This indicated that many of the health defects reported in the past were due to problems during
development, rather than problems with the clock in adults. However, this does not exclude the
possibility that functional rhythms in gene expression are needed during specific developmental
windows. To test this, constitutive expression experiments as described above would be decisive.
Nevertheless, the fact that BMAL1 knockout mice show health defects lends some credence
to the hypothesis that it is the loss of a functioning TTFL that may lead to disrupted protein
homeostasis.
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Intriguingly, a recent study from the Cao laboratory has reported rhythmic phosphorylation of
eIF2α as well as rhythmic activity in GCN2, which is an eIF2α kinase [341]. The authors found
that ATF4 binds to a Per2 promoter (as well as several other clock genes), thus stimulating its
transcription. They then propose that there is a significant role of the ISR in circadian physiology,
and a possible link between dysregulated ISR and circadian dysfunction in neurodegenerative
diseases. I find these results less than convincing, since they were based on data from a timecourse
that was carried out over 24 hours only. In addition, samples were taken from mouse tissues
so we cannot be certain that any rhythms were cell-autonomous. Finally, they did not directly
measure GCN2 activity. Nevertheless, the study does raise the possibility of rhythmic regulation
of the ISR, and regulation of the TTFL by the ISR. This means that the TTFL itself may be a key
regulator of protein homeostasis through the rhythmic regulation of eIF2α phosphorylation. To
confirm the regulation of the ISR by the cell-autonomous clock it would be necessary to test for
rhythmic eIF2α phosphorylation in cell culture, using clock gene mutants including CKO cells
and BMAL1 knockout cells.

Chapter 7
Perspectives and future work
The goal of this thesis was to improve our understanding of how circadian rhythms are generated.
In this work, I characterised the circadian coordination of the proteome and the phosphoproteome
at the cell-autonomous level. To my knowledge, this is the second study of circadian proteomics
in cell culture, and compared to the first [137], I achieved deeper coverage and drew insights
from the parallel use of CRY1−/−; CRY2−/− (CKO) cells. Specifically, this work revealed
the reciprocal circadian regulation of cellular ion content and cytosolic protein concentration.
Surprisingly I found that in the absence of the canonical transcriptional-translational feedback
loop (TTFL) a larger proportion of the proteome was under rhythmic control. This provides
strong evidence for the post-translational oscillator (PTO) model of circadian rhythm generation
as described in Chapter 1, and suggests that the regulation of intracellular protein:ion ratio may
be a direct output of the PTO (Figure 7.1).
I went on to explore the elusive rhythms in the PER2::LUC reporter in CKO cells. The PTO
model would predict that rhythmic post-translational modification of clock proteins is a direct
output of the PTO, and should persist in the absence of the TTFL. I discovered that manipulations
of the proteostasis network modulated the robustness of the PER2::LUC rhythms. I hypothesised
that because of its disordered structure, the behaviour of PER2 in biomolecular condensates in
the cell may be a major source of experimental variation. Few instances of circadian rhythms in
absence of CRY have been reported in the past [286, 288, 287], and the experimental variation
may be the reason for this. Experiments altering the intracellular protein:ion ratio (for example
with media of varying osmolarity) and imaging the localisation and diffusion rate of PER2,
for example using the PER2::Venus fluorescent reporter [342], would be helpful in testing this
hypothesis.
Aside from the experimental variation, the observations of PER2::LUC rhythms in CKO
cells provide evidence for PTO activity. Since PER2 is a key component of the TTFL, PER2 may
act as a key temporal signalling node, transmitting timing information from the PTO to the TTFL
in order to coordinate gene expression and provide robustness to timekeeping. The discovery
























Figure 7.1 An expanded post-translational oscillator model. In light of the findings presented
in this thesis, I propose some modifications of the post-translational oscillator (PTO) model
shown in Figure 1.3 and Wong and O’Neill (2018) [6]. My phosphoproteomics work revealed
that phosphatase as well as kinase activity may be important in the cellular clockwork. The
antiphasic rhythms in intracellular ion content and cytosolic protein concentration are direct
outputs of the PTO since they are present in cells lacking a functioning TTFL. Cryptochromes
are required for protein homeostasis, and indeed the presence of the TTFL is associated with
fewer proteins and phosphosites being under rhythmic regulation in abundance. This is depicted
with a dashed line because more work is required to distinguish whether this is a direct output of
the TTFL, or an indirect output via non-timekeeping functions of cryptochrome proteins.
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of the strong effects of picrotoxin on PER2::LUC behaviour also suggests that PER2 is a key
signalling node. Moreover, the elucidation of its mechanism of action through the functional,
structural and mass-spectrometry approaches described in Chapter 3 will provide more insight
into how PER2 is regulated, and how it transmits timing information. It is possible that the PTO
signals to the TTFL in other ways in addition to PER2. For example, it has been shown that
period length may be modulated by a molecular switch that consists of a slow conformational
change in the intrinsically disordered C-terminal transactivation domain of BMAL1, and this is
regulated by molecular chaperones called cyclophilins [343]. This is critical for permitting the
binding of CRY1 to this region [344], resulting in the inhibition of CLOCK/BMAL1 complex
activity. This fascinating mechanism suggests that the regulation of BMAL1 protein structure
may also be a crucial signalling conduit between the PTO and the TTFL.
This has parallels with previous work in cyanobacteria. As described in Chapter 1, a purely
post-translational circadian oscillator in S. elongatus was elucidated by reconstitution in vitro,
using only 3 proteins (KaiA, KaiB and KaiC) with Mg.ATP [115], demonstrating the function of
a PTO circadian clock for the first time. More recent work has shown in silico and in vivo that
the PTO in cyanobacteria is elaborated by a TTFL that confers robustness to the timekeeping
[121]. Furthermore, it was shown that the histidine kinase SasA interacts with KaiC [345], and
subsequently phosphorylates a DNA-binding protein called RpaA [346]. KaiC also regulates
RpaA via a negative feedback loop involving a protein called LabA [347]. CikA is another
protein important in the cyanobacterial clock, originally discovered as an input pathway [348].
Subsequently it was found that these three major pathways (SasA, LabA and CikA) work in
concert to transmit timing information from the KaiA/B/C oscillator to modulate RpaA activity,
resulting in the circadian coordination of gene expression [349]. There is no amino acid sequence
similarity between any of these cyanobacterial proteins and the mammalian TTFL components,
but I hypothesise that this network motif may be conserved. If mammalian PTO components
are found, this hypothesis may be tested by genetically altering the interactions between PTO
components and putative signal transducers like PER2.
A key remaining question is: what are the components of the mammalian PTO? My pro-
teomics dataset provides a resource that may be used in the search for the minimal set of
components required to sustain a circadian oscillation in mammalian cells. As mentioned in
Chapter 4, investigation of the activity of kinases including CAMK2, and the activity of phos-
phatase regulators such as Ppp1 regulatory subunit 12A across the circadian cycle may reveal
characteristics or components of the PTO. After this, experiments involving the constitutive
activation of putative PTO components at their average activation level pharmacologically or
genetically would abolish all circadian rhythms in the cell if the PTO model is correct.
However, with the data that we have so far, I propose that CK1 is likely to be either a
component of the PTO itself, or a very important regulator. This is because CK1 inhibition
modulates period length in WT cells, CKO cells and red blood cells [100]. In addition, relatively
little is known about phosphatases and the relevant adaptors that confer specificity to regulate the
120 Perspectives and future work
cellular clock. However, kinases and phosphatases need to be balanced to ensure correct protein
functions, and also to regulate the biophysical properties of the cell, since most phosphorylation
modifications occur in IDRs [334], and this is a key regulator of structure and function of such
proteins [335]. Hence I would also like to propose a speculative model for period determination,
whereby kinases progressively phosphorylate IDPs, resulting in these proteins gradually coming
out of biomolecular condensates. This is a state of net phosphorylation in the cell. Eventually,
phosphatases and/or phosphatase adaptors (perhaps including Ppp1 regulatory subunit 12A), are
released, and so the balance in the cell gradually tips towards net de-phosphorylation, resulting in
re-formation of the biomolecular condensates, and the process starting again. This model would
be compatible with the findings about CK1 modulating period length, since it is an abundant
and promiscuous kinase in the cell. To explore this model in more depth in future work, it
would be valuable to perform proteomic and phosphoproteomic analyses of biomolecular con-
densates to analyse their components. This in turn could inform the experimenter of appropriate
stoichiometry of kinases and phosphatases, to enable an attempt at reconstituting this in vitro
using recombinant proteins in a similar manner to how the molecular clock of Synechococcus
elongatus was elucidated [115]. Such a demonstration would show the minimal components that
are necessary and sufficient to generate a circadian rhythm in mammals.
Constitutive expression of the CRY proteins, and of other clock proteins will also help to
distinguish between the convergent and divergent models of the evolutionary history of circadian
rhythm generation as described in Chapter 1. Constitutive activation of post-translational
mechanisms as described above would also help to distinguish between these models. As
described above, reconstitution of a PTO in vitro akin to the elucidation of the cyanobacterial
clock would be supportive of the divergence model, and my proteomics and phosphoproteomics
datasets may facilitate this line of experimentation. Moreover, according to the divergence model,
PTO components should be conserved amongst many species. Hence it would be valuable to
conduct proteomic and phosphoproteomics studies as well constitutive expression experiments
in many eukaryotic species to test this model.
Intriguingly, the overlap in rhythmic protein and phosphopeptide identities between genotypes
was very small (Figure 4.4). This suggests that in WT cells, the TTFL may be substantially
modulating the rhythmic output of the PTO. In addition, my proteomics dataset revealed that a
larger number of proteins were rhythmic in CKO cells compared to WT, and that they also had
a larger relative amplitude of protein/ion rhythms. These experiments suggest that the TTFL
suppresses the oscillations in many proteins (Figure 7.1). This is contrary to the traditional
view that the TTFL generates circadian oscillations, and suggests that there may be deleterious
consequences for high amplitude rhythms in cellular protein and ion content. I characterised
the defects in the proteostasis network of CKO cells, showing the physiological consequences
in vitro and in vivo. I found that CKO cells had a different set point of protein homeostasis
compared to wild-type cells, and this renders them more sensitive to proteotoxic stress-inducing
stimuli. Given this finding, it would be reasonable to suspect that CKO mice could be more
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prone to neurodegenerative diseases and cancer. Clock function is intricately linked to both
neurodegenerative diseases [350] and cancer [351], and so it would be worthwhile to investigate
if these diseases occur in CKO mice. This disrupted proteostasis could be related to the loss
of a functioning TTFL, or it could represent a TTFL-independent function of CRY proteins.
As described in Chapter 6, constitutive expression of both CRY1 and CRY2 would help to
distinguish these possibilities. In both cases, my work reveals that CRY proteins are major
components of the proteostasis network, particularly in the regulation of protein degradation by
the proteasome.
Finally, this thesis supports the PTO model for circadian rhythm generation in mammalian
cells, and more generally provides evidence for divergent evolution of circadian rhythms in
eukaryotes. I propose new roles of the TTFL (Figure 7.1): transmission of timing information
from the PTO to gene expression programmes, conferring robustness to cellular timekeeping,
and participating in the cellular protein homeostasis network.
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Appendix A







Table A.1 Proteomics data: Proteins rhythmic in both WT and CKO cells.
Uniprot ID Gene name WT pVal CKO pVal WT Relative Amplitude CKO Relative Amplitude
Q9CYZ6 2810428I15Rik 0.03827552 0.036692444 0.231094538 0.184061457
Q8K449 Abca9 0.01783095 0.016589697 0.292209383 0.194747797
Q61102 Abcb7 0.01142425 0.011836272 0.272633212 0.299357135
A5D6P3 Abcc1 0.0258595 0.000276886 0.14520119 0.142331345
Q3U645 Abcd3 0.02836791 0.000133547 0.19886745 0.30797014
Q9Z1Q2 Abhd16a 0.00065554 0.006312679 0.157743149 0.218023605
Q7M759 Abhd17b 0.0049913 0.033206837 0.104889556 0.191078386
E9QMV2 Abracl 0.03786309 0.027758531 0.199639222 0.221840428
D3Z041 Acsl1 0.03473324 0.016475332 0.119429467 0.121360338
Q3UC67 Acsl5 0.03166854 0.000136517 0.22951726 0.199756061
Q8JZQ2 Afg3l2 0.01925344 0.011836272 0.185449802 0.19232578
O08715 Akap1 0.00570066 0.001955667 0.223806675 0.162286104
P45377 Akr1b8 0.00707723 0.014049397 0.113865643 0.153439304
Q9CTE8 Alg5 0.02361011 0.001027592 0.184276193 0.239197396
Q8VDI9 Alg9 0.03832596 0.003954018 0.317497554 0.272509255
Q8BH79 Ano10 0.0301981 0.000142758 0.239919491 0.252754141
Q6P9J9 Ano6 0.00189258 0.030368323 0.206247743 0.119169996
Q9CZ52 Antxr1 0.00753382 0.033215354 0.188732022 0.183344301
Q78IK4 Apool 0.01470966 0.002307443 0.174247354 0.195331128
A2AL85 Asph;ASPH 0.01774832 0.001363455 0.169996211 0.235398893
Q6PA06 Atl2 0.02318151 0.000904116 0.203750758 0.222931844
Continued on next page
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Table A.1 – continued from previous page
Uniprot ID Gene name WT pVal CKO pVal WT Relative Amplitude CKO Relative Amplitude
Q91YH5 Atl3 0.0455385 0.00212129 0.188759136 0.188921678
Q9EPE9 Atp13a1;mKIAA1825 0.00392479 0.003383938 0.178155456 0.214400081
O55143 Atp2a2 0.01398533 0.00130592 0.195413576 0.269399072
G5E829 Atp2b1 0.04214819 8.19E-05 0.108781275 0.14783681
P56135 Atp5j2 0.03797319 0.001398173 0.310115125 0.311066534
Q9CPQ8 Atp5l 0.03981225 0.000143518 0.223006903 0.249718939
Q8CJ69 Bmper 0.03291128 0.009557936 0.192771106 0.104503969
E9PZJ6 Casc4 0.00367158 0.009806438 0.219475673 0.339525313
Q8K1A6 Cc2d1a 0.00030754 0.005868324 0.127980678 0.110707539
D3Z7R9 Ccpg1 0.0099826 0.038077524 0.274966193 0.547351231
Q920X8 CD14;Cd14 0.00451192 2.17E-05 0.121380856 0.153807103
A0A0R4J090 Cd1d1;Cd1d2 0.03166854 0.002644792 0.185002579 0.229854938
Q9DCG2 Cd302 0.01613317 0.006269802 0.214558408 0.150413982
P60766 Cdc42 0.00028677 0.000194561 0.146053973 0.165246088
Q8BSI9 Cdh2 0.00530323 0.008756278 0.13755918 0.101626685
Q14AX8 Cemip 0.00909988 0.003892676 0.243592472 0.224228077
Q8BMK4 Ckap4 0.00255649 0.000513796 0.184189269 0.224611882
B1AWE0 Clta 0.00012894 0.042097534 0.109536263 0.142478736
O88587-2 Comt 0.00268266 0.009816873 0.123239269 0.100955733
Q8BGD5 Cpt1c 0.03166854 0.003541078 0.180109872 0.247982647
A8C1T7 Creld1 0.041956 0.035878562 0.167478663 0.224005253
A0A0G2JEK2 Crip1 0.0354387 0.022848494 0.325521982 0.158790444
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Q9CQX2 Cyb5b 0.03036832 0.000128942 0.329136171 0.20398406
Q3UGB8 Derl1 0.03622183 0.030368323 0.195191889 0.207246485
Q61712 Dnajc1 0.02247904 0.002980432 0.189105353 0.252628022
Q8C7X2-2 Emc1 0.03416436 0.001297197 0.129301276 0.191425785
Q99KI3 Emc3 0.01941308 0.000655544 0.178882441 0.238250455
Q99K41 Emilin1 0.00123918 0.022966188 0.354379768 0.278845654
Q3TDP9 Emilin2 0.00366318 0.035754802 0.371862876 0.298775194
Q9D379 Ephx1 0.00184006 0.005851816 0.296346464 0.232107866
Q4FK22 Ergic1 0.02463624 0.019678126 0.260578793 0.338250757
Q3U7R1 Esyt1 0.00134193 0.002023083 0.134936812 0.163267266
Q3TZZ7 Esyt2 0.00699348 0.000942518 0.18256939 0.165750978
Q9D6U8 Fam162a 0.01251043 0.027836815 0.171055379 0.221043067
F8VPU2 Farp1 7.56E-05 2.85E-05 0.120722698 0.120961957
Q9DC36 Flot2 0.01880642 0.00700442 0.127885347 0.162222911
Q6P551 Fzd7 0.00012894 0.049392657 0.137926059 0.197417612
Q3U6L3 Glrx 0.02173786 0.000210635 0.104240547 0.112451414
G3X9L6 Gm10250;Atp5h 0.04261058 0.000944105 0.163637975 0.256711756
F7BGR7 Gm21992;Rbm4 0.00845342 0.0338516 0.101845659 0.174186404
P27601 Gna13 0.041956 0.00045555 0.12018219 0.118593032
Q9D8V0 Hm13 0.00190351 0.000436315 0.306511873 0.269153234
Q0VGQ1 Hsd17b12 0.01639096 0.000542238 0.240827286 0.266167464
E9PZ16 Hspg2 0.03532 0.02361011 0.16793524 0.136135804
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Q9DCE9 Igtp;Ifggd1 0.04209753 0.003892676 0.222711271 0.185629108
P43406 Itgav 0.00042773 0.006993482 0.136455546 0.146353824
Q6PE70 Itgb5 0.04415854 0.000633693 0.194129233 0.206784878
P70227 Itpr3 0.04495807 0.00058999 0.179588859 0.188099768
Q8C1D8 Iws1 0.0416378 0.016464467 0.142142825 0.245443031
Q9CX60 Lbh 0.041956 0.000920029 0.156398704 0.206706837
B0V2Q7 Lclat1 0.03402657 0.024997518 0.249192166 0.325062696
Q9Z2I0 Letm1 0.0072875 0.000938932 0.184647657 0.202918709
Q8C3X8 Lmf2 0.00684893 0.003310315 0.200085814 0.239100658
Q91V01 Lpcat3 0.04033662 0.005851816 0.219336669 0.223084202
Q8CG19 Ltbp1 0.01819977 0.005241449 0.363115575 0.290459208
Q3TCS3 Lyn 0.03284821 0.016464219 0.191542158 0.201136261
Q8BW75 Maob 0.02391164 0.02246245 0.344397887 0.323548452
Q9WVS7 Map2k5 0.04495807 0.04936 0.271120757 0.219281714
Q8CIC9 Mgat1 0.04129501 0.003310315 0.167536897 0.205464538
Q8VEK8 Mgp 0.03427274 0.026023623 0.244889104 0.191604527
Q3U026 Mogs 0.00195567 0.000914748 0.151695536 0.263309272
Q3TNL9 mt-Nd1;ND1;Mtnd1 0.01475859 0.016919691 0.198830038 0.23834468
Q791T5-2 Mtch1 0.04490404 0.030660766 0.183910219 0.183901421
Q80WJ7 Mtdh 0.03294338 0.000180172 0.182267613 0.194325566
Q69ZN7 Myof 0.00243292 0.000374716 0.125449714 0.134776501
D3YU17 Ncln 0.00493313 0.005571215 0.190404362 0.282748394
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I1E4X7 Nudt3 0.00264479 0.012805751 0.100891467 0.499287321
Q78XF5 Ostc 0.02602362 0.016919691 0.219313119 0.259618247
Q9DBN4 P33monox;4833439L19Rik 0.00477897 0.032943379 0.255992814 0.28933408
Q3TFP8 Pgrmc1 0.01131361 0.001888211 0.16238676 0.206833938
Q80UU9 Pgrmc2 0.01254481 0.00440628 0.2203438 0.192421818
A0A140LI54 Pnpla6 0.00249565 0.01366647 0.216132107 0.293411343
P37040 Por 0.0342497 0.000287037 0.179887705 0.199763553
Q3UYK2 Psen1 0.01812287 0.008751564 0.392265561 0.266748618
G3UXZ5 Psme1 0.04976531 0.01070303 0.129699666 0.106730756
O35074 Ptgis 0.0027019 0.001027592 0.20221821 0.205596294
P35831 Ptpn12 0.02674643 0.024636235 0.117657897 0.105027965
Q8BVI4 Qdpr 0.019127 2.25E-05 0.109646895 0.143136631
Q0PD34 Rab22a 0.044424 0.028594776 0.176528942 0.189229188
Q3TW01 Rab32 0.00453072 0.002556633 0.196456466 0.103909566
Q0PD50 Rab8a 0.01123123 0.005289286 0.122852626 0.185384733
P63321 Rala 2.90E-05 9.67E-05 0.13766813 0.161320311
Q8BHS3 Rbm22 0.00188821 0.029493439 0.104450752 0.147043261
Q3UDZ1 Rhog 0.04033662 0.013836182 0.121212721 0.192717169
Q9EPK2-3 Rp2 0.0217331 0.015993946 0.170209113 0.165858629
Q642K1 Rpl18 0.03131733 0.005365325 0.217663209 0.198929602
P62717 Rpl18a 0.00063369 0.017748324 0.189273436 0.356597343
Q9D823 Rpl37 0.01202064 0.014889348 0.406589945 0.386814263
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Q5RKP4 Rpn1 0.04026344 0.003931613 0.164095583 0.235535223
Q61833 Rpn2 0.00742829 0.004694659 0.200630101 0.238279008
P62071 Rras2 0.02549298 0.00130592 0.12391819 0.158421317
A2AVJ7 Rrbp1 0.00332753 2.48E-08 0.139166624 0.177469213
Q8R127 Sccpdh 0.00047126 0.000870614 0.114663159 0.273586568
Q3V1F2 Sdc1 0.00917376 0.031048975 0.208648188 0.284918516
O08547 Sec22b 0.00924962 0.001685058 0.189305903 0.223668974
Q8BU14 Sec62 0.00955794 0.000513796 0.255273515 0.323881271
Q8VHE0 Sec63 0.04129501 0.001448108 0.199134604 0.205326463
Q8BUH8 Senp7 0.0390597 0.021587192 0.671074401 0.13443294
Q543J5 Serpinc1 0.01372641 0.000848266 0.302731284 0.636318795
E9QM38 Slc12a2 0.04860164 0.001863418 0.132246852 0.173947295
Q99MR3 Slc12a9 0.02318151 0.007305522 0.136124566 0.163539783
Q80UP8 Slc20a2 0.03402657 0.000117451 0.284575987 0.311177029
Q8BH59 Slc25a12 0.01565867 0.004853271 0.125145218 0.166226373
Q8C140 Slc25a13 0.00332753 0.002980432 0.134287677 0.203716957
P48962 Slc25a4 0.00014627 0.000195304 0.195432698 0.240276025
Q545A2 Slc25a5 0.01358108 0.001485251 0.170236649 0.24843706
Q8C145 Slc39a6 0.038254 9.00E-06 0.2087089 0.241841835
Q3TN39 Slc3a2 0.00059508 2.17E-05 0.154051448 0.169593748
A0A0R4J2A1 Slc8a1 0.01702451 0.000389121 0.199804723 0.312537654
Q923B6 Spcs1 0.00223532 0.000699247 0.140620071 0.141026811
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P70452 Steap4 0.00415161 0.028418643 0.182083461 0.137304786
Q4VBD2 Stx4 0.00730552 0.000633693 0.389308843 0.347579554
Q9R099 Tapt1 0.02327732 0.002531526 0.129399037 0.176900622
Q3TR40 Tbl2 0.04785872 0.037463767 0.107867104 0.19868341
Q8C7F9 Thbs1 0.03138856 0.031939111 0.175487761 0.174598845
Q571B0 Tm9sf2 0.0116671 0.000617118 0.171449846 0.229967184
Q6PDC2 Tm9sf3 0.02391164 0.003438451 0.173753705 0.173414936
Q91W52 Tmed9 0.01886713 0.000888304 0.156787056 0.298176028
Q8CIV2 Tmem19 0.01583427 0.016328269 0.46368206 0.365944906
Q9DBS1 Tmem259 0.01086893 0.000852211 0.23423959 0.257068531
Q4VAE3 Tmem43 0.00502999 0.004614887 0.261737699 0.286118391
Q8VBT0 Tmem65 0.00489102 0.003490476 0.315701289 0.278888435
Q8BXZ1 Tmx1 0.01467195 0.001215581 0.143000366 0.225677095
Q80YX1 Tmx3 0.00012971 0.023664432 0.199574987 0.183750086
Q4FK50 Tnc 0.01599395 0.00753382 0.185803904 0.266138299
Q924Z5 Tpst1 0.00184006 8.19E-05 0.294960848 0.422069286
P70697 Tram2 0.019127 0.006402875 0.110150653 0.114660281
Q3UN04 Urod 0.00042127 0.000611841 0.267636594 0.412657926
Q3TX38 Usp30 0.04215855 0.011928667 0.165451328 0.274820128
Q6DID7 Vdac3 0.01197957 0.000193467 0.184929528 0.25405945
Q9CQW1 Wls 0.01114243 4.34E-06 0.148005624 0.136509328
O88967 Ykt6 0.02949344 0.000436315 0.20696017 0.227120429
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B2KGA7 Yme1l1 0.0390597 0.021737855 0.173790221 0.182846954
B9EHY2 Zbtb8os 0.00684893 0.011441537 0.213857271 0.321843964







Table A.2 Phosphoproteomics data: Phosphosites rhythmic in both WT and CKO cells. Phosphosites are presented as Uniprot ID, serine/threonine,
residue number and multiplicity. Multiplicity refers to the number of phosphates present on the phosphopeptide quantified.
Phosphosite Gene name WT pVal CKO pVal WT Relative Amplitude CKO Relative Amplitude
E9Q616_S1321___1 Ahnak 0.001840057 0.003527738 0.342095065 0.264229562
P31750_S124___3 Akt1 0.015310792 0.005197659 0.133596893 0.151000908
P31750_S126___3 Akt1 0.015310792 0.005197659 0.133596893 0.151000908
P31750_S129___3 Akt1 0.015310792 0.005197659 0.133596893 0.151000908
Q9CZ52_S360___1 Antxr1 0.014045017 0.046892 0.286925766 0.392478216
G5E829_T1165___2 Atp2b1 0.043500786 8.49E-05 0.506311307 0.476498649
G5E829_S1155___2 Atp2b1 0.007117576 8.49E-05 0.499151748 0.476498674
Q02248_S552___1 Ctnnb1 0.010868927 0.008941295 0.310087593 0.258773323
G3X9V2_S914___1 Ctnnd1 0.047546073 0.01583427 0.286225378 0.274867172
Q60598_S405___2 Cttn 0.032266344 0.000307539 0.208800291 0.270564365
Q61712_S478___2 Dnajc1 0.014235152 0.004308406 0.373325966 0.448192237
E9PWE8_S635___1 Dpysl3 0.002732952 0.028470303 0.253120255 0.149946464
A0A1D5RLL3_S719___1 Efr3a 0.001899092 0.025667153 0.339429693 0.318679092
Q01279_S1166___1 Egfr 0.001829495 0.005619759 0.466178069 0.466220973
Q544H0_T41___1 Eif3g 0.003541078 0.000852211 0.144176679 0.216321763
B2RUK2_S1324___1 Erbb2ip 0.005029992 0.021074095 0.220098365 0.235539894
B2RUK2_T485___1 Erbb2ip 0.000944105 0.013162667 0.403696017 0.421760031
Q3TZZ7_S685___2 Esyt2 0.005989559 0.015310792 0.416362987 0.425784397
F8VPU2_S427___1 Farp1 0.000263591 0.000218515 0.274286368 0.237291021
F8VPU2_T24___1 Farp1 0.000131795 0.000403018 0.438954615 0.36143499
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A0A0R4J0H8_S208___1 Fndc3b 0.003327533 0.002732952 0.281914414 0.372533302
P97825_S79___1 Hn1 0.029625408 0.01851 0.320070576 1.456407557
Q9CX86_S84___1 Hnrnpa0 0.029149989 0.003610838 0.737826576 1.132287522
E9PX30_S433___1 Map4k5 0.007055476 0.000942518 0.362204992 0.221373588
Q80WJ7_S423___1 Mtdh 0.013084578 8.07E-06 0.412481878 0.456231572
Q80WJ7_S565___1 Mtdh 0.01851 0.022966188 0.354631089 0.761299353
Q80WJ7_S454___1 Mtdh 0.032065782 0.000266997 0.327635086 0.456760294
Q9CWE0_S235___1 Mtfr1l 0.007404 0.00045136 0.161389785 0.188317954
Q7TPW1_S16___1 Nexn 0.007219078 0.049392657 0.209825202 0.135475508
Q9D6Z1_S513___1 Nop56 0.047546073 0.048895756 0.434005913 0.506653054
Q3B7Z2_S191___2 Osbp 0.046307288 0.005694061 0.224104429 0.258607353
Q6P9R2_S339___1 Oxsr1;mKIAA1101 0.001005353 0.034026565 0.259535753 0.215565222
Q9Z0P4_T145___1 Palm 0.001252466 0.005324053 0.165953005 0.336783929
Q3UFJ3_S295___2 Pdha1 0.001831592 0.001840057 0.346543764 0.317761089
Q5EBQ2_S52___1 Pebp1 0.03341363 0.000460014 0.171154698 0.219815154
Q3TFP8_S161___1 Pgrmc1 0.0206264 0.000632881 0.437193251 0.469835407
Q80UU9_T205___1 Pgrmc2 0.014297388 0.000977661 0.408008332 0.445038259
E9Q9J4_S38___1 Ppip5k2 0.018199765 0.04554134 0.387264941 0.244473112
Q9DBR7_S994___1 Ppp1r12a 0.004361526 3.55E-05 0.305413618 0.344303942
Q3UYK2_S329___1 Psen1 0.011667095 0.018672043 0.509009132 0.413908698
Q99P72_S105___1 Rtn4 0.019522002 0.000588803 0.339919284 0.288254596
Q6GQT6_S934___1 Scap 0.005674837 0.005197659 0.383233348 0.553775685
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Q80U72_S1566___2 Scrib 0.049172889 0.016589697 0.317585305 0.227805962
O08547_S137___1 Sec22b 0.014049397 0.000203112 0.468208475 0.49245273
Q8BU14_T375___1 Sec62 0.021484499 4.40E-05 0.519546812 0.625263303
Q9DBG7_S295___3 Srpr 0.0095635 0.015184162 0.33088762 0.418600989
Q9DBG7_S296___3 Srpr 0.0095635 0.015184162 0.33088762 0.418600989
Q9DBG7_S297___3 Srpr 0.0095635 0.015184162 0.33088762 0.418600989
E9PUK6_S655___2 Srrm1 0.028367909 0.003817673 0.26885876 0.748893731
E9PUK6_S591___2 Srrm1 0.042778588 8.80E-05 0.342849713 0.350138151
E9PUK6_T593___2 Srrm1 0.042778588 8.80E-05 0.342849713 0.350138151
Q8BTI8_S333___1 Srrm2 0.01451771 0.046918451 0.320928701 0.911132252
Q8BTI8_S1269___1 Srrm2 0.016891313 0.031362013 0.190452486 0.123221776
Q8BTI8_T1428___1 Srrm2 0.003538612 0.007908036 0.335808304 0.807266218
Q8BTI8_S1400___1 Srrm2 0.04319 0.023770516 0.478623024 0.542797374
Q3THA6_S233___1 Srsf7 0.001903508 0.032911278 0.459413393 0.304851094
P70452_S15___1 Stx4;Stx4a 0.017573688 0.037973186 0.243283594 0.317580548
A0A1B0GS91_S1098___1 Svil 0.008877204 0.005157676 0.495618012 0.361554252
H3BL37_S1339___1 Tcof1 0.009403222 0.000580969 0.352411299 0.34592718
B9EHJ3_S617___1 Tjp1 0.010174577 0.020319576 0.176495862 0.209668421
Q8VBT0_S245___1 Tmx1 0.000633693 0.00130592 0.597274629 0.48453256
A0A0N4SVC2_S96___3 Tra2a 0.014738132 0.018670004 0.312060411 0.908173313
A0A0N4SVC2_S98___3 Tra2a 0.014738132 0.018670004 0.312060411 0.908173313
A0A0N4SVC2_S94___3 Tra2a 0.014738132 0.018670004 0.312060411 0.908173313
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Q924Z5_S332___1 Tram2 0.001327694 1.71E-05 0.490573928 0.699568452
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Figure A.1 Circadian features of PER2::LUC rhythms in CKO cells. A) PER2::LUC
rhythms in CKO cells are temperature-compensated. Mean±SEM, n=4, 2-way ANOVA, p=0.8
for temperature effect. Q10 values are annotated. B) PER2::LUC rhythms in CKO cells can be
entrained by temperature cycles. C) Per2 mRNA abundance measured using qPCR. Mean±SEM.
Representative parallel PER2::LUC recordings are shown below, n=3. D) Per2:Luciferase
transcriptional reporter stably expressed in WT and CKO mouse embryonic fibroblasts. Repre-


















































































Figure A.2 Post-translational modification of PER2 in CKO cells. A) PER2::LUC recordings
as a reference, illustrating time points 1 and 2, occurring at the rising and falling of PER2::LUC
respectively. B) PER2::LUC half-life measured by fitting an exponential decay curve to the traces
in A) that have been treated with cycloheximide (CHX), n=4, t test. C) PER2::LUC recordings
of cells treated with 0.3 µM PF670462 (CK1 inhibitor) or DMSO control. Mean±SEM, n=4. D)
Quantification of period length from C). Mean±SEM, n=4, t-test.








































Figure A.3 Examples of WT and CKO mouse behavioural recordings. A) Single-plotted
actogram of a wild-type mouse, showing 14 days of recording over the transition between
12h:12h light:dark (LD) cycles and constant darkness (DD). During LD, most wheel running
occurs during the dark phase (entrainment). During DD, behaviour is temporally organised
in a circadian fashion, to occur at the predicted dark phase. B) Single-plotted actogram of a
CRY1−/−; CRY2−/− mouse under the same conditions. This demonstrates normal entrainment
to LD cycles, but arrhythmic behaviour in DD.
